
<html lang="en"     class="pb-page"  data-request-id="021fb2f4-b116-498c-9efd-c92917748a40"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm8003653;website:website:acspubs;issue:issue:10.1021/jmcmar.2008.51.issue-15;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 2-Chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a Potent Inducer of Apoptosis with High In Vivo Activity" /></meta><meta name="dc.Creator" content="Nilantha  Sirisoma" /></meta><meta name="dc.Creator" content="Shailaja  Kasibhatla" /></meta><meta name="dc.Creator" content="Azra  Pervin" /></meta><meta name="dc.Creator" content="Hong  Zhang" /></meta><meta name="dc.Creator" content="Songchun  Jiang" /></meta><meta name="dc.Creator" content="J. Adam  Willardsen" /></meta><meta name="dc.Creator" content="Mark B.  Anderson" /></meta><meta name="dc.Creator" content="Vijay  Baichwal" /></meta><meta name="dc.Creator" content="Gary G.  Mather" /></meta><meta name="dc.Creator" content="Kevin  Jessing" /></meta><meta name="dc.Creator" content="Raouf  Hussain" /></meta><meta name="dc.Creator" content="Khanh  Hoang" /></meta><meta name="dc.Creator" content="Christopher M.  Pleiman" /></meta><meta name="dc.Creator" content="Ben  Tseng" /></meta><meta name="dc.Creator" content="John  Drewe" /></meta><meta name="dc.Creator" content="Sui Xiong  Cai" /></meta><meta name="dc.Description" content="Using a live cell, high-throughput caspase-3 activator assay, we have identified a novel series of 4-anilinoquinazolines as inducers of apoptosis. In this report, we discuss the discovery of 2-chlo..." /></meta><meta name="Description" content="Using a live cell, high-throughput caspase-3 activator assay, we have identified a novel series of 4-anilinoquinazolines as inducers of apoptosis. In this report, we discuss the discovery of 2-chlo..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 24, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm8003653" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm8003653" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm8003653" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm8003653" /></link>
        
    
    

<title>Discovery of 2-Chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a Potent Inducer of Apoptosis with High In Vivo Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm8003653" /></meta><meta property="og:title" content="Discovery of 2-Chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a Potent Inducer of Apoptosis with High In Vivo Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0002.jpeg" /></meta><meta property="og:description" content=" Using a live cell, high-throughput caspase-3 activator assay, we have identified a novel series of 4-anilinoquinazolines as inducers of apoptosis. In this report, we discuss the discovery of 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine, compound 2b (EP128265, MPI-0441138) as a highly active inducer of apoptosis (EC50 for caspase activation of 2 nM) and as a potent inhibitor of cell proliferation (GI50 of 2 nM) in T47D cells. Compound 2b inhibited tubulin polymerization, was effective in cells overexpressing ABC transporter Pgp-1, and was efficacious in the MX-1 human breast and PC-3 prostate cancer mouse models. In contrast to the SAR of 4-anilinoquinazolines as EGFR kinase inhibitors, the methyl group on the nitrogen linker was essential for the apoptosis-inducing activity of 4-anilinoquinazolines and substitution in the 6- and 7-positions of the quinazoline core structure decreased potency." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm8003653"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm8003653">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm8003653&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm8003653&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm8003653&amp;href=/doi/10.1021/jm8003653" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 4771-4779</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm8003587" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm8003834" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 2-Chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (EP128265, MPI-0441138) as a Potent Inducer of Apoptosis with High In Vivo Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nilantha++Sirisoma">Nilantha Sirisoma</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shailaja++Kasibhatla">Shailaja Kasibhatla</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Azra++Pervin">Azra Pervin</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Zhang">Hong Zhang</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Songchun++Jiang">Songchun Jiang</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J.+Adam++Willardsen">J. Adam Willardsen</a></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+B.++Anderson">Mark B. Anderson</a></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vijay++Baichwal">Vijay Baichwal</a></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary+G.++Mather">Gary G. Mather</a></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Jessing">Kevin Jessing</a></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raouf++Hussain">Raouf Hussain</a></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Khanh++Hoang">Khanh Hoang</a></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+M.++Pleiman">Christopher M. Pleiman</a></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Tseng">Ben Tseng</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Drewe">John Drewe</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sui+Xiong++Cai">Sui Xiong Cai</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 858-202-4006. Fax: 858-202-4000. E-mail: <a href="/cdn-cgi/l/email-protection#5c2f3f3d351c392c353f392c28723f3331"><span class="__cf_email__" data-cfemail="7f0c1c1e163f1a0f161c1a0f0b511c1012">[emailÂ protected]</span></a></div><div class="corresp-fn" id="afn1">â EpiCept Corporation.</div><div class="corresp-fn" id="afn2">â¡Myriad Pharmaceuticals, Inc.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm8003653&amp;href=/doi/10.1021%2Fjm8003653" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 4771â4779</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 24, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 March 2008</li><li><span class="item_label"><b>Published</b> online</span>24 July 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 August 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm8003653" title="DOI URL">https://doi.org/10.1021/jm8003653</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4771%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNilantha%2BSirisoma%252C%2BShailaja%2BKasibhatla%252C%2BAzra%2BPervin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D15%26contentID%3Djm8003653%26title%3DDiscovery%2Bof%2B2-Chloro-N-%25284-methoxyphenyl%2529-N-methylquinazolin-4-amine%2B%2528EP128265%252C%2BMPI-0441138%2529%2Bas%2Ba%2BPotent%2BInducer%2Bof%2BApoptosis%2Bwith%2BHigh%2BIn%2BVivo%2BActivity%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4779%26publicationDate%3DAugust%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm8003653"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2119</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">45</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm8003653" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 2-Chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (EP128265, MPI-0441138) as a Potent Inducer of Apoptosis with High In Vivo Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nilantha&quot;,&quot;last_name&quot;:&quot;Sirisoma&quot;},{&quot;first_name&quot;:&quot;Shailaja&quot;,&quot;last_name&quot;:&quot;Kasibhatla&quot;},{&quot;first_name&quot;:&quot;Azra&quot;,&quot;last_name&quot;:&quot;Pervin&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Songchun&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Adam Willardsen&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;B. Anderson&quot;},{&quot;first_name&quot;:&quot;Vijay&quot;,&quot;last_name&quot;:&quot;Baichwal&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;G. Mather&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Jessing&quot;},{&quot;first_name&quot;:&quot;Raouf&quot;,&quot;last_name&quot;:&quot;Hussain&quot;},{&quot;first_name&quot;:&quot;Khanh&quot;,&quot;last_name&quot;:&quot;Hoang&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;M. Pleiman&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Tseng&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Drewe&quot;},{&quot;first_name&quot;:&quot;Sui&quot;,&quot;last_name&quot;:&quot;Xiong Cai&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;4771-4779&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm8003653&quot;},&quot;abstract&quot;:&quot;Using a live cell, high-throughput caspase-3 activator assay, we have identified a novel series of 4-anilinoquinazolines as inducers of apoptosis. In this report, we discuss the discovery of 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine, compound 2b (EP128265, MPI-0441138) as a highly active inducer of apoptosis (EC50 for caspase activation of 2 nM) and as a potent inhibitor of cell proliferation (GI50 of 2 nM) in T47D cells. Compound 2b inhibited tubulin polymerization, was effective in cells overexpressing ABC transporter Pgp-1, and was efficacious in the MX-1 human breast and PC-3 prostate cancer mouse models. In contrast to the SAR of 4-anilinoquinazolines as EGFR kinase inhibitors, the methyl group on the nitrogen linker was essential for the apoptosis-inducing activity of 4-anilinoquinazolines and substitution in the 6- and 7-positions of the quinazoline core structure decreased potency.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8003653&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8003653" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8003653&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8003653" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8003653&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8003653" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm8003653&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8003653&amp;href=/doi/10.1021/jm8003653" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm8003653" /></input><a href="/doi/pdf/10.1021/jm8003653" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (150 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm8003653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm8003653%26sid%3Dliteratum%253Aachs%26pmid%3D18651728%26genre%3Darticle%26aulast%3DSirisoma%26date%3D2008%26atitle%3DDiscovery%2Bof%2B2-Chloro-N-%25284-methoxyphenyl%2529-N-methylquinazolin-4-amine%2B%2528EP128265%252C%2BMPI-0441138%2529%2Bas%2Ba%2BPotent%2BInducer%2Bof%2BApoptosis%2Bwith%2BHigh%2BIn%2BVivo%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D15%26spage%3D4771%26epage%3D4779%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291264" title="Kinase inhibitors">Kinase inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Using a live cell, high-throughput caspase-3 activator assay, we have identified a novel series of 4-anilinoquinazolines as inducers of apoptosis. In this report, we discuss the discovery of 2-chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine, compound <b>2b</b> (EP128265, MPI-0441138) as a highly active inducer of apoptosis (EC<sub>50</sub> for caspase activation of 2 nM) and as a potent inhibitor of cell proliferation (GI<sub>50</sub> of 2 nM) in T47D cells. Compound <b>2b</b> inhibited tubulin polymerization, was effective in cells overexpressing ABC transporter Pgp-1, and was efficacious in the MX-1 human breast and PC-3 prostate cancer mouse models. In contrast to the SAR of 4-anilinoquinazolines as EGFR kinase inhibitors, the methyl group on the nitrogen linker was essential for the apoptosis-inducing activity of 4-anilinoquinazolines and substitution in the 6- and 7-positions of the quinazoline core structure decreased potency.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26722" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26722" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Apoptosis or programmed cell death is a process that organisms use to eliminate excessive cells and to control cell numbers.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Caspases, a family of cysteine proteases, plays a critical role for the initiation as well as execution of apoptosis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> It has been well documented that improperly regulated apoptosis can lead to many diseases. Excessive apoptosis could be the cause of debilitating damage from acute diseases such as stroke, heart attack, or liver failure, as well as from neurodegenerative diseases,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> with several caspase inhibitors currently in clinical trials for the treatment of liver injury.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Abnormal inhibition of apoptosis, such as overexpression of antiapoptotic Bcl-2 proteins, could result in unchecked cell proliferation as well as cause cancer treatment failure.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> In addition, many chemotherapeutics are known to induce apoptosis. Therefore, promoting apoptosis has been suggested as a promising strategy for cancer drug discovery.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Several novel approaches to promote apoptosis are currently being explored, including the discovery and development of Bcl-2 inhibitors,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> inhibitors of MDM2-p53 interaction,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> inhibitors of XIAP,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Smac mimetics<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and activators of procaspase-3.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p last">We have been interested in the discovery and development of apoptosis inducers as potential anticancer agents and have developed a cell-based anticancer screening apoptosis platform (ASAP<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: ASAP, anticancer screening apoptosis platform; SAR, structure activity relationship; TIP47, tail interacting protein; IGF II, insulin growth factor II; HTS, high-throughput screening; BBB, bloodâbrain barrier; AUC, concentrationâtime curves.</p></div> ) using novel fluorescent caspase-3 substrates.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> We have reported the discovery and structureâactivity relationship (SAR) studies of several novel series of apoptosis inducers as well as the identification of their molecular targets,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> including gambogic acid (<b>1a</b>) as a fast and potent apoptosis inducer<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and the transferrin receptor as its molecular target,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> 3-aryl-5-aryl-1,2,4-oxadiazoles (<b>1b</b>) as tumor selective apoptosis inducers<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and tail interacting protein (TIP47), an insulin growth factor II (IGF II) receptor binding protein as its molecular target,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> as well as 4-aryl-4<i>H</i>-chromenes (<b>1c</b>) as potent apoptosis inducers<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and vascular disrupting agents.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In this study, we report the discovery of <i>N</i><sup>4</sup>-(4-methoxyphenyl)-<i>N</i><sup>4</sup>-methyl-<i>N</i><sup>2</sup>-((<i>E</i>)-3,7-dimethylocta-2,6-dienyl)quinazoline-2,4-diamine (<b>2a</b>) as a novel apoptosis inducer utilizing our cell- and caspase-based apoptosis high-throughput screening (HTS) assay. SAR and target identification studies demonstrate that 2-chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2b</b>, EP128265, MPI-0441138, Chart 1) is an inhibitor of tubulin polymerization and a potent inducer of apoptosis with significant in vivo activity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01512" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01512" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p"><i>N</i><sup>4</sup>-(4-Methoxyphenyl)-<i>N</i><sup>4</sup>-methyl-<i>N</i><sup>2</sup>-(<i>E</i>)-3,7-dimethylocta-2,6-dienyl)quinazoline-2,4-diamine (<b>2a</b>) was obtained commercially and its structure was confirmed by <sup>1</sup>H NMR and MS. 2-Chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2b</b>) was prepared from reaction of 2,4-dichloroquinazoline (<b>3a</b>) with <i>N</i>-methyl-4-methoxyaniline (<b>4a</b>). Similarly, compounds <b>2d</b>, <b>2g</b>, and <b>2i</b>â<b>2k</b> were prepared from reaction of <b>3a</b> with the corresponding 4-substituted <i>N</i>-Me-aniline <b>4b</b>â<b>4f</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). <i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2c</b>), 2-chloro-6,7-dimethoxy-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2s</b>), 2,6-dichloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2t</b>), and 2,7-dichloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2u</b>) were prepared similarly via reaction of aniline <b>4a</b> with 4-chloroquinazoline (<b>3b</b>), 2,4-dichloro-6,7-dimethoxyquinazoline (<b>3c</b>), 2,4,6-trichloroquinazoline (<b>3d</b>), and 2,4,7-trichloroquinazoline (<b>3e</b>), respectively. Substituted 2,4-dichloroquinazolines <b>3d</b>â<b>3e</b> were prepared from the corresponding substituted anthranilic acids via reaction with potassium cyanate, followed by treatment of the substituted quinazoline-2,4-diones with phosphorus oxychloride.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> 4-(4-Methoxyphenoxy)quinazoline (<b>2v</b>) was prepared via reaction of <b>3b</b> with 4-methoxyphenol.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> 2-Chloro-<i>N</i>-(4-methoxybenzyl)-<i>N</i>-methylquinazolin-4-amine (<b>2w</b>) was prepared via reaction of <b>3a</b> with <i>N</i>-methyl-4-methoxybenzylamine. 2-Chloro-<i>N</i>-(4-hydroxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2h</b>) was prepared from demethylation of compound <b>2b</b> via treatment with BBr<sub>3</sub>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0006.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) 4-R-PhNMeH (<b>4a</b>â<b>f</b>), IPA, HCl.</p></p></figure><div class="NLM_p">2-Chloro-<i>N</i>-(4-methoxyphenyl)quinazolin-4-amine (<b>6a</b>) was prepared via reaction of <b>3a</b> with 4-methoxyaniline <b>5a</b>. Similarly, reaction of <b>3c</b> with <b>5a</b> produced 2-chloro-6,7-dimethoxy-<i>N</i>-(4-methoxyphenyl)quinazolin-4-amine (<b>6b</b>). Reaction of <b>6a</b> with ethyl iodide in the presence of sodium hydride produced 2-chloro-<i>N</i>-ethyl-<i>N</i>-(4-methoxyphenyl)quinazolin-4-amine (<b>2r</b>) (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Similarly, reaction of <b>3a</b> with substituted aniline <b>5b</b>â<b>5h</b> and 6-methoxypyridin-3-amine (<b>5i</b>) produced compounds <b>6c</b>â<b>6j</b>. Reaction of <b>6c</b>â<b>6j</b> with methyl iodide in the presence of sodium hydride produced compounds <b>2e</b>â<b>2f</b> and <b>2l</b>â<b>2q</b>.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0005.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) ArNH<sub>2</sub> (<b>5a</b>â<b>i</b>), NaAc, THF/H<sub>2</sub>O; (b)MeI or EtI, NaH, DMF.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> HTS and SAR Studies</h3><div class="NLM_p">Compound <b>2a</b> was identified as an inducer of apoptosis from our cell- and caspase-based HTS assay<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and found to have good activity in T47D cells with an EC<sub>50</sub> value of 290 nM. The HTS assay also was used for SAR study of analogues of <b>2a</b> as described previously.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Compound <b>2a</b> has a large hydrophobic group at the 2-position of the quinazoline, with a ClogP value of 6.58, which was considered undesirable for a potential drug. We initiated the exploration of the SAR of <b>2a</b> via replacing the large hydrophobic group at the 2-position with smaller functional groups. Compounds <b>2b</b> and <b>2c</b>, with a Cl or H group at the 2-position, were found to be much more active than <b>2a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>2b</b> was found to have an EC<sub>50</sub> value of 2 nM in our caspase activation assay in T47D cells, which was about 3-fold and >100-fold more potent than <b>2c</b> and <b>2a</b>, respectively, suggesting that a small group at the 2-position was preferred for apoptosis inducing activity. In addition, compound <b>2b</b> and <b>2c</b> have ClogP values of 4.51 and 3.67, respectively, which are 2â3 units less than that of <b>2a</b> and are expected to have improved aqueous solubility.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of 4-Arylaminoquinazolines in the Caspase Activation Assay</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0004.gif" alt="" id="gr4" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col width="" align="left" /></col><col width="" align="left" /></col><col width="" align="left" /></col><col width="" align="left" /></col><col width="" align="left" /></col><col width="" align="left" /></col></colgroup><thead><tr valign="top"><th align="left" valign="top">Â </th><th align="left" valign="top">Â </th><th align="left" valign="top">Â </th><th align="left" valign="top">Â </th><th align="left" valign="top">Â </th><th colspan="2" align="center" valign="top">EC<sub>50</sub> (Î¼M) <sup><i>b</i></sup></th></tr><tr valign="top"><th align="left" valign="top">entry</th><th align="left" valign="top">R<sub>1</sub></th><th align="left" valign="top">R<sub>2</sub></th><th align="left" valign="top">R<sub>3</sub></th><th align="left" valign="top">R<sub>4</sub></th><th align="left" valign="top">T47D</th><th align="left" valign="top">HCT-116</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>2a</b></td><td align="left" valign="top">NHR<sup><i>a</i></sup></td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">OMe</td><td align="left" valign="top">0.29âÂ±â0.020</td><td align="left" valign="top">0.46âÂ±â0.098</td></tr><tr valign="top"><td align="left" valign="top"><b>2b</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">OMe</td><td align="left" valign="top">0.002âÂ±â0.0001</td><td align="left" valign="top">0.002âÂ±â0.0001</td></tr><tr valign="top"><td align="left" valign="top"><b>2c</b></td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">OMe</td><td align="left" valign="top">0.006âÂ±â0.0002</td><td align="left" valign="top">0.008 Â±â0.0001</td></tr><tr valign="top"><td align="left" valign="top"><b>2d</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">0.21âÂ±â0.007</td><td align="left" valign="top">0.30âÂ±â0.010</td></tr><tr valign="top"><td align="left" valign="top"><b>2e</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">OEt</td><td align="left" valign="top">0.005âÂ± 0.0002</td><td align="left" valign="top">0.005âÂ±â0.0003</td></tr><tr valign="top"><td align="left" valign="top"><b>2f</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">OPh</td><td align="left" valign="top">>10</td><td align="left" valign="top">>10</td></tr><tr valign="top"><td align="left" valign="top"><b>2g</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">Me</td><td align="left" valign="top">0.015âÂ±â0.001</td><td align="left" valign="top">0.021âÂ±â0.004</td></tr><tr valign="top"><td align="left" valign="top"><b>2h</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">OH</td><td align="left" valign="top">0.085âÂ±â0.003</td><td align="left" valign="top">0.12âÂ±â0.003</td></tr><tr valign="top"><td align="left" valign="top"><b>2i</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">OCF<sub>3</sub></td><td align="left" valign="top">0.049âÂ±â0.001</td><td align="left" valign="top">0.059âÂ± 0.003</td></tr><tr valign="top"><td align="left" valign="top"><b>2j</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">Cl</td><td align="left" valign="top">0.068âÂ±â0.002</td><td align="left" valign="top">0.072âÂ±â0.004</td></tr><tr valign="top"><td align="left" valign="top"><b>2k</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">NO<sub>2</sub></td><td align="left" valign="top">0.77âÂ± 0.07</td><td align="left" valign="top">1.4âÂ±â0.05</td></tr><tr valign="top"><td align="left" valign="top"><b>2l</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">OMe</td><td align="left" valign="top">H</td><td align="left" valign="top">0.025âÂ±â0.002</td><td align="left" valign="top">0.031âÂ±â0.002</td></tr><tr valign="top"><td align="left" valign="top"><b>2m</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">OMe</td><td align="left" valign="top">H</td><td align="left" valign="top">H</td><td align="left" valign="top">4.44âÂ±â0.071</td><td align="left" valign="top">>10</td></tr><tr valign="top"><td align="left" valign="top"><b>2n</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td align="left" valign="top">OMe</td><td align="left" valign="top">OMe</td><td align="left" valign="top">0.009âÂ± 0.0001</td><td align="left" valign="top">0.015âÂ±â0.0001</td></tr><tr valign="top"><td align="left" valign="top"><b>2o</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">H</td><td colspan="2" align="center" valign="top">OCH<sub>2</sub>O</td><td align="left" valign="top">0.031âÂ± 0.002</td><td align="left" valign="top">0.065âÂ±â0.005</td></tr><tr valign="top"><td align="left" valign="top"><b>2p</b></td><td align="left" valign="top">Cl</td><td align="left" valign="top">OMe</td><td align="left" valign="top">OMe</td><td align="left" valign="top">H</td><td align="left" valign="top">0.68âÂ±â0.017</td><td align="left" valign="top">1.11 Â±â0.055</td></tr></tbody></table><table class="table frame_topbot"><colgroup><col width="12.5%" align="left" /></col><col width="12.5%" align="left" /></col><col width="12.5%" align="left" /></col><col width="12.5%" align="left" /></col><col width="12.5%" align="left" /></col><col width="12.5%" align="left" /></col><col width="12.5%" align="left" /></col><col width="12.5%" align="left" /></col></colgroup><thead><tr valign="top"><th colspan="8" align="center" valign="top"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0003.gif" alt="" id="_i6" /></img></th></tr><tr valign="top"><th align="left" valign="top">Â </th><th align="left" valign="top">Â </th><th align="left" valign="top">Â </th><th align="left" valign="top">Â </th><th align="left" valign="top">Â </th><th align="left" valign="top">Â </th><th colspan="2" align="center" valign="top">EC<sub>50</sub> (Î¼M) <sup><i>b</i></sup></th></tr><tr valign="top"><th align="left" valign="top">entry</th><th align="left" valign="top">R<sub>6</sub></th><th align="left" valign="top">R<sub>7</sub></th><th align="left" valign="top">R</th><th align="left" valign="top">Q</th><th align="left" valign="top">A</th><th align="left" valign="top">T47D</th><th align="left" valign="top">HCT-116</th></tr></thead><tbody><tr valign="top"><td align="left"><b>2q</b></td><td align="left">H</td><td align="left">H</td><td align="left">Cl</td><td align="left">NMe</td><td align="left">N</td><td align="left">0.017âÂ±â0.004</td><td align="left">0.029âÂ±â0.007</td></tr><tr valign="top"><td align="left"><b>2r</b></td><td align="left">H</td><td align="left">H</td><td align="left">Cl</td><td align="left">NEt</td><td align="left">C</td><td align="left">0.039 Â±â0.005</td><td align="left">0.049âÂ±â0.004</td></tr><tr valign="top"><td align="left"><b>2s</b></td><td align="left">OMe</td><td align="left">OMe</td><td align="left">Cl</td><td align="left">NMe</td><td align="left">C</td><td align="left">0.59âÂ±â0.030</td><td align="left">0.97âÂ±â0.14</td></tr><tr valign="top"><td align="left"><b>2t</b></td><td align="left">Cl</td><td align="left">H</td><td align="left">Cl</td><td align="left">NMe</td><td align="left">C</td><td align="left">0.010âÂ±â0.003</td><td align="left">0.013âÂ±â0.002</td></tr><tr valign="top"><td align="left"><b>2u</b></td><td align="left">H</td><td align="left">Cl</td><td align="left">Cl</td><td align="left">NMe</td><td align="left">C</td><td align="left">0.30 Â±â0.011</td><td align="left">0.35âÂ±â0.028</td></tr><tr valign="top"><td align="left"><b>2v</b></td><td align="left">H</td><td align="left">H</td><td align="left">H</td><td align="left">O</td><td align="left">C</td><td align="left">>10	â</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>2w</b></td><td align="left">H</td><td align="left">H</td><td align="left">Cl</td><td align="left">NMeCH<sub>2</sub></td><td align="left">C</td><td align="left">0.068âÂ±â0.004</td><td align="left">0.12âÂ±â0.006</td></tr><tr valign="top"><td align="left"><b>6a</b></td><td align="left">H</td><td align="left">H</td><td align="left">Cl</td><td align="left">NH</td><td align="left">C</td><td align="left">>10</td><td align="left">>10</td></tr><tr valign="top"><td align="left"><b>6b</b></td><td align="left">OMe</td><td align="left">OMe</td><td align="left">Cl</td><td align="left">NH</td><td align="left">C</td><td align="left">>10</td><td align="left">>10</td></tr><tr valign="top"><td align="left">colchicine</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">NA</td><td align="left">0.009âÂ±â0.001</td><td align="left">0.015âÂ±â0.004</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0007.gif" alt="" id="ig1" /></img></p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Data are the mean of three or more experiments and are reported as mean <b>Â±</b> standard error of the mean (SEM).</p></div></div></div><div class="NLM_p">By maintaining the Cl group at the 2-position of quinazoline, we explored the SAR of substitution in the anilino ring. Compound <b>2d</b> was observed to be 100-fold less active than <b>2b</b>, indicating that the 4-OMe group was important for the apoptosis inducing activity of <b>2b</b>. The 4-OEt analogue <b>2e</b> and 4-Me analogue <b>2g</b> were >2-fold and >7-fold less active than <b>2b</b>, and the OPh analogue <b>2f</b> was not observed to be active in vitro up to 10000 nM, indicating that there was a size limited pocket at the 4-position of the anilino ring. The 4-OH analogue <b>2h</b> was >40-fold less active than <b>2b</b>, indicating that a hydrophilic group at the 4-position was less preferred than hydrophobic group. The 4-OCF<sub>3</sub> analogue <b>2i</b>, 4-Cl analogue <b>2j</b>, and 4-NO<sub>2</sub> analogue <b>2k</b> were >20-, > 30-, and >350-fold less active than <b>2b</b>, respectively, suggesting that electron withdrawing groups are not preferred. The pyridyl analogue <b>2q</b> was less active than <b>2b</b> but still was highly active in vitro with an EC<sub>50</sub> value of 17 nM, indicating that a pyridyl group could be used to replace the phenyl group. Compound <b>2p</b> has a ClogP value of 3.84, which is almost one unit less than that of <b>2b</b> and might increase its aqueous solubility.</div><div class="NLM_p">Compound <b>2l</b>, with an OMe group at the 3-position, was observed to be >10-fold less active than <b>2b</b>, indicating that the position of the 4-OMe group was important for in vitro activity. Compound <b>2m</b>, with the OMe group moved to the 2-position, was >2000-fold less active than <b>2b</b>, and even >20-fold less active than the nonsubstituted analogue <b>2d</b>, indicating that a 2-OMe group contributes negatively to activity. The 3,4-dimethoxy analogue <b>2n</b> was a potent compound and was only 4-fold less active than <b>2b</b>. The 3,4-methylenedioxy analogue <b>2o</b> was 3-fold less potent than <b>2n</b>. The 2,3-dimethoxy analogue <b>2p</b> was >20-fold less active than the 3-methoxy analogue <b>2l</b>, confirming that the 2-methoxy group contributed negatively to activity, probably due to some unfavorable interaction with its target.</div><div class="NLM_p">The SAR of the linker nitrogen was also explored. Compound <b>6a</b>, with no substitution at the linker nitrogen, was not active in our caspase activation assay up to 10000 nM and >5000-fold less active than <b>2b</b>, indicating that the methyl group is essential for the apoptosis inducing activity. Similarly, compound <b>6b</b> was not observed to be active in vitro up to 10000 nM. The <i>N-</i>ethyl analogue <b>2r</b> was about 20-fold less active than <b>2b</b>, suggesting a size limited pocket in that position. In addition, compound <b>2v</b>, with the <i>N-</i>Me linker in <b>2c</b> replaced by an O linker, was not active up to 10000 nM and >1000 fold less active than <b>2c</b>, confirming the importance of a small alkyl group in the linker for apoptosis inducing activity. The benzyl analogue <b>2w</b> was >30-fold less active than <b>2b</b>, indicating that a more rigid NMe linker was preferred over the flexible NMeCH<sub>2</sub> linker. The critical role of a small alkyl group at the linker nitrogen for the apoptosis inducing activity of <b>2b</b> and related 4-anilinoquinazolines could be due to the alkyl group causing a change in the conformation of the molecules or the alkyl group contributing an important hydrophobic interaction with its molecular target, or a combination of both.</div><div class="NLM_p">We also explored the SAR of compounds with substitutions at the 6- and 7-positions of the quinazoline. The 6,7-dimethoxy analogue <b>2s</b> was about 300-fold less active than <b>2b</b>, indicating that substitutions at the 6,7-position of quinazoline are not preferred. Interestingly, the 6-chloro analogue <b>2t</b> was only 5-fold less active than <b>2b</b>, while the 7-Cl analogue <b>2u</b> was >100-fold less active than <b>2b</b>, suggesting that substitution at the 6-position was more tolerated than the 7-position.</div><div class="NLM_p">The activities of compounds tested toward the human nonsmall cell lung cancer cell line HCT-116 were roughly parallel to their activity toward T47D cells. Compound <b>2b</b> was also highly active in HCT-116 cells with an EC<sub>50</sub> value of 2 nM. Compounds <b>2f</b>, <b>2v</b>, <b>6a</b>, and <b>6b</b> were not observed to be active in T47D or in HCT-116 cells.</div><div class="NLM_p">Selected compounds were also tested by the traditional growth inhibition assay to confirm that the active compounds can inhibit cancer cell growth. The growth inhibition assays in T47D and HCT-116 cells were run in a 96-well microtiter plate as described previously.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In brief, T47D and HCT-116 cells were exposed continuously to test compound for 48 h at 37 Â°C. CellTiter-Glo reagent (Promega) was added, the samples were mixed by agitation, incubated at room temperature for 10â15 min, and then read using a luminescent plate reader (model Spectrafluor Plus Tecan Instrument). The GI<sub>50</sub> was defined as 50% inhibition of cell proliferation. GI<sub>50</sub> values, in comparison with their EC<sub>50</sub> values, are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of Caspase Activation Activity and Inhibition of Cell Proliferation Activity of 4-arylaminoquinazolines</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">Â </th><th colspan="2" align="char" valign="middle" char="Â±">T47D</th><th colspan="2" align="char" valign="middle" char="Â±">HCT116</th></tr><tr valign="top"><th align="center" valign="middle">Â </th><th align="center" valign="middle" char="Â±">EC<sub>50</sub><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a> (Î¼M)</th><th align="center" valign="middle" char="Â±">GI<sub>50</sub><a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a>(Î¼M)</th><th align="center" valign="middle" char="Â±">EC<sub>50</sub><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a> (Î¼M)</th><th align="center" valign="middle" char="Â±">GI<sub>50</sub><a class="ref internalNav" href="#tbl2-fn2" aria-label="b">b</a>(Î¼M)</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top"><b>2a</b></td><td align="char" valign="top" char="Â±">0.29âÂ±â0.020</td><td align="char" valign="top" char="Â±">0.85âÂ±â0.16</td><td align="char" valign="top" char="Â±">0.46âÂ±â0.098</td><td align="char" valign="top" char="Â±">0.35âÂ±â0.049</td></tr><tr valign="top"><td align="left" valign="top"><b>2b</b></td><td align="char" valign="top" char="Â±">0.002âÂ±â0.0001</td><td align="char" valign="top" char="Â±">0.001âÂ±â0.0005</td><td align="char" valign="top" char="Â±">0.002âÂ±â0.0001</td><td align="char" valign="top" char="Â±">0.002âÂ±â0.0001</td></tr><tr valign="top"><td align="left" valign="top"><b>2q</b></td><td align="char" valign="top" char="Â±">0.017âÂ±â0.004</td><td align="char" valign="top" char="Â±">0.037âÂ±â0.002</td><td align="char" valign="top" char="Â±">0.029âÂ±â0.007</td><td align="char" valign="top" char="Â±">0.040âÂ±â0.002</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Data are the mean of three or more experiments and are reported as mean <b>Â±</b> standard error of the mean (SEM).</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Data are the mean of three experiments and are reported as mean Â± standard error of the mean (SEM).</p></div></div></div><div class="NLM_p">Compound <b>2b</b> was found to be the most potent inhibitor of cancer cell growth among the compounds tested, with GI<sub>50</sub> of 1â2 nM in T47D and HCT-116 cells. The compounds that are more active in the apoptosis induction assay, as measured by caspase activation, also are more potent in the growth inhibition assay, indicating a good correlation between our cell-based apoptosis induction assay and the traditional cell growth inhibition assay. Additionally, P388 mouse leukemia cells that overexpress the ABC transporter Pgp-1 (P388-ADR)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> were tested for resistance to compound <b>2b</b> in comparison with the tubulin interacting agents vinblastine and docetaxel. Compound <b>2b</b> displayed similar growth inhibition in P388 and P388-ADR cell lines with IC<sub>50</sub> values of 2.1 and 2.2 nM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Vinblastine was less active in the P388-ADR cell line, with a shift in IC<sub>50</sub> values from 0.6 to 27 nM. Docetaxel was also less active in the Pgp-1 overexpressing cell line, shifting its IC<sub>50</sub> values from 2 to 277 nM. These results show that different from that of vinblastine and docetaxel, the activity of compound <b>2b</b> is not affected by overexpression of Pgp-1, suggesting that <b>2b</b> might not be a substrate for Pgp-1.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cytotoxicity of Compound <b>2b</b> in Non-drug-resistant P388 Cells and in Cells Overexpressing the ABC Transporter Pgp-1 (P388-ADR)</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">Â </th><th colspan="3" align="center" valign="middle" char="Â±">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></th></tr><tr valign="top"><th align="center" valign="middle">cell line</th><th align="center" valign="middle" char="Â±"><b>2b</b></th><th align="center" valign="middle" char="Â±">vinblastine</th><th align="center" valign="middle" char="Â±">docetaxel</th></tr></thead><tbody><tr valign="top"><td align="left" valign="top">P388</td><td align="char" valign="top" char="Â±">2.1âÂ±â0.2</td><td align="char" valign="top" char="Â±">0.6âÂ±â0.2</td><td align="char" valign="top" char="Â±">2âÂ±â0.7</td></tr><tr valign="top"><td align="left" valign="top">P388/ADR (MDR-1)</td><td align="char" valign="top" char="Â±">2.2âÂ±â0.2</td><td align="char" valign="top" char="Â±">27âÂ±â60</td><td align="char" valign="top" char="Â±">277âÂ±â117</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Data are the mean of three experiments and are reported as mean Â± standard error of the mean (SEM).</p></div></div></div><div class="NLM_p">We noted that compound <b>2b</b> and several of the well-known kinase inhibitors, including compounds <b>7a</b> (Iressa) and <b>7b</b> (Tarceva) (Charts <a class="ref internalNav" href="#cht1" aria-label=""></a> and <a class="ref internalNav" href="#cht2" aria-label=""></a>), are all substituted 4-anilinoquinazolines. 4-Anilinoquinazolines have been extensively explored as kinase inhibitors,<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> and it has been reported that substitutions at the 2-position or the linker nitrogen of 4-anilinoquinazolines are not preferred, while substitutions at the 6,7-positions are beneficial for kinase inhibiting activity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> For example, methylation of the <i>N</i>-linking nitrogen of 4-anilinoquinazoline and 4-(3-bromoanilino)-6,7-dimethoxyquinazoline led to 300-fold and 6000-fold drop of EGFR kinase inhibiting activity.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> In addition, it was reported that introduction of a Cl group to the 2-position of the quinazoline ring of 4-(3-chloroanilino)-6,7-dimethoxyquinazoline resulted in a 10000-fold loss of activity, and 4-(3-chloroanilino)quinazoline was >100-fold less active than 4-(3-chloroanilino)-6,7-dimethoxyquinazoline as EGFR kinase inhibitor.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Therefore, the SAR of the 2-position and linker nitrogen, as well as substitutions at the 6- and 7-positions of 4-anilinoquinazolines as apoptosis inducers was significantly different from the reported SAR of 4-anilinoquinazolines as EGFR kinase inhibitors.</div><figure id="cht1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0001.jpeg" id="gc1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="cht2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0010.jpeg" id="gc2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">One of the most striking differences in the SAR of EGFR kinase inhibitors and the apoptosis inducers reported here is with the methyl group at the linker nitrogen. The methyl group was found to be critical for the apoptosis inducing activity of 4-anilinoquinazolines, while methylation at the linker nitrogen of anilinoquinazolines have been reported to be highly disfavored for their activity as EGFR kinase inhibitors. It has been reported that <i>N</i>-methylation caused the anilino ring to move completely out of the plane.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>The critical role of the methyl group in <b>2b</b> suggested that a nonplanar structure of the anilino group vs the quinazoline ring was essential for the apoptosis inducing activity of these compounds. The differences in SAR suggest that these compounds should interact with different targets, which was confirmed in our target identification studies. Applying a photoaffinity agent, the molecular target of compound <b>2b</b> and related analogues has been identified as Î²-tubulin.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p last">Several crystal structures of 4-anilinoquinazoline-based inhibitors binding to kinases have been determined. These structures showed that the quinazoline ring binds to the hinge region and the N1 of the quinazoline functions as a hydrogen acceptor and contributes to a hydrogen bonding, and the NH group in the anilino group does not contribute to hydrogen bonding.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> Interestingly, 4-(3-hydroxyanilino)-6,7-dimethoxyquinazoline was found to bind to CDK2 with the anilino group essentially coplanar with the quinazoline ring system, while 4-(3-methylsulfanylanilino)-6,7-dimethoxyquinazoline was found to bind to p38 kinase, with the anilino group out of plane of the quinazoline ring system, indicating that structurally similar 4-anilinoquinazolines can bind to different kinases with different conformations.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Our SAR has shown that the methyl group at the linker nitrogen of 4-anilinoquinazolines is essential for the apoptosis inducing activity, and the SAR of 4-anilinoquinazolines as EGFR kinase inhibitors has shown that <i>N</i>-methylation of the linker nitrogen is highly undesirable due to noncoplanarity of the two rings. However, because 4-anilinoquinazolines and 4-arylaminoquinazolines have been found to bind to many different kinases, including c-Src/Abl,<a onclick="showRef(event, 'cit26b'); return false;" href="javascript:void(0);" class="ref cit26b">(26b)</a> aurora A and B,<a onclick="showRef(event, 'cit26c'); return false;" href="javascript:void(0);" class="ref cit26c">(26c)</a> CDK2, and P38,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> some of these inhibitors might tolerate a <i>N</i>-Me at the linker nitrogen. In fact, it has been reported that <i>N-</i>methyl-4-anilino-6,7-dimethoxyquinazoline is a potent inhibitor (IC<sub>50</sub> of 500 nM) of colony stimulating factor-1 receptor (CSF-1R) tyrosine kinase inhibitor, while the corresponding 4-anilino-6,7-dimethoxyquinazoline is not active in the same assay up to 50000 nM.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Therefore, it might be possible to combine the SAR of 4-anilinoquinazolines as apoptosis inducers with the SAR for kinase inhibitors to prepare compounds that are active as both apoptosis inducers and kinase inhibitors.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> These multifunctional ligands might have advantages over single functional ligands for the treatment of cancer because combination treatments for cancer are commonly practiced and have been found in general to be more effective than single agent treatment.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Characterization of Compound <b>2b</b></h3><div class="NLM_p">Compound <b>2b</b> has been found to induce apoptosis in tumor cells as indicated by a variety of markers of apoptosis.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> For example, <b>2b</b> treatment induced DNA fragmentation in several cells, including prostate carcinoma cells Du145 and 22Rv1, colorectal carcinoma cells Caco-2, and breast carcinoma cells MDA-MB-231. Induction of DNA fragmentation by <b>2b</b> was accompanied by caspase-3 activation and PARP cleavage, two other markers of apoptosis.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Compound <b>2b</b> was found to inhibit tubulin polymerization, with an IC<sub>50</sub> of less than 400 nM, which is similar to the potency of colchicine (500 nM) under the same assay conditions. Similar to compound <b>2b</b>, colchicine was found to be a potent apoptosis inducer, with an EC<sub>50</sub> value of 9 nM in our assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). These data corroborate with the target identification that inhibition of tubulin polymerization is the primary mechanism of action of <b>2b</b> for induction of apoptosis. The potential binding site of <b>2b</b> at tubulin was determined by using a fluorescent labeled colchicine in a tubulin binding competition assay. Compound <b>2b</b> was found to compete with fluorescent labeled colchicine for binding to tubulin, with a potency similar to that of nonlabeled colchicine, indicating that <b>2b</b> binds at or near the colchicine site of tubulin.</div><div class="NLM_p">Importantly, compound <b>2b</b> was found to be highly active in the MX-1 breast cancer model, a model that is not specific for certain agents and is widely used for testing common chemotherapeutics such as camptothecin derivatives<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and paclitaxel derivatives.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The MX-1 in vivo experiment was performed as described previously.<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> Compound <b>2b</b> inhibited tumor growth dose dependently and produced >95% tumor growth inhibition with once weekly intravenous (iv) dosing at 10 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A) and is well tolerated with maximum body weight decrease of <10% for the 10 mg/kg dose. The maximum tolerated dose (MTD) of <b>2b</b> was determined to be 25 mg/kg when dosed once weekly, providing a good therapeutic index (TI) of 2.5. Compound <b>2b</b> also produced 90% tumor growth inhibition in the MX-1 model when dosed once every day for 5 days for 2 weeks at a dose of 2.5 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B). In addition, <b>2b</b> significantly inhibited the growth of human PC-3 prostate cancer xenografts in nude mice (<i>P</i> = 0.003, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C).</div><figure id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>2b</b> inhibited the growth of established (â¼100 mm<sup>3</sup>) MX-1 (A) and (B), and PC-3 (C) tumor xenografts in Crl:Nu/Nu-nuBR mice. Compound <b>2b</b> was dosed iv once weekly for two weeks at 5, 7.5, or 10 mg/kg (MX-1 model, A), once a day for 5 days for two weeks at 1.25 or 2.5 mg/kg (MX-1 model, B), and once weekly for two weeks at 10 mg/kg (PC-3 model, C), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Significantly, compound <b>2b</b> was found to have high bloodâbrain barrier (BBB) penetration. Using plasma from blood samples and homogenized whole brain samples, the brain to plasma ratio of the area under the concentrationâtime curves (AUC) of <b>2b</b> after iv dosing was determined via LC-MS/MS to be about 30 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), suggesting that compound <b>2b</b> and related analogues might have good anticancer activity against brain tumors, for which there are currently few treatment options.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The high BBB penetration of <b>2b</b> was predicted based on its structure, which has a low molecular weight of 300, four hydrogen bond acceptors, and no hydrogen bond donor, features that are known to favor brain exposure of small molecules.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In comparison, it was reported that the cerebrospinal fluid (CSF) AUC was 7% of that of plasma for the structurally related 4-anilinoquinazloline kinase inhibitor <b>7b</b>,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> which has three more hydrogen bond acceptors and one more hydrogen bond donator than that of <b>2b</b>.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Concentration of compound <b>2b</b> in brain and plasma after a single iv dose of 2.5 mg/kg in mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conclusion, using a cell- and caspase-based HTS assay, we discovered a series of 4-anilinoquinazolines as potent apoptosis inducers. The SAR of 4-anilinoquinazolines as apoptosis inducers was different from the reported SAR of 4-anilinoquinazolines as EGFR kinase inhibitors. Through SAR studies, compound <b>2b</b> has been identified as a potent apoptosis inducer with excellent activity in the MX-1 and PC-3 mouse xenograft cancer models. The primary molecular target of <b>2b</b> appears to be tubulin. Additional SAR studies and lead optimization of <b>2b</b> will be presented in future publications.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86033" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86033" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General Methods and Materials</h3><div class="NLM_p last">Commercial-grade reagents and solvents obtained from Acros, Aldrich, Apin Lancaster, TCI, or VWR were used without further purification except as indicated. All reactions were stirred magnetically; moisture-sensitive reactions were performed under argon in oven-dried glassware. Thin-layer chromatography (TLC), usually using ethyl acetate/hexane as the solvent system, was used to monitor reactions. Solvents were removed by rotary evaporation under reduced pressure; where appropriate, the compound was further dried using a vacuum pump. The <sup>1</sup>H NMR spectra were recorded at 300 MHz. All samples were prepared as dilute solutions in deuteriochloroform (CDCl<sub>3</sub>) with v/v 0.05% tetramethylsilane (TMS). Chemical shifts are reported in parts per million (ppm) downfield from TMS (0.00 ppm), and <i>J</i> coupling constants are reported in hertz. Elemental analyses were performed by Numega Resonance Laboratories, Inc. (San Diego, CA). LCMS was run in the ESI mode using an Xterra MS C18 (Waters) 4.6 mm Ã 50 mm 5 u column; HPLC purity was performed using 4.6 mm Ã 150 mm Xterra C18 5 u column. Both LCMS and LC were reverse phase with a acetonitile/water containing 0.01% v/v TFA gradient at a flow rate of 0.5 mL/min. SFC was run using a normal phase Phenomenex Luna 5 u silica 4.6 mm Ã 250 mm column. Mobile phase was liquid CO<sub>2</sub> with methanol as the modifying solvent. A gradient was used in which the concentration of methanol was ramped from 5% to 50% over a course of 12 min with a 200 bar column back-pressure at 40 Â°C at a flow rate of 3 mL/min. Human breast T47D and human small cell lung HCT-116 tumor cell lines were purchased from the American Type Culture Collection (Manasas, VA). Compound <b>2a</b> was obtained commercially (Tripos, St. Louis MO), and the structure was confirmed by <sup>1</sup>H NMR and MS. Compound <b>2v</b> was prepared from 4-chloroquinazoline and 4-methoxyphenol according to reported procedure.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 2-Chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2b</b>)</h3><div class="NLM_p">A solution of 2,4-dichloroquinazoline (<b>3a</b>, 300 mg, 1.51 mmol) and <i>N</i>-methyl-4-methoxyaniline (<b>4a,</b> 248 mg, 1.81 mmol) in 5 mL isopropanol with a drop of concentrated HCl was stirred at room temperature for 8 h. The mixture was filtered, and the solid was washed with isopropanol, then dried under vacuum to give <b>2b</b> as a white powder (260 mg, 87%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.66 (dd, <i>J</i> = 8.4 and 0.9, 1H), 7.75 (ddd, <i>J</i> = 8.1, 7.5 and 0.9, 1H), 7.26â7.19 (m, 3H), 7.14 (ddd, <i>J</i> = 8.1, 7.5 and 0.9, 1H), 7.06 (dd, <i>J</i> = 6.9 and 2.4, 2H), 6.75 (d, <i>J</i> = 8.7, 1H), 3.91 (s, 3H), 3.81 (s, 3H). Anal. (C<sub>16</sub>H<sub>16</sub>ClN<sub>3</sub>O) C, H, N.</div><div class="NLM_p last">The following compounds were prepared by a procedure similar to that described for the preparation of compound <b>2b</b>.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <i>N</i>-(4-Methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2c</b>)</h3><div class="NLM_p last">Compound <b>2c</b> was prepared from 4-chloroquinazoline and <b>4a</b> and was isolated as a white powder (79%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.81 (s, 1H), 7.81 (d, <i>J</i> = 8.1, 1H), 7.57 (ddd, <i>J</i> = 8.1, 5.4 and 2.7, 1H), 7.09â7.14 (m, 2H), 7.03â7.06 (m, 2H), 6.9â6.93 (m, 2H). Anal. (C<sub>16</sub>H<sub>15</sub>C<sub>l2</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 2-Chloro-<i>N</i>-methyl-<i>N</i>-phenylquinazolin-4-amine (<b>2d</b>)</h3><div class="NLM_p last">Compound <b>2d</b> was prepared from <b>3a</b> and <i>N</i>-methylaniline and was isolated as a white powder (80%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.76 (dd, <i>J</i> = 8.7 and 1.5, 1H), 7.56 (ddd, <i>J</i> = 8.1, 6.6 and 1.5, 1H), 7.46â7.35 (m, 3H), 7.24â7.20 (m, 2H), 6.98 (ddd, <i>J</i> = 8.7, 6.6 and 1.5, 1H), 6.90 (dd, <i>J</i> = 8.7 and 1.5, 1H), 3.65 (s, 3H). Anal. (C<sub>15</sub>H<sub>12</sub>ClN<sub>3</sub>Â·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 2-Chloro-<i>N</i>-(4-methylphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2g</b>)</h3><div class="NLM_p last">Compound <b>2g</b> was prepared from <b>3a</b> and <i>N</i>-methyl-4-methylaniline and was isolated as a white powder (84%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.69 (d, <i>J</i> = 8.4, 1H), 7.75 (dd, <i>J</i> = 8.1 and 7.5, 1H), 7.39 (d, <i>J</i> = 7.8, 2H), 7.25 (d, <i>J</i> = 7.8, 2H), 7.13 (d, <i>J</i> = 8.2, 1H), 6.74 (d, <i>J</i> = 8.7, 1H), 3.81 (s, 3H), 2.49 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>14</sub>ClN<sub>3</sub> (M + H<sup>+</sup>), 284.0954; found, 284.0952.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 2-Chloro-<i>N</i>-methyl-<i>N</i>-(4-trifluoromethoxyphenyl)quinazolin-4-amine (<b>2i</b>)</h3><div class="NLM_p last">Compound <b>2i</b> was prepared from <b>3a</b> and <i>N</i>-methyl-4-trifluoromethoxyaniline and was isolated as a white powder (44%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.93 (dd, <i>J</i> = 8.4 and 0.6, 1H), 7.61(ddd, <i>J</i> = 8.4, 4.5 and 1.2, 1H), 7.29â7.22 (m, 4H), 7.06 (ddd, <i>J</i> = 8.4, 4.5 and 1.2, 1H), 6.91 (d, <i>J</i> = 8.7, 1H), 3.65 (s, 3H). Anal. (C<sub>16</sub>H<sub>11</sub>ClF<sub>3</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-Chloro-<i>N</i>-(4-chlorophenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2j</b>)</h3><div class="NLM_p last">Compound <b>2j</b> was prepared from <b>3a</b> and <i>N</i>-methyl-4-chloroaniline, and was isolated as a white powder (50%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.66 (d, <i>J</i> = 8.4, 1H), 7.78 (ddd, <i>J</i> = 8.1, 7.5 and 2.4, 1H), 7.57 (d, <i>J</i> = 8.7, 2H), 7.28 (d, <i>J</i> = 8.7, 2H), 7.19 (ddd, <i>J</i> = 8.1, 7.5 and 2.4, 1H), 6.79 (d, <i>J</i> = 8.4, 1H), 3.83 (s, 3H). Anal. (C<sub>15</sub>H<sub>11</sub>C<sub>l2</sub>N<sub>3</sub>) C, H, N.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Chloro-<i>N</i>-(4-nitrophenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2k</b>)</h3><div class="NLM_p last">Compound <b>2k</b> was prepared from <b>3a</b> and <i>N</i>-methyl-4-nitroaniline and was isolated as a white powder (12%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.24 (d, <i>J</i> = 8.7, 2H), 7.81 (dd, <i>J</i> = 8.1 and 2.4, 1H), 7.68 (ddd, <i>J</i> = 8.1, 7.5 and 2.4, 1H), 7.28 (d, <i>J</i> = 8.7, 2H), 7.18 (ddd, <i>J</i> = 8.1, 7.5 and 2.4, 1H), 7.07 (d, <i>J</i> = 7.8, 1H), 3.75 (s, 3H). HRMS calcd for C<sub>15</sub>H<sub>11</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 315.0649; found, 315.0652.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Chloro-<i>N</i>-(4-methoxybenzyl)-<i>N</i>-methylquinazolin-4-amine (<b>2w</b>)</h3><div class="NLM_p last">Compound <b>2w</b> was prepared from <b>3a</b> and <i>N</i>-methyl-4-methoxybenzylamine, and was isolated as a white powder (60%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.93 (dd, <i>J</i> = 8.4 and 1.2, 1H), 7.78 (dd, <i>J</i> = 8.4 and 1.5, 1H), 7.68 (ddd, <i>J</i> = 8.4, 7.5 and 1.5, 1H), 7.34â7.26 (m, 3H), 6.96â6.92 (m, 2H), 4.94 (s, 2H), 3.83 (s, 3H), 3.31 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>16</sub>ClN<sub>3</sub>O (M + H<sup>+</sup>), 314.1055; found, 314.1053.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-Chloro-<i>N</i>-(4-methoxyphenyl)quinazolin-4-amine (<b>6a</b>)</h3><div class="NLM_p last">Compound <b>6a</b> was prepared from <b>3a</b> and 4-methoxyaniline (<b>5a</b>) and was isolated as an off-white powder (77%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 10.25 (s, 1H), 8.58 (d, <i>J</i> = 8.4, 1H), 7.88 (t, <i>J</i> = 7.2, 1H), 7.71â7.63 (m, 4H), 7.03â6.99 (m, 2H), 3.79 (s, 3H). Anal. (C<sub>15</sub>H<sub>12</sub>ClN<sub>3</sub>OÂ·0.8H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-Chloro-6,7-dimethoxy-<i>N</i>-(4-methoxyphenyl)quinazolin-4-amine (<b>6b</b>)</h3><div class="NLM_p last">Compound <b>6b</b> was prepared from 2,4-dichloro-6,7-dimethoxyquinazoline (<b>3c</b>) and <b>5a</b> and was isolated as an off-white powder (10%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.10 (s, 1H), 7.70â7.68 (m, 2H), 7.23 (s, 1H), 6.96â6.94 (m, 2H), 4.07 (s, 3H), 3.99 (s, 3H), 3.85 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>15</sub>ClN<sub>3</sub>O<sub>3</sub> (M + Na<sup>+</sup>), 368.0778; found, 368.0781.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-Chloro-<i>N</i>-(6-methoxypyridin-3-yl)quinazolin-4-amine (<b>6i</b>)</h3><div class="NLM_p">A mixture of <b>3a</b> (61 mg, 0.31 mmol), 6-methoxypyridin-3-amine (40 mg, 0.32 mmol), and sodium acetate (38 mg, 0.46 mmol) in 3 mL of solvent (THF:water/1:1) was stirred at 60 Â°C for 45 min. The reaction mixture was diluted with 25 mL of ethyl acetate, and it was washed with saturated NaCl, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by chromatography (40% ethyl acetate/hexanes) on silica gel to give <b>6i</b> as a solid (86 mg, 98%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.38 (d, <i>J</i> = 3.0, 1H), 8.07 (dd, <i>J</i> = 8.7 and 3.0, 1H), 7.89â7.79 (d, <i>J</i> = 8.4, 1H), 7.86 (m, 2H), 7.59â7.53 (m, 2H), 6.84 (d, <i>J</i> = 8.7, 1H), 3.96 (s, 3H).</div><div class="NLM_p last">The following compounds were prepared by a procedure similar to that described for the preparation of compound <b>6i</b>.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-Chloro-6,7-dimethoxy-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2s</b>)</h3><div class="NLM_p last">Compound <b>2s</b> was prepared from <b>3c</b> and <b>4a</b> and was isolated as a white solid (60%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.19 (s, 1H), 7.32â7.26 (m, 2H), 7.09â7.07 (m, 2H), 6.16 (s, 1H), 4.03 (s, 3H), 3.87 (s, 3H), 3.75 (s, 3H), 3.32 (s, 3H). Anal. (C<sub>18</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>3</sub>Â·0.6H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2,6-Dichloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2t</b>)</h3><div class="NLM_p last">Compound <b>2t</b> was prepared from 2,4,6-trichloroquinazoline (<b>3d</b>) and <b>4a</b> and was isolated as a yellow solid (30%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.66 (d, <i>J</i> = 8.7, 1H), 7.49 (dd, <i>J</i> = 8.7 and 2.1, 1H), 7.18â7.12 (m, 2H), 7.02â6.96 (m, 2H), 6.78 (dd, <i>J</i> = 2.1 and 0.6, 1H), 3.88 (s, 3H), 3.61 (s, 3H). Anal. (C<sub>16</sub>H<sub>13</sub>Cl<sub>2</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2,7-Dichloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2u</b>)</h3><div class="NLM_p last">Compound <b>2u</b> was prepared from 2,4,7-trichloroquinazoline (<b>3e</b>) and <b>4a</b> and was isolated as a light-yellow solid (40%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.70 (d, <i>J</i> = 2.4, 1H), 7.16â7.11 (m, 2H), 6.98â6.92 (m, 3H), 6.80 (d, <i>J</i> = 9.3, 1H), 3.86 (s, 3H), 3.60 (s, 3H). Anal. (C<sub>16</sub>H<sub>13</sub>Cl<sub>2</sub>N<sub>3</sub>O) C, H, N.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Chloro-<i>N</i>-(6-methoxypyridin-3-yl)-<i>N-</i>methylquinazolin-4-amine (<b>2q</b>)</h3><div class="NLM_p">To a solution of <b>6i</b> (19.4 mg, 0.068 mmol) in 1 mL of DMF cooled at 0 Â°C was added methyl iodide (100 Î¼L, 1.61 mmol), followed by sodium hydride (60% oil suspension, 5 mg, 0.13 mmol). The mixture was stirred at 0 Â°C for 1 h, then allowed to warm to room temperature and stirred for 1 h. The reaction mixture was quenched by adding 50 Î¼L of water and diluted with 25 mL of ethyl acetate. The solution was washed with water (25 mL Ã 3), saturated NaCl, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by chromatography (20% ethyl acetate/hexanes) to give <b>2q</b> as a solid (14.3 mg, 70%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.06 (d, <i>J</i> = 2.7, 1H), 7.57â7.79 (m, 1H), 7.60 (ddd, <i>J</i> = 8.1, 6.6 and 1.2, 1H), 7.44 (dd, <i>J</i> = 8.7 and 2.7, 1H), 7.09 (ddd, <i>J</i> = 8.1, 6.6 and 1.2, 1H), 6.99â7.02 (m, 1H), 6.82 (dd, <i>J</i> = 8.7 and 0.6, 1H), 3.97 (s, 3H), 3.61 (s, 3H). Anal. (C<sub>15</sub>H<sub>13</sub>ClN<sub>4</sub>O<sub></sub>Â·0.2H<sub>2</sub>O) C, H, N.</div><div class="NLM_p last">The following compounds were prepared by a procedure similar to that described for the preparation of compound <b>2q</b>.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-Chloro-<i>N</i>-(4-ethoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2e</b>)</h3><div class="NLM_p last">Compound <b>2e</b> was prepared from <b>6c</b> and methyl iodide and was isolated as a solid (28%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.73 (m, 1H), 7.55 (m, 1H), 7.12 (m, 2H), 7.00 (m, 1H), 6.93 (m, 3H), 4.07 (q, <i>J</i> = 7.2, 2H), 3.61 (s, 3H), 1.46 (t, <i>J</i> = 7.2, 3H). Anal. (C<sub>17</sub>H<sub>16</sub>ClN<sub>3</sub>O) C, H, N.</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Chloro-<i>N</i>-(4-phenoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2f</b>)</h3><div class="NLM_p last">Compound <b>2f</b> was prepared from <b>6d</b> and methyl iodide and was isolated as a solid (41%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.74â7.77 (m, 1H), 7.59 (ddd, <i>J</i> = 8.4, 6.6 and 1.5, 1H), 7.36â7.42 (m, 2H), 7.10â7.20 (m, 3H), 7.03â7.10 (m, 5H), 6.97â7.00 (m, 1H), 3.64 (s, 3H). HRMS calcd for C<sub>21</sub>H<sub>16</sub>ClN<sub>3</sub>O (M + H<sup>+</sup>), 362.1060; found, 362.1062.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Chloro-<i>N</i>-(3-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2l</b>)</h3><div class="NLM_p last">Compound <b>2l</b> was prepared from <b>6e</b> and methyl iodide and was isolated as a solid (60%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.74â7.76 (m, 1H), 7.57 (ddd, <i>J</i> = 8.4, 6.0 and 1.8, 1H), 7.32 (t, <i>J</i> = 7.8, 1H), 6.98â7.03 (m, 2H), 6.89 (dd, <i>J</i> = 8.1 and 2.4, 1H), 6.75â6.81 (m, 2H), 3.65 (s, 3H), 3.37 (s, 3H). Anal. (C<sub>16</sub>H<sub>14</sub>ClN<sub>3</sub>O) C, H, N.</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-Chloro-<i>N</i>-(2-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2m</b>)</h3><div class="NLM_p last">Compound <b>2m</b> was prepared from <b>6f</b> and methyl iodide and was isolated as a solid (72%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.72 (d, <i>J</i> = 8.1, 1H), 7.54 (ddd, <i>J</i> = 8.4, 6.6 and 1.5, 1H), 7.20 (dd, <i>J</i> = 8.4 and 1.8, 1H), 6.87â7.04 (m, 4H), 3.67 (s, 3H), 3.56 (s, 3H). Anal. (C<sub>16</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub></sub>Â·0.7H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-Chloro-<i>N</i>-(3,4-dimethoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2n</b>)</h3><div class="NLM_p last">Compound <b>2n</b> was prepared from <b>6g</b> and methyl iodide and was isolated as a solid (54%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.72â7.75 (m, 1H), 7.57 (ddd, <i>J</i> = 8.4, 6.6 and 1.5, 1H), 7.01 (ddd, <i>J</i> = 8.7, 6.9 and 1.2, 1H), 6.88â6.96 (m, 2H), 6.73â6.81 (m, 2H), 3.94 (s, 3H), 3.80 (s, 3H), 3.63 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>16</sub>ClN<sub>3</sub>O<sub>2</sub> (M + Na<sup>+</sup>), 352.0829; found, 352.0832.</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Chloro-<i>N</i>-(3,4-methylenedioxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2o</b>)</h3><div class="NLM_p last">Compound <b>2o</b> was prepared from <b>6j</b> and methyl iodide and was isolated as a solid (66%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.73â7.76 (m, 1H), 7.58 (m, 1H), 7.07 (m, 2H), 6.82 (d, <i>J</i> = 8.4, 1H), 6.72 (m, 1H), 6.68 (m, 1H), 6.06 (s, 2H), 3.59 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>16</sub>ClN<sub>3</sub>O<sub>2</sub> (M + H<sup>+</sup>), 314.0696; found, 314.0755.</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Chloro-<i>N</i>-(2,3-dimethoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2p</b>)</h3><div class="NLM_p last">Compound <b>2p</b> was prepared from <b>6h</b> and methyl iodide and was isolated as a solid (71%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.74 (d, <i>J</i> = 8.4, 1H), 7.53â7.59 (m, 1H), 7.12 (t, <i>J</i> = 8.4, 1H), 6.94â7.01 (m, 3H), 6.87 (dd, <i>J</i> = 8.1 and 1.5, 1H), 3.89 (s, 3H), 3.56 (s, 3H). Anal. (C<sub>17</sub>H<sub>16</sub>ClN<sub>3</sub>O<sub>2</sub>Â·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-Chloro-<i>N</i>-ethyl-<i>N</i>-(4-methoxyphenyl)quinazolin-4-amine (<b>2r</b>)</h3><div class="NLM_p last">Compound <b>2r</b> was prepared from <b>6a</b> and ethyl iodide and was isolated as a solid (58%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.69â7.72 (m, 1H), 7.53 (ddd, <i>J</i> = 8.1, 6.9 and 1.5, 1H), 7.09â7.14 (m, 2H), 6.94â6.70 (m, 3H), 6.83â6.87 (m, 1H), 4.13 (q, <i>J</i> = 7.2, 2H), 3.87 (s, 1H), 1.30 (t, <i>J</i> = 6.9, 3H). Anal. (C<sub>17</sub>H<sub>16</sub>ClN<sub>3</sub>O) C, H, N.</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Chloro-<i>N</i>-(4-hydroxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>2h</b>)</h3><div class="NLM_p last">To a solution of <b>2b</b> (100 mg, 0.33 mmol) in 30 mL dichloromethane cooled at â20 Â°C was added slowly 60 Î¼L of BBr<sub>3</sub> (0.67 mmol). The reaction mixture was stirred at â20 Â°C for 2 h. It was warmed to room temperature and stirred for another 2 h. The reaction mixture was diluted with ethyl acetate (50 mL) and washed with cold 5% sodium bicarbonate. The organic phase was dried and concentrated. The residue was purified by chromatography using ethyl acetate and hexane (1:3) to give <b>2h</b> as a solid (57 mg, 57%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.65â7.56 (m, 2H), 7.04â6.87 (m, 5H), 3.59 (s, 3H). HRMS calcd for C<sub>15</sub>H<sub>12</sub>ClN<sub>3</sub>O (M + H<sup>+</sup>), 286.0747; found, 286.0747.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/jm8003653">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Table of elemental analysis and HPLC data for the targeted compounds <b>2b</b>â<b>2w</b> and <b>6a</b>â<b>6b</b>. Also included are experimentals for intermediates <b>6c</b>â<b>6h</b> and <b>6j</b>, procedures for caspase activation assay, growth inhibition assay, tubulin inhibition assay, colchicine binding competition assays as well as MX-1 and PC-3 tumor model studies of <b>2b</b>, and determination of brain/plasma AUC ratio of <b>2b</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8003653/suppl_file/jm8003653-file003.pdf">jm8003653-file003.pdf (133.86 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm8003653" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sui Xiong Cai</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#aeddcdcfc7eecbdec7cdcbdeda80cdc1c3"><span class="__cf_email__" data-cfemail="592a3a3830193c29303a3c292d773a3634">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nilantha Sirisoma</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shailaja Kasibhatla</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Azra Pervin</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Zhang</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Songchun Jiang</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Adam Willardsen</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark B. Anderson</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vijay Baichwal</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary G. Mather</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Jessing</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raouf Hussain</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Khanh Hoang</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher M. Pleiman</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Tseng</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Drewe</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, Myriad Pharmaceuticals, Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Reed, J. C.</span><span> </span><span class="NLM_article-title">Apoptosis-based therapies</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">1</span> <span class="NLM_fpage">111</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1038%2Fnrd726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=12120092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhs1ajt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=111-121&author=J.+C.+Reed&title=Apoptosis-based+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis-based therapies</span></div><div class="casAuthors">Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many of today's medical illnesses can be attributed directly or indirectly to problems with apoptosis, a programmed cell-suicide mechanism.  Disorders in which defective regulation of apoptosis contributes to disease pathogenesis or progression can involve either cell accumulation, in which cell eradication or cell turnover is impaired, or cell loss, in which the cell-suicide program is inappropriately triggered.  Identification of the genes and gene products that are responsible for apoptosis, together with emerging information about the mechanisms of action and structures of apoptotic regulatory and effector proteins, has laid a foundation for the discovery of drugs, some of which are now undergoing evaluation in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpISfg-GY-sBLVg90H21EOLACvtfcHk0lgT1Q9OrSHwhw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhs1ajt7w%253D&md5=6aa262ef018388d755e46a718b130aa2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd726%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DApoptosis-based%2520therapies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D111%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kumar, S.</span><span> </span><span class="NLM_article-title">Caspase function in programmed cell death</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">32</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1038%2Fsj.cdd.4402060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17082813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSqur%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=32-43&author=S.+Kumar&title=Caspase+function+in+programmed+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase function in programmed cell death</span></div><div class="casAuthors">Kumar, S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-43</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The first proapoptotic caspase, CED-3, was cloned from Caenorhabditis elegans in 1993 and shown to be essential for the developmental death of all somatic cells.  Following the discovery of CED-3, caspases have been cloned from several vertebrate and invertebrate species.  As reviewed in other articles in this issue of Cell Death and Differentiation, many caspases function in nonapoptotic pathways.  However, as is clear from the worm studies, the evolutionarily conserved role of caspases is to execute programmed cell death.  In this article, I will specifically focus on caspases that function primarily in cell death execution.  In particular, the physiol. function of caspases in apoptosis is discussed using examples from the worm, fly and mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzox0vEkRLhLVg90H21EOLACvtfcHk0lggLK2MTzl1rg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSqur%252FF&md5=c8ae1b9aebbf7a28a9b5e08a001bacbb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402060%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DCaspase%2520function%2520in%2520programmed%2520cell%2520death%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D32%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Callus, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span> </span><span class="NLM_article-title">Caspase inhibitors: viral, cellular and chemical</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">73</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1038%2Fsj.cdd.4402034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=16946729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSqur%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=73-78&author=B.+A.+Callusauthor=D.+L.+Vaux&title=Caspase+inhibitors%3A+viral%2C+cellular+and+chemical"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase inhibitors: viral, cellular and chemical</span></div><div class="casAuthors">Callus, B. A.; Vaux, D. L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-78</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Caspases, key mediators of apoptosis, are a structurally related family of cysteine proteases that cleave their substrates at aspartic acid residues either to cause cell death or to activate cytokines as part of an immune response.  They can be controlled upstream by the regulation of signals that lead to zymogen activation, or downstream by inhibitors that prevent them from reaching their substrates.  This review specifically looks at caspase inhibitors as distinct from caspase regulators: those produced by the cell itself; those whose genes are carried by viruses; and artificial caspase inhibitors used for research and potentially as therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1O85HHyBCYbVg90H21EOLACvtfcHk0lggLK2MTzl1rg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSqur%252FI&md5=179fae906a55facdd614a25e60036d1d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402034%26sid%3Dliteratum%253Aachs%26aulast%3DCallus%26aufirst%3DB.%2BA.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26atitle%3DCaspase%2520inhibitors%253A%2520viral%252C%2520cellular%2520and%2520chemical%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D73%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Linton, S. D.</span><span> </span><span class="NLM_article-title">Caspase inhibitors: a pharmaceutical industry perspective</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">1697</span> <span class="NLM_lpage">1717</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.2174%2F156802605775009720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=16375749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28XislSlsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1697-1717&author=S.+D.+Linton&title=Caspase+inhibitors%3A+a+pharmaceutical+industry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase inhibitors: a pharmaceutical industry perspective</span></div><div class="casAuthors">Linton, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1697-1716</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Caspase inhibition has been demonstrated to be therapeutically effective in moderating excessive programmed cell death, or apoptosis.  Publications detailing programs in the pharmaceutical industry have been more frequent in recent years, ranging from SAR studies to clin. relevant animal models of disease.  A summary of the work published in this exciting new area is presented, outlining the broad applicability of this fundamental cellular mechanism across several disease indications.  This area of research has matured to the level of advancing compds. into clin. trials: VX-740 (Pralnacasan) and VX-765 as anti-inflammatory agents, and IDN-6556, a pan-caspase inhibitor as an anti-apoptotic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNuWiIlXtZQLVg90H21EOLACvtfcHk0lggLK2MTzl1rg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislSlsb4%253D&md5=90117df2461483c7833cb80f27c4e861</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F156802605775009720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802605775009720%26sid%3Dliteratum%253Aachs%26aulast%3DLinton%26aufirst%3DS.%2BD.%26atitle%3DCaspase%2520inhibitors%253A%2520a%2520pharmaceutical%2520industry%2520perspective%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1697%26epage%3D1717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">OâDriscoll, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linehan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clynes, M.</span><span> </span><span class="NLM_article-title">Survivin: role in normal cells and in pathological conditions</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">131</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.2174%2F1568009033482038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=12678716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1alt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=131-152&author=L.+O%E2%80%99Driscollauthor=R.+Linehanauthor=M.+Clynes&title=Survivin%3A+role+in+normal+cells+and+in+pathological+conditions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Survivin: Role in normal cells and in pathological conditions</span></div><div class="casAuthors">O'Driscoll, L.; Linehan, R.; Clynes, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-152</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Survivin, an inhibitor of apoptosis (IAP) contg. one baculovirus IAP repeat (BIR) domain, has been reported to be capable of regulating both cellular proliferation and apoptotic cell death.  Survivin splice variants, survivin-ÎEx3 and survivin-2B, have apparently retained and lost anti-apoptotic potential, resp.  As survivin was first discovered due to its high homol. with effector cell protease receptor (EPR-1), a protein involved in blood coagulation, it has been suggested (but not proven) that EPR-1 may act as a natural anti-sense to survivin in cells.  Survivin homologs have been found in non-human species.  Survivin expression has been described during embryonic development and in adult cancerous tissues, with greatly reduced expression in adult normal differentiated tissues, particularly if their proliferation index is low.  Survivin has been defined as a universal tumor antigen and as the fourth most significant transcriptosome expressed in human tumors.  Although survivin is usually located in the cell cytoplasmic region and assocd. with poor prognosis in cancer, nuclear localization, indicative of favorable prognosis, has also been reported.  Survivin expression has also been reported in a no. of proliferating normal adult tissues.  Extensive research has been conducted, aimed at increasing our understanding of survivin, by detg. its sub-cellular structure and location, mechanism(s) of action and control of expression.  While much important information on this mol. has been accumulated, there are still many areas of controversy or limited information.  Further research may enable exploitation of survivin overexpression in cancer compared to normal tissues, making survivin a potentially attractive target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTyDh2jQIlKLVg90H21EOLACvtfcHk0lggLK2MTzl1rg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1alt7s%253D&md5=444e29c17b6ad4954f8a1a8e182850af</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568009033482038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033482038%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Driscoll%26aufirst%3DL.%26aulast%3DLinehan%26aufirst%3DR.%26aulast%3DClynes%26aufirst%3DM.%26atitle%3DSurvivin%253A%2520role%2520in%2520normal%2520cells%2520and%2520in%2520pathological%2520conditions%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D131%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Fischer, U</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Osthoff, K</span><span> </span><span class="NLM_article-title">New approaches and therapeutics targeting apoptosis in disease</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">57</span> <span class="NLM_fpage">187</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=187-215&author=U+Fischerauthor=K+Schulze-Osthoff&title=New+approaches+and+therapeutics+targeting+apoptosis+in+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DU%26aulast%3DSchulze-Osthoff%26aufirst%3DK%26atitle%3DNew%2520approaches%2520and%2520therapeutics%2520targeting%2520apoptosis%2520in%2520disease%26jtitle%3DPharmacol.%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D187%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Promoting apoptosis as a strategy for cancer drug discovery</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">876</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1038%2Fnrc1736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=16239906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Witb7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=876-885&author=S.+W.+Fesik&title=Promoting+apoptosis+as+a+strategy+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Promoting apoptosis as a strategy for cancer drug discovery</span></div><div class="casAuthors">Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">876-885</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Apoptosis is deregulated in many cancers, making it difficult to kill tumors.  Drugs that restore the normal apoptotic pathways have the potential for effectively treating cancers that depend on aberrations of the apoptotic pathway to stay alive.  Apoptosis targets that are currently being explored for cancer drug discovery include the tumor-necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors, the BCL2 family of anti-apoptotic proteins, inhibitor of apoptosis (IAP) proteins and MDM2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOkjz2FXKfBbVg90H21EOLACvtfcHk0lhs1ECmJ8CsAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Witb7J&md5=0976f3fb83374260702a71fd856a4834</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc1736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1736%26sid%3Dliteratum%253Aachs%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DPromoting%2520apoptosis%2520as%2520a%2520strategy%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D876%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span> </span><span class="NLM_article-title">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span> <span class="citation_source-journal">Cancer Cell.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">10</span> <span class="NLM_fpage">389</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1016%2Fj.ccr.2006.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17097561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=389-399&author=M.+F.+van+Delftauthor=A.+H.+Weiauthor=K.+D.+Masonauthor=C.+J.+Vandenbergauthor=L.+Chenauthor=P.+E.+Czabotarauthor=S.+N.+Willisauthor=C.+L.+Scottauthor=C.+L.+Dayauthor=S.+Coryauthor=J.+M.+Adamsauthor=A.+W.+Robertsauthor=D.+C.+Huang&title=The+BH3+mimetic+ABT-737+targets+selective+Bcl-2+proteins+and+efficiently+induces+apoptosis+via+Bak%2FBax+if+Mcl-1+is+neutralized"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span></div><div class="casAuthors">van Delft, Mark F.; Wei, Andrew H.; Mason, Kylie D.; Vandenberg, Cassandra J.; Chen, Lin; Czabotar, Peter E.; Willis, Simon N.; Scott, Clare L.; Day, Catherine L.; Cory, Suzanne; Adams, Jerry M.; Roberts, Andrew W.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Since apoptosis is impaired in malignant cells overexpressing prosurvival Bcl-2 proteins, drugs mimicking their natural antagonists, BH3-only proteins, might overcome chemoresistance.  Of seven putative BH3 mimetics tested, only ABT-737 triggered Bax/Bak-mediated apoptosis.  Despite its high affinity for Bcl-2, Bcl-xL, and Bcl-w, many cell types proved refractory to ABT-737.  We show that this resistance reflects ABT-737's inability to target another prosurvival relative, Mcl-1.  Downregulation of Mcl-1 by several strategies conferred sensitivity to ABT-737.  Furthermore, enforced Mcl-1 expression in a mouse lymphoma model conferred resistance.  In contrast, cells overexpressing Bcl-2 remained highly sensitive to ABT-737.  Hence, ABT-737 should prove efficacious in tumors with low Mcl-1 levels, or when combined with agents that inactivate Mcl-1, even to treat those tumors that overexpress Bcl-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAmMTX4bzgbVg90H21EOLACvtfcHk0lhs1ECmJ8CsAg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK&md5=6c1de734427cb187fbb9002fd9269ca8</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.027%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DVandenberg%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DScott%26aufirst%3DC.%2BL.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DThe%2520BH3%2520mimetic%2520ABT-737%2520targets%2520selective%2520Bcl-2%2520proteins%2520and%2520efficiently%2520induces%2520apoptosis%2520via%2520Bak%252FBax%2520if%2520Mcl-1%2520is%2520neutralized%26jtitle%3DCancer%2520Cell.%26date%3D2006%26volume%3D10%26spage%3D389%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Pyrogallol-based molecules as potent inhibitors of the antiapoptotic Bcl-2 proteins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">1723</span> <span class="NLM_lpage">1726</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061400l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1723-1726&author=G.+Tangauthor=C.-Y.+Yangauthor=Z.+Nikolovska-Coleskaauthor=J.+Guoauthor=S.+Qiuauthor=R.+Wangauthor=W.+Gaoauthor=G.+Wangauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=S.+Jiangauthor=P.+P.+Rollerauthor=S.+Wang&title=Pyrogallol-based+molecules+as+potent+inhibitors+of+the+antiapoptotic+Bcl-2+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm061400l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061400l%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPyrogallol-based%2520molecules%2520as%2520potent%2520inhibitors%2520of%2520the%2520antiapoptotic%2520Bcl-2%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1723%26epage%3D1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnie, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyenne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallblad, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitching, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norbedo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saravanan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, H. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunec, J.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the MDM2-p53 proteinâprotein interaction based on an isoindolinone scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">6209</span> <span class="NLM_lpage">6221</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0601194" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6209-6221&author=I.+R.+Hardcastleauthor=S.+U.+Ahmedauthor=H.+Atkinsauthor=G.+Farnieauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=S.+Guyenneauthor=C.+Huttonauthor=P.+Kallbladauthor=S.+J.+Kempauthor=M.+S.+Kitchingauthor=D.+R.+Newellauthor=S.+Norbedoauthor=J.+S.+Northenauthor=R.+J.+Reidauthor=K.+Saravananauthor=H.+M.+G.+Willemsauthor=J.+Lunec&title=Small-molecule+inhibitors+of+the+MDM2-p53+protein%E2%88%92protein+interaction+based+on+an+isoindolinone+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm0601194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601194%26sid%3Dliteratum%253Aachs%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DAhmed%26aufirst%3DS.%2BU.%26aulast%3DAtkins%26aufirst%3DH.%26aulast%3DFarnie%26aufirst%3DG.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DGuyenne%26aufirst%3DS.%26aulast%3DHutton%26aufirst%3DC.%26aulast%3DKallblad%26aufirst%3DP.%26aulast%3DKemp%26aufirst%3DS.%2BJ.%26aulast%3DKitching%26aufirst%3DM.%2BS.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNorbedo%26aufirst%3DS.%26aulast%3DNorthen%26aufirst%3DJ.%2BS.%26aulast%3DReid%26aufirst%3DR.%2BJ.%26aulast%3DSaravanan%26aufirst%3DK.%26aulast%3DWillems%26aufirst%3DH.%2BM.%2BG.%26aulast%3DLunec%26aufirst%3DJ.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520protein%25E2%2588%2592protein%2520interaction%2520based%2520on%2520an%2520isoindolinone%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6209%26epage%3D6221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">3432</span> <span class="NLM_lpage">3435</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051122a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3432-3435&author=K.+Dingauthor=Y.+Luauthor=Z.+Nikolovska-Coleskaauthor=G.+Wangauthor=S.+Qiuauthor=S.+Shangaryauthor=W.+Gaoauthor=D.+Qinauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=S.+Wang&title=Structure-based+design+of+spiro-oxindoles+as+potent%2C+specific+small-molecule+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Ding, Ke; Lu, Yipin; Nikolovska-Coleska, Zaneta; Wang, Guoping; Qiu, Su; Shangary, Sanjeev; Gao, Wei; Qin, Dongguang; Stuckey, Jeanne; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3432-3435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, specific, non-peptide small-mol. inhibitors of the MDM2-p53 interaction were successfully designed.  The most potent inhibitor (MI-63) has a Ki value of 3 nM binding to MDM2 and greater than 10,000-fold selectivity over Bcl-2/Bcl-xL proteins.  MI-63 is highly effective in activation of p53 function and in inhibition of cell growth in cancer cells with wild-type p53 status.  MI-63 has excellent specificity over cancer cells with deleted p53 and shows a minimal toxicity to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptppiErNrFXrVg90H21EOLACvtfcHk0liCTdCkpY5pMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D&md5=186a2ba028ad9b8f71107aa1c2555421</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm051122a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051122a%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520spiro-oxindoles%2520as%2520potent%252C%2520specific%2520small-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3432%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">5805</span> <span class="NLM_lpage">5808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5805-5808&author=J.+Chenauthor=Z.+Nikolovska-Coleskaauthor=G.+Wangauthor=S.+Qiuauthor=S.+Wang&title=Design%2C+synthesis%2C+and+characterization+of+new+embelin+derivatives+as+potent+inhibitors+of+X-linked+inhibitor+of+apoptosis+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520new%2520embelin%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5805%26epage%3D5808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Brabander, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harran, P. G.</span><span> </span><span class="NLM_article-title">A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death</span> <span class="citation_source-journal">Science</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">305</span> <span class="NLM_fpage">1471</span> <span class="NLM_lpage">1474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1126%2Fscience.1098231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=15353805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFartL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1471-1474&author=L.+Liauthor=R.+M.+Thomasauthor=H.+Suzukiauthor=J.+K.+De+Brabanderauthor=X.+Wangauthor=P.+G.+Harran&title=A+small+molecule+Smac+mimic+potentiates+TRAIL-+and+TNFalpha-mediated+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A Small Molecule Smac Mimic Potentiates TRAIL- and TNFÎ±-Mediated Cell Death</span></div><div class="casAuthors">Li, Lin; Thomas, Ranny Mathew; Suzuki, Hidetaka; De Brabander, Jef K.; Wang, Xiaodong; Harran, Patrick G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5689</span>),
    <span class="NLM_cas:pages">1471-1474</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We describe the synthesis and properties of a small mol. mimic of Smac, a pro-apoptotic protein that functions by relieving inhibitor-of-apoptosis protein (IAP)-mediated suppression of caspase activity.  The compd. binds to X chromosome-encoded IAP (XIAP), cellular IAP 1 (cIAP-1), and cellular IAP 2 (cIAP-2) and synergizes with both tumor necrosis factor Î± (TNFÎ±) and TNF-related apoptosis-inducing ligand (TRAIL) to potently induce caspase activation and apoptosis in human cancer cells.  The mol. has allowed a temporal, unbiased evaluation of the roles that IAP proteins play during signaling from TRAIL and TNF receptors.  The compd. is also a lead structure for the development of IAP antagonists potentially useful as therapy for cancer and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri19S7A9uW8bVg90H21EOLACvtfcHk0lgiBUrgbx02WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFartL8%253D&md5=75945f9e8637c8ce303e15f95395f449</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1098231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1098231%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DDe%2BBrabander%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHarran%26aufirst%3DP.%2BG.%26atitle%3DA%2520small%2520molecule%2520Smac%2520mimic%2520potentiates%2520TRAIL-%2520and%2520TNFalpha-mediated%2520cell%2520death%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1471%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Putt, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandhorst, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoagland, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchwell, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerge, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helferich, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergenrother, P. J.</span><span> </span><span class="NLM_article-title">Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">543</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1038%2Fnchembio814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=16936720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1aht7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=543-550&author=K.+S.+Puttauthor=G.+W.+Chenauthor=J.+M.+Pearsonauthor=J.+S.+Sandhorstauthor=M.+S.+Hoaglandauthor=J.+T.+Kwonauthor=S.+K.+Hwangauthor=H.+Jinauthor=M.+I.+Churchwellauthor=M.+H.+Choauthor=D.+R.+Doergeauthor=W.+G.+Helferichauthor=P.+J.+Hergenrother&title=Small-molecule+activation+of+procaspase-3+to+caspase-3+as+a+personalized+anticancer+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy</span></div><div class="casAuthors">Putt, Karson S.; Chen, Grace W.; Pearson, Jennifer M.; Sandhorst, Joseph S.; Hoagland, Martin S.; Kwon, Jung-Taek; Hwang, Soon-Kyung; Jin, Hua; Churchwell, Mona I.; Cho, Myung-Haing; Doerge, Daniel R.; Helferich, William G.; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">543-550, S543/1-S543/29</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutation and aberrant expression of apoptotic proteins are hallmarks of cancer.  These changes prevent proapoptotic signals from being transmitted to executioner caspases, thereby averting apoptotic death and allowing cellular proliferation.  Caspase-3 is the key executioner caspase, and it exists as an inactive zymogen that is activated by upstream signals.  Notably, concns. of procaspase-3 in certain cancerous cells are significantly higher than those in noncancerous controls.  Here we report the identification of a small mol., PAC-1 (I) that directly activates procaspase-3 to caspase-3 in vitro and induces apoptosis in cancerous cells isolated from primary colon tumors in a manner directly proportional to the concn. of procaspase-3 inside these cells.  We found that PAC-1 retarded the growth of tumors in three different mouse models of cancer, including two models in which PAC-1 was administered orally.  PAC-1 is the first small mol. known to directly activate procaspase-3 to caspase-3, a transformation that allows induction of apoptosis even in cells that have defective apoptotic machinery.  The direct activation of executioner caspases is an anticancer strategy that may prove beneficial in treating the many cancers in which procaspase-3 concns. are elevated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0HBfttN1PcbVg90H21EOLACvtfcHk0lgiBUrgbx02WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1aht7g%253D&md5=0847c9ec073c912680dd1f715a94a5de</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnchembio814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio814%26sid%3Dliteratum%253Aachs%26aulast%3DPutt%26aufirst%3DK.%2BS.%26aulast%3DChen%26aufirst%3DG.%2BW.%26aulast%3DPearson%26aufirst%3DJ.%2BM.%26aulast%3DSandhorst%26aufirst%3DJ.%2BS.%26aulast%3DHoagland%26aufirst%3DM.%2BS.%26aulast%3DKwon%26aufirst%3DJ.%2BT.%26aulast%3DHwang%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DChurchwell%26aufirst%3DM.%2BI.%26aulast%3DCho%26aufirst%3DM.%2BH.%26aulast%3DDoerge%26aufirst%3DD.%2BR.%26aulast%3DHelferich%26aufirst%3DW.%2BG.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DSmall-molecule%2520activation%2520of%2520procaspase-3%2520to%2520caspase-3%2520as%2520a%2520personalized%2520anticancer%2520strategy%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D543%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, E.</span><span> </span><span class="NLM_article-title">Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">39</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=39-42&author=S.+X.+Caiauthor=H.-Z.+Zhangauthor=J.+Guastellaauthor=J.+Dreweauthor=W.+Yangauthor=E.+Weber&title=Design+and+synthesis+of+rhodamine+110+derivative+and+caspase-3+substrate+for+enzyme+and+cell-based+fluorescent+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWeber%26aufirst%3DE.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520rhodamine%2520110%2520derivative%2520and%2520caspase-3%2520substrate%2520for%2520enzyme%2520and%2520cell-based%2520fluorescent%2520assay%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D39%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span> </span><span class="NLM_article-title">A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structureâactivity relationship studies, to identification of potential anticancer agents and molecular targets</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">2627</span> <span class="NLM_lpage">2644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.2174%2F092986706778201521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17017915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1SktbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2627-2644&author=S.+X.+Caiauthor=J.+Dreweauthor=S.+Kasibhatla&title=A+chemical+genetics+approach+for+the+discovery+of+apoptosis+inducers%3A+from+phenotypic+cell+based+HTS+assay+and+structure%E2%88%92activity+relationship+studies%2C+to+identification+of+potential+anticancer+agents+and+molecular+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets</span></div><div class="casAuthors">Cai, Sui Xiong; Drewe, John; Kasibhatla, Shailaja</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2627-2644</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The approach of chem. genetics has been widely used to study biol. systems and to discover new drugs, signaling pathways and targets.  The current review focuses on the development and utilization of a cell- and caspase-based apoptosis induction assay for the discovery of apoptosis inducers.  We began with the development of a cell based phenotypic assay, which was used for the identification of small mols. that exhibit apoptosis inducing activities, including N-Ph nicotinamides, gambogic acid, indole-2-carboxylic acid benzylidene-hydrazides, 4-aryl-4H-chromenes and 3-aryl-5-aryl-1,2,4-oxadiazoles.  Through medicinal chem. and biol. studies, in vivo active compds. were identified, such as MX116407 as a tumor vascular disrupting agent with potent in vivo anticancer activity.  The mol. targets of in vivo active compds. were identified using reagents designed and synthesized based on the SAR, including the identification of tail-interacting protein 47 (TIP47), an insulin-like growth factor II (IGF II) receptor binding protein, as the mol. target of 3-aryl-5-aryl-1,2,4-oxadiazoles; and Transferrin receptor I (TfR), a transmembrane protein that interacts with transferrin (Tf) for the transport of iron into cells, as the mol. target of gambogic acid.  We demonstrated that chem. genetics is a very useful approach for anticancer drug research, from the discovery of potential drugs, to the understanding of signaling pathways and identification of druggable targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bmsD_VBUGLVg90H21EOLACvtfcHk0ljmENjm9nlu_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1SktbY%253D&md5=d4ca29e8367b8dd6a882df747760c9a2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F092986706778201521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706778201521%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DKasibhatla%26aufirst%3DS.%26atitle%3DA%2520chemical%2520genetics%2520approach%2520for%2520the%2520discovery%2520of%2520apoptosis%2520inducers%253A%2520from%2520phenotypic%2520cell%2520based%2520HTS%2520assay%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520studies%252C%2520to%2520identification%2520of%2520potential%2520anticancer%2520agents%2520and%2520molecular%2520targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2627%26epage%3D2644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery, Characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">309</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=309-317&author=H.-Z.+Zhangauthor=S.+Kasibhatlaauthor=Y.+Wangauthor=J.+Herichauthor=J.+Guastellaauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery%2C+Characterization+and+SAR+of+gambogic+acid+as+a+potent+apoptosis+inducer+by+a+HTS+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%252C%2520Characterization%2520and%2520SAR%2520of%2520gambogic%2520acid%2520as%2520a%2520potent%2520apoptosis%2520inducer%2520by%2520a%2520HTS%2520assay%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D309%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maliartchouk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehlsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span> </span><span class="NLM_article-title">A novel role for transferrin receptor in triggering apoptosis when targeted with gambogic acid</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">102</span> <span class="NLM_fpage">12095</span> <span class="NLM_lpage">12100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=12095-12100&author=S.+Kasibhatlaauthor=K.+Jessenauthor=S.+Maliartchoukauthor=J.+Wangauthor=N.+Englishauthor=J.+Dreweauthor=L.+Quiauthor=S.+Archerauthor=A.+Ponceauthor=N.+Sirisomaauthor=S.+Jiangauthor=H.-Z.+Zhangauthor=K.+Gehlsenauthor=S.+X.+Caiauthor=D.+R.+Greenauthor=B.+Tseng&title=A+novel+role+for+transferrin+receptor+in+triggering+apoptosis+when+targeted+with+gambogic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DJessen%26aufirst%3DK.%26aulast%3DMaliartchouk%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DEnglish%26aufirst%3DN.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DQui%26aufirst%3DL.%26aulast%3DArcher%26aufirst%3DS.%26aulast%3DPonce%26aufirst%3DA.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DGehlsen%26aufirst%3DK.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DTseng%26aufirst%3DB.%26atitle%3DA%2520novel%2520role%2520for%2520transferrin%2520receptor%2520in%2520triggering%2520apoptosis%2520when%2520targeted%2520with%2520gambogic%2520acid%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D12095%26epage%3D12100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuemmerle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliis-Mason, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogran-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery and structure activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">48</span> <span class="NLM_fpage">5215</span> <span class="NLM_lpage">5223</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050292k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5215-5223&author=H.-Z.+Zhangauthor=S.+Kasibhatlaauthor=J.+Kuemmerleauthor=W.+Kemnitzerauthor=K.+Oliis-Masonauthor=L.+Quiauthor=C.+Crogran-Grundyauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+and+structure+activity+relationship+of+3-aryl-5-aryl-1%2C2%2C4-oxadiazoles+as+a+new+series+of+apoptosis+inducers+and+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm050292k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050292k%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DKuemmerle%26aufirst%3DJ.%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DOliis-Mason%26aufirst%3DK.%26aulast%3DQui%26aufirst%3DL.%26aulast%3DCrogran-Grundy%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationship%2520of%25203-aryl-5-aryl-1%252C2%252C4-oxadiazoles%2520as%2520a%2520new%2520series%2520of%2520apoptosis%2520inducers%2520and%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5215%26epage%3D5223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Jessen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maliartchouk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuemmerle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehlsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span> </span><span class="NLM_article-title">Identification of tail interacting protein (TIP47), an IGFII receptor binding protein as the molecular target for tumor selective apoptosis-inducing agents, 3,5-diaryl-[1,2,4]-oxadiazoles</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">761</span> <span class="NLM_lpage">771</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1158%2F1535-7163.MCT-04-0333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=15897240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFyksbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=761-771&author=K.+Jessenauthor=N.+Englishauthor=J.+Wangauthor=L.+Quiauthor=R.+Brandauthor=S.+Maliartchoukauthor=J.+Dreweauthor=J.+Kuemmerleauthor=H.-Z.+Zhangauthor=K.+Gehlsenauthor=B.+Tsengauthor=S.+X.+Caiauthor=S.+Kasibhatla&title=Identification+of+tail+interacting+protein+%28TIP47%29%2C+an+IGFII+receptor+binding+protein+as+the+molecular+target+for+tumor+selective+apoptosis-inducing+agents%2C+3%2C5-diaryl-%5B1%2C2%2C4%5D-oxadiazoles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and mechanism of action of novel tumor-selective and apoptosis-inducing 3,5-diaryl-1,2,4-oxadiazole series using a chemical genetics approach</span></div><div class="casAuthors">Jessen, Katayoun A.; English, Nicole M.; Wang, Jean Yu; Maliartchouk, Sergei; Archer, Shannon P.; Qiu, Ling; Brand, Regina; Kuemmerle, Jared; Zhang, Han-Zhong; Gehlsen, Kurt; Drewe, John; Tseng, Ben; Cai, Sui Xiong; Kasibhatla, Shailaja</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">761-771</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A novel series of 3,5-diaryl-oxadiazoles was identified as apoptosis-inducing agents through our cell and chem. genetics-based screening assay for compds. that induce apoptosis using a chem. genetics approach.  Several analogs from this series including MX-74420 and MX-126374 were further characterized.  MX-126374, a lead compd. from this series, was shown to induce apoptosis and inhibit cell growth selectively in tumor cells.  To elucidate the mechanism(s) by which this class of compds. alters the signal transduction pathway that ultimately leads to apoptosis, expression profiling using the Affymetrix Gene Chip array technol. was done along with other mol. and biochem. analyses.  Interestingly, we have identified several key genes (cyclin D1, transforming growth factor-Î²1, p21, and insulin-like growth factor-BP3) that are altered in the presence of this compd., leading to characterization of the pathway for activation of apoptosis.  MX-126374 also showed significant inhibition of tumor growth as a single agent and in combination with paclitaxel in murine tumor models.  Using photoaffinity labeling, tail-interacting protein 47, an insulin-like growth factor-II receptor binding protein, was identified as the mol. target.  Further studies indicated that down-regulation of tail-interacting protein 47 in cancer cells by small interfering RNA shows a similar pathway profile as compd. treatment.  These data suggest that 3,5-diaryl-oxadiazoles may be a new class of anticancer drugs that are tumor-selective and further support the discovery of novel drugs and drug targets using chem. genetic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEAny0NCb5B7Vg90H21EOLACvtfcHk0ljmENjm9nlu_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFyksbs%253D&md5=2c345caac3c38b49e28ae06ba68019de</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-04-0333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-04-0333%26sid%3Dliteratum%253Aachs%26aulast%3DJessen%26aufirst%3DK.%26aulast%3DEnglish%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DQui%26aufirst%3DL.%26aulast%3DBrand%26aufirst%3DR.%26aulast%3DMaliartchouk%26aufirst%3DS.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DKuemmerle%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DGehlsen%26aufirst%3DK.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DKasibhatla%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520tail%2520interacting%2520protein%2520%2528TIP47%2529%252C%2520an%2520IGFII%2520receptor%2520binding%2520protein%2520as%2520the%2520molecular%2520target%2520for%2520tumor%2520selective%2520apoptosis-inducing%2520agents%252C%25203%252C5-diaryl-%255B1%252C2%252C4%255D-oxadiazoles%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D761%26epage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labreque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meerovitch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouffard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rej, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structureâactivity relationships of the 4-aryl group</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">6299</span> <span class="NLM_lpage">6310</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049640t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6299-6310&author=W.+Kemnitzerauthor=S.+Kasibhatlaauthor=S.+Jiangauthor=H.+Zhangauthor=Y.+Wangauthor=J.+Zhaoauthor=S.+Jiaauthor=J.+Herichauthor=D.+Labrequeauthor=R.+Storerauthor=K.+Meerovitchauthor=D.+Bouffardauthor=R.+Rejauthor=R.+Denisauthor=C.+Blaisauthor=S.+Lamotheauthor=G.+Attardoauthor=H.+Gourdeauauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high-throughput+screening+assay.+1.+Structure%E2%88%92activity+relationships+of+the+4-aryl+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm049640t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049640t%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DLabreque%26aufirst%3DD.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DMeerovitch%26aufirst%3DK.%26aulast%3DBouffard%26aufirst%3DD.%26aulast%3DRej%26aufirst%3DR.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DBlais%26aufirst%3DC.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high-throughput%2520screening%2520assay.%25201.%2520Structure%25E2%2588%2592activity%2520relationships%2520of%2520the%25204-aryl%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6299%26epage%3D6310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogan-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 3. Structure-activity relationships of fused rings at the 7,8-positions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">2858</span> <span class="NLM_lpage">2864</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070216c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2858-2864&author=W.+Kemnitzerauthor=J.+Dreweauthor=S.+Jiangauthor=H.+Zhangauthor=J.+Zhaoauthor=C.+Crogan-Grundyauthor=L.+Xuauthor=S.+Lamotheauthor=H.+Gourdeauauthor=R.+Denisauthor=B.+Tsengauthor=S.+Kasibhatlaauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high-throughput+screening+assay.+3.+Structure-activity+relationships+of+fused+rings+at+the+7%2C8-positions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fjm070216c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070216c%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DCrogan-Grundy%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high-throughput%2520screening%2520assay.%25203.%2520Structure-activity%2520relationships%2520of%2520fused%2520rings%2520at%2520the%25207%252C8-positions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2858%26epage%3D2864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogan-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labreque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubenick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structureâactivity relationships of <i>N</i>-alkyl-substituted pyrrole fused at the 7-, 8-positions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">51</span> <span class="NLM_fpage">417</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7010657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=417-423&author=W.+Kemnitzerauthor=J.+Dreweauthor=S.+Jiangauthor=H.+Zhangauthor=C.+Crogan-Grundyauthor=D.+Labrequeauthor=M.+Bubenickauthor=G.+Attardoauthor=R.+Denisauthor=S.+Lamotheauthor=H.+Gourdeauauthor=B.+Tsengauthor=S.+Kasibhatlaauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+a+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high+throughput+screening+assay.+4.+Structure%E2%88%92activity+relationships+of+N-alkyl-substituted+pyrrole+fused+at+the+7-%2C+8-positions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Fjm7010657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7010657%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCrogan-Grundy%26aufirst%3DC.%26aulast%3DLabreque%26aufirst%3DD.%26aulast%3DBubenick%26aufirst%3DM.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520a%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high%2520throughput%2520screening%2520assay.%25204.%2520Structure%25E2%2588%2592activity%2520relationships%2520of%2520N-alkyl-substituted%2520pyrrole%2520fused%2520at%2520the%25207-%252C%25208-positions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D417%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meerovitch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouffard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span> </span><span class="NLM_article-title">Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">1365</span> <span class="NLM_lpage">1374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=15542775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslCktr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1365-1374&author=S.+Kasibhatlaauthor=H.+Gourdeauauthor=K.+Meerovitchauthor=J.+Dreweauthor=S.+Reddyauthor=L.+Qiuauthor=H.+Zhangauthor=F.+Bergeronauthor=D.+Bouffardauthor=Q.+Yangauthor=J.+Herichauthor=S.+Lamotheauthor=S.+X.+Caiauthor=B.+Tseng&title=Discovery+and+mechanism+of+action+of+a+novel+series+of+apoptosis+inducers+with+potential+vascular+targeting+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity</span></div><div class="casAuthors">Kasibhatla, Shailaja; Gourdeau, Henriette; Meerovitch, Karen; Drewe, John; Reddy, Sanjeeva; Qiu, Ling; Zhang, Hong; Bergeron, Frederick; Bouffard, David; Yang, Quan; Herich, John; Lamothe, Serge; Cai, Sui Xiong; Tseng, Ben</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1365-1374</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A novel series of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes was identified as apoptosis-inducing agents through our cell-based apoptosis screening assay.  Several analogs from this series, MX-58151, MX-58276, MX-76747, MX-116214, MX-126303, and MX-116407, were synthesized and further characterized.  MX-116407, a lead compd. from this series, induced apoptosis with an EC50 of 50 nmol/L and inhibited cell growth with a GI50 of 37 nmol/L in T47D breast cancer cells.  Treatment of cells with these analogs led to G2-M arrest, cleavage of essential proapoptotic caspase substrates, and induction of nuclear fragmentation.  We identified these compds. as tubulin destabilizers with binding site at or close to the colchicine binding site.  Compds. in this series were also active in drug-resistant cancer cell lines with a GI50 value for one of the analogs (MX-58151) of 2.5 nmol/L in paclitaxel-resistant, multidrug-resistant MES-SA/DX5 tumor cells.  This series of compds. displayed high selectivity against proliferating vs. resting cells.  Interestingly, these compds. were shown to disrupt preformed endothelial cell capillary tubules in vitro and affect functional vasculature to induce tumor necrosis in vivo and are thus likely to work as tumor vasculature targeting agents.  Among these compds., MX-116407 showed capillary tubule disruption activity in vitro at concns. well below the cytotoxic dose.  In a sep. study, we further characterized the antitumor efficacy and pharmacokinetic profile of this series of compds. and identified MX-116407 as a potent apoptosis-inducing agent with apparent activity as tumor vasculature targeting agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHfYJ2bcTW_LVg90H21EOLACvtfcHk0li9uexU6plO_A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslCktr4%253D&md5=912ac5b5c08149c875b7c60f132f50ff</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DMeerovitch%26aufirst%3DK.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBergeron%26aufirst%3DF.%26aulast%3DBouffard%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DTseng%26aufirst%3DB.%26atitle%3DDiscovery%2520and%2520mechanism%2520of%2520action%2520of%2520a%2520novel%2520series%2520of%2520apoptosis%2520inducers%2520with%2520potential%2520vascular%2520targeting%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1365%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desputeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kianicka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Custeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span> </span><span class="NLM_article-title">Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4<i>H</i>-chromenes, a novel series of anticancer agents</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">1375</span> <span class="NLM_lpage">1383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=15542776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslCktr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1375-1383&author=H.+Gourdeauauthor=L.+Leblondauthor=B.+Hamelinauthor=C.+Desputeauauthor=K.+Dongauthor=I.+Kianickaauthor=D.+Custeauauthor=C.+Bourdeauauthor=L.+Geertsauthor=S.+X.+Caiauthor=J.+Dreweauthor=D.+Labrecqueauthor=S.+Kasibhatlaauthor=B.+Tseng&title=Antivascular+and+antitumor+evaluation+of+2-amino-4-%283-bromo-4%2C5-dimethoxy-phenyl%29-3-cyano-4H-chromenes%2C+a+novel+series+of+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents</span></div><div class="casAuthors">Gourdeau, Henriette; Leblond, Lorraine; Hamelin, Bettina; Desputeau, Clemence; Dong, Kelly; Kianicka, Irenej; Custeau, Dominique; Boudreau, Chantal; Geerts, Lilianne; Cai, Sui-Xiong; Drewe, John; Labrecque, Denis; Kasibhatla, Shailaja; Tseng, Ben</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1375-1384</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A novel series of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes was identified as potent apoptosis inducers through a cell-based high throughput screening assay.  Six compds. from this series, MX-58151, MX-58276, MX-76747, MX-116214, MX-116407, and MX-126303, were further profiled and shown to have potent in vitro cytotoxic activity toward proliferating cells only and to interact with tubulin at the colchicine-binding site, thereby inhibiting tubulin polymn. and leading to cell cycle arrest and apoptosis.  Furthermore, these compds. were shown to disrupt newly formed capillary tubes in vitro at low nanomolar concns.  These data suggested that the compds. might have vascular targeting activity.  In this study, we have evaluated the ability of these compds. to disrupt tumor vasculature and to induce tumor necrosis.  We investigated the pharmacokinetic and toxicity profiles of all six compds. and examd. their ability to induce tumor necrosis.  We next examd. the antitumor efficacy of a subset of compds. in three different human solid tumor xenografts.  In the human lung tumor xenograft (Calu-6), MX-116407 was highly active, producing tumor regressions in all 10 animals.  Moreover, MX-116407 significantly enhanced the antitumor activity of cisplatin, resulting in 40% tumor-free animals at time of sacrifice.  Our results identify MX-116407 as the lead candidate and strongly support its continued development as a novel anticancer agent for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYs5tq0pO-nbVg90H21EOLACvtfcHk0lgTZI2jN-eBnQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslCktr0%253D&md5=fa04cb51c2d3d9c3b51e4f286856f25b</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DLeblond%26aufirst%3DL.%26aulast%3DHamelin%26aufirst%3DB.%26aulast%3DDesputeau%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DK.%26aulast%3DKianicka%26aufirst%3DI.%26aulast%3DCusteau%26aufirst%3DD.%26aulast%3DBourdeau%26aufirst%3DC.%26aulast%3DGeerts%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DLabrecque%26aufirst%3DD.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26atitle%3DAntivascular%2520and%2520antitumor%2520evaluation%2520of%25202-amino-4-%25283-bromo-4%252C5-dimethoxy-phenyl%2529-3-cyano-4H-chromenes%252C%2520a%2520novel%2520series%2520of%2520anticancer%2520agents%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1375%26epage%3D1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Elslager, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbel, L. M.</span><span> </span><span class="NLM_article-title">Synthesis and antimalarial effects of <i>N</i><sup>2</sup>-aryl-<i>N</i><sup>4</sup>-[(dialkylamino)alkyl]- and <i>N</i><sup>4</sup>-aryl-<i>N</i><sup>2</sup>-[(dialkylamino)alkyl]-2,4-quinazolinediamines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1981</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">127</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00134a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=127-140&author=E.+F.+Elslagerauthor=C.+Hessauthor=J.+Johnsonauthor=D.+Ortwineauthor=V.+Chuauthor=L.+M.+Werbel&title=Synthesis+and+antimalarial+effects+of+N2-aryl-N4-%5B%28dialkylamino%29alkyl%5D-+and+N4-aryl-N2-%5B%28dialkylamino%29alkyl%5D-2%2C4-quinazolinediamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00134a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00134a002%26sid%3Dliteratum%253Aachs%26aulast%3DElslager%26aufirst%3DE.%2BF.%26aulast%3DHess%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DV.%26aulast%3DWerbel%26aufirst%3DL.%2BM.%26atitle%3DSynthesis%2520and%2520antimalarial%2520effects%2520of%2520N2-aryl-N4-%255B%2528dialkylamino%2529alkyl%255D-%2520and%2520N4-aryl-N2-%255B%2528dialkylamino%2529alkyl%255D-2%252C4-quinazolinediamines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Badiger, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nargund, K. S.</span><span> </span><span class="NLM_article-title">Substituted phenyl quinazolyl ethers</span> <span class="citation_source-journal">J. Karnatak Univ.</span><span class="NLM_year" style="font-weight: bold;">1960</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">10</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADyaF3sXisleisQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1960&pages=10-17&author=V.+V.+Badigerauthor=K.+S.+Nargund&title=Substituted+phenyl+quinazolyl+ethers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted phenyl quinazolyl ethers</span></div><div class="casAuthors">Badiger, V. V.; Nargund, K. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Karnatak University</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10-17</span>CODEN:
                <span class="NLM_cas:coden">JKAUAR</span>;
        ISSN:<span class="NLM_cas:issn">0453-3348</span>.
    </div><div class="casAbstract">Several substituted phenyl 4-quinazolyl ethers which are expected to show enhanced antibacterial activity were prepd. by refluxing the substituted phenol (0.05 mole) and 4-chloroquinazoline (0.05 mole) 2 hrs. with a soln. of NaOEt prepd. from Na (0.05 mole) in abs. EtOH (15 ml.).  The mixt. was then dild. with H2O and made alk. to dissolve unreacted phenol.  In the case of dihydric phenols, the reaction mixt. was made neutral and steam distd.  If the ethers were solids, they were filtered off and crystd. from alc.  Liquid ethers were extd. with Et2O, dried over anhyd. CaCl2, the Et2O removed, and the residue distd. in vacuo.  The following (substituted phenyl)-4-quinazolyl ethers and their derivs. were prepd. [substituent, % yield, m.p. or b.p., picrate m.p. (crystd. from alc.) and, if any, the hydrochloride (HCl) m.p. (crystd. from Et2O) or acetyl (Ac) deriv. m.p. (crystn. solvent) given]: 2-Cl, 21, 123Â°, 178Â°, HCl 190Â° (decompn.); 3-Cl, 26, 101Â°, 176Â°;  4-Cl, 21, 113Â°, 184Â°, HCl 210Â°;  2,3-Cl2, 27, 146Â°, 174Â°, HCl 200Â° (decompn.); 2,4-Cl2, 36, 173Â°, 194Â°, HCl 180Â°;  2,6-Cl2, 20, 160Â°, 184-5Â°; 3,5-Cl2, 20, 133Â°, 163Â°, HCl 196Â° (decompn.); 3,4-Cl2, 21, 130Â°, 178Â°; 2-Me, 45, 135-40Â°/15 mm. (n27D 1.5671, d27 1.003), 178Â°; 3-Me, 66, 138-40Â°/15 mm. (n27D 1.5676, d27 1.003), 179Â°; 4-Me, 125-27Â°/10 mm. (n27D 1.5652, d27 1.003), 180Â°; 4-OH, 42, 209Â°, 185Â°, Ac 208Â° (Me2CO); 4-OH, 67, 196-7Â°, 174,Â° Ac 179Â° (dil. alc.); 2-MeO, 42, 155-60Â°/15 mm. (n27D 1.5700, d27 1.003), 180Â°; 3-MeO, 42, 145Â°/6 mm. (n27D 1.5683, d27 1.004), 185Â°; 4-MeO, 50, 144Â°/6 mm. (n27D 1.5680, d27 1.004), 183Â°; 4-NO2, 62, 209Â°, 185Â°; 2,4-Cl(O2N), 70, 206Â°, 198Â°; 2,6,4-Cl2(O2N), 90, 243Â°, 200Â°.  Î²-Naphthyl 4-quinazolyl ether (b10 165-6Â°, n27D 1.5990, d27 1.004) was prepd. in 43% yield (picrate m. 180-1Â°).  Î±-Naphthyl 4-quinazolyl ether (b10 163-5Â°, n27D 1.5998, d27 1.005) was prepd. in 50% yield (picrate m. 180-1Â°).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXglEwjVYOC7Vg90H21EOLACvtfcHk0lgTZI2jN-eBnQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXisleisQ%253D%253D&md5=d16ce0ffed06729fbb5ee2585a7c8e7f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBadiger%26aufirst%3DV.%2BV.%26aulast%3DNargund%26aufirst%3DK.%2BS.%26atitle%3DSubstituted%2520phenyl%2520quinazolyl%2520ethers%26jtitle%3DJ.%2520Karnatak%2520Univ.%26date%3D1960%26volume%3D5%26spage%3D10%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span> </span><span class="NLM_article-title">Discovery of substituted <i>N</i>-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">46</span> <span class="NLM_fpage">2474</span> <span class="NLM_lpage">2481</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0205200" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2474-2481&author=S.+X.+Caiauthor=B.+Nguyenauthor=S.+Jiaauthor=J.+Herichauthor=J.+Guastellaauthor=S.+Reddyauthor=B.+Tsengauthor=J.+Dreweauthor=S.+Kasibhatla&title=Discovery+of+substituted+N-phenyl+nicotinamides+as+potent+inducers+of+apoptosis+using+a+cell-+and+caspase-based+high+throughput+screening+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0205200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0205200%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DKasibhatla%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520substituted%2520N-phenyl%2520nicotinamides%2520as%2520potent%2520inducers%2520of%2520apoptosis%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high%2520throughput%2520screening%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2474%26epage%3D2481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mayer, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D.</span><span> </span><span class="NLM_article-title">Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P-glycoprotein</span> <span class="citation_source-journal">J. Exp. Ther. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">107</span> <span class="NLM_lpage">120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1046%2Fj.1359-4117.2002.1009x.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=12415627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD38XosVSgtbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=107-120&author=L.+D.+Mayerauthor=K.+T.+Limauthor=D.+Hartley&title=Identification+of+two+distinct+intracellular+sites+that+contribute+to+the+modulation+of+multidrug+resistance+in+P388%2FADR+cells+expressing+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P-glycoprotein</span></div><div class="casAuthors">Mayer, Lawrence D.; Lim, Kye-Taek; Hartley, Daria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Therapeutics and Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-120</span>CODEN:
                <span class="NLM_cas:coden">JETOFX</span>;
        ISSN:<span class="NLM_cas:issn">1359-4117</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Although the ability of chemosensitizers to modulate P-glycoprotein (PGP)-based multidrug resistance (MDR) has been extensively studied, relatively little is known about the cellular pharmacol. of the PGP inhibitors themselves in MDR cells.  The studies described here have correlated the in vitro accumulation and retention properties of verapamil (VRP) in murine P388 (sensitive) and P388/ADR (MDR) cells with doxorubicin (DOX) uptake and cytotoxicity modulation characteristics in order to better understand VRP-tumor cell interactions that give rise to MDR modulation.  VRP is rapidly taken up by DOX-sensitive and -resistant P388 cells where greater than 50% maximal VRP uptake occurs within 10 min of initial exposure at 37Â°.  Whereas chemosensitization and DOX uptake in P388/ADR cells increase with increasing VRP concn. until a plateau is achieved at approx. 5 Î¼M VRP, cellular modulator levels increase proportionally with increasing VRP concns. beyond 20 Î¼M.  Subsequent to removal of noncell-assocd. modulator, VRP levels in both sensitive and resistant cells rapidly fall below 10% of those obtained at uptake equil.  However, a residual amt. of VRP remains assocd. with the cells for extended time periods after the cells are washed.  Pulse exposures of P388/ADR cells to high concns. of VRP (50-100 Î¼M) are capable of providing extended cell-assocd. VRP levels comparable to those obtained with continuous exposure at biol. active VRP concns. (1-3 Î¼M) and this leads to chemosensitization.  These results are consistent with the existence of high- and low-affinity intracellular VRP pools in P388 MDR cells, both of which can contribute to the reversal of drug resistance.  It is suggested that these properties should be taken into consideration during the design and evaluation of preclin. in vivo MDR models where pulsed exposure to high concns. of resistance modulators often occurs.  Special attention must be given to whether such high concn. pulses are desirable and/or achievable in relevant clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq3a5HR_0amLVg90H21EOLACvtfcHk0ljkJpkjxpU7HQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosVSgtbg%253D&md5=6ded8d99d931686ab685269eef68f937</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1046%2Fj.1359-4117.2002.1009x.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1359-4117.2002.1009x.x%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DL.%2BD.%26aulast%3DLim%26aufirst%3DK.%2BT.%26aulast%3DHartley%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520two%2520distinct%2520intracellular%2520sites%2520that%2520contribute%2520to%2520the%2520modulation%2520of%2520multidrug%2520resistance%2520in%2520P388%252FADR%2520cells%2520expressing%2520P-glycoprotein%26jtitle%3DJ.%2520Exp.%2520Ther.%2520Oncol.%26date%3D2002%26volume%3D2%26spage%3D107%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">56</span> <span class="NLM_fpage">51</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1016%2FS0014-827X%2801%2901026-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=11347967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltFKqsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=51-56&author=W.+A.+Denny&title=The+4-anilinoquinazoline+class+of+inhibitors+of+the+erbB+family+of+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases</span></div><div class="casAuthors">Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">51-56</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">The erbB family of receptor tyrosine kinase enzymes, and particularly EGFR and HER2/neu, have become important targets for potential anticancer drugs.  The substrate protein binding site theor. is the more attractive intracellular target on these enzymes, possessing lower homol. than the ATP site between different receptor kinases.  However, a major breakthrough in this field was the discovery that 4-anilinoquinazolines are potent and selective inhibitors, despite binding at the ATP site.  The very tight structure-activity relationships shown by these compds. suggested a clearly-defined binding mode, where the quinazoline ring binds in the adenine pocket and the anilino ring binds in an adjacent, unique lipophilic pocket.  A unique cysteine (Cys-773) adjacent to the quinazoline binding site has prompted the development of irreversible inhibitors that target this residue.  Three 4-anilinoquinazoline analogs (two reversible and one irreversible inhibitor) have been evaluated clin. as anticancer drugs.  Data from the most advanced, the reversible inhibitor Iressa, suggest that this class of compds. may be of value in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6rVaLzsNOfLVg90H21EOLACvtfcHk0ljkJpkjxpU7HQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltFKqsbw%253D&md5=83511311545c258eb424046d446795c9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2801%2901026-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252801%252901026-6%26sid%3Dliteratum%253Aachs%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DThe%25204-anilinoquinazoline%2520class%2520of%2520inhibitors%2520of%2520the%2520erbB%2520family%2520of%2520receptor%2520tyrosine%2520kinases%26jtitle%3DFarmaco%26date%3D2001%26volume%3D56%26spage%3D51%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Klutchko, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Althaus, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherwood, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smaill, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-<i>d</i>]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">1475</span> <span class="NLM_lpage">1485</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050936o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1475-1485&author=S.+R.+Klutchkoauthor=H.+Zhouauthor=R.+T.+Wintersauthor=T.+P.+Tranauthor=A.+J.+Bridgesauthor=I.+W.+Althausauthor=D.+M.+Amatoauthor=W.+L.+Elliottauthor=P.+A.+Ellisauthor=M.+A.+Meadeauthor=B.+J.+Robertsauthor=D.+W.+Fryauthor=A.+J.+Gonzalesauthor=P.+J.+Harveyauthor=J.+M.+Nelsonauthor=V.+Sherwoodauthor=H.-K.+Hanauthor=G.+Paceauthor=J.+B.+Smaillauthor=W.+A.+Dennyauthor=H.+D.+H.+Showalter&title=Tyrosine+kinase+inhibitors.+19.+6-Alkynamides+of+4-anilinoquinazolines+and+4-anilinopyrido%5B3%2C4-d%5Dpyrimidines+as+irreversible+inhibitors+of+the+erbB+family+of+tyrosine+kinase+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm050936o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050936o%26sid%3Dliteratum%253Aachs%26aulast%3DKlutchko%26aufirst%3DS.%2BR.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWinters%26aufirst%3DR.%2BT.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DAlthaus%26aufirst%3DI.%2BW.%26aulast%3DAmato%26aufirst%3DD.%2BM.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DEllis%26aufirst%3DP.%2BA.%26aulast%3DMeade%26aufirst%3DM.%2BA.%26aulast%3DRoberts%26aufirst%3DB.%2BJ.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DGonzales%26aufirst%3DA.%2BJ.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DNelson%26aufirst%3DJ.%2BM.%26aulast%3DSherwood%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DH.-K.%26aulast%3DPace%26aufirst%3DG.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252019.%25206-Alkynamides%2520of%25204-anilinoquinazolines%2520and%25204-anilinopyrido%255B3%252C4-d%255Dpyrimidines%2520as%2520irreversible%2520inhibitors%2520of%2520the%2520erbB%2520family%2520of%2520tyrosine%2520kinase%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1475%26epage%3D1485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert-van der Brempt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgentin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterbein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, G</span><span> </span><span class="NLM_article-title"><i>N</i>-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2<i>H</i>-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">6465</span> <span class="NLM_lpage">6488</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060434q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6465-6488&author=L.+F.+Hennequinauthor=J.+Allenauthor=J.+Breedauthor=J.+Curwenauthor=M.+Fennellauthor=T.+P.+Greenauthor=C.+Lambert-van+der+Bremptauthor=R.+Morgentinauthor=R.+A.+Normanauthor=A.+Olivierauthor=L.+Otterbeinauthor=P.+A.+Pleauthor=N.+Warinauthor=G+Costello&title=N-%285-Chloro-1%2C3-benzodioxol-4-yl%29-7-%5B2-%284-methylpiperazin-1-yl%29ethoxy%5D-5-%28tetrahydro-2H-pyran-4-yloxy%29quinazolin-4-amine%2C+a+novel%2C+highly+selective%2C+orally+available%2C+dual-specific+c-Src%2FAbl+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fjm060434q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060434q%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DCurwen%26aufirst%3DJ.%26aulast%3DFennell%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DT.%2BP.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26aulast%3DMorgentin%26aufirst%3DR.%26aulast%3DNorman%26aufirst%3DR.%2BA.%26aulast%3DOlivier%26aufirst%3DA.%26aulast%3DOtterbein%26aufirst%3DL.%26aulast%3DPle%26aufirst%3DP.%2BA.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DCostello%26aufirst%3DG%26atitle%3DN-%25285-Chloro-1%252C3-benzodioxol-4-yl%2529-7-%255B2-%25284-methylpiperazin-1-yl%2529ethoxy%255D-5-%2528tetrahydro-2H-pyran-4-yloxy%2529quinazolin-4-amine%252C%2520a%2520novel%252C%2520highly%2520selective%252C%2520orally%2520available%252C%2520dual-specific%2520c-Src%252FAbl%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6465%26epage%3D6488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert-van der Brempt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J.-J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Savi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dousson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortlock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odedra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.; Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brightwell, S.</span><span> </span><span class="NLM_article-title">Discovery of nove l and potent thiazoloquinazolines as selective eaurora A and B kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">955</span> <span class="NLM_lpage">970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050786h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=955-970&author=F.+H.+Jungauthor=G.+Pasquetauthor=C.+Lambert-van+der+Bremptauthor=J.-J.+M.+Lohmannauthor=N.+Warinauthor=F.+Renaudauthor=H.+Germainauthor=C.+De+Saviauthor=N.+Robertsauthor=T.+Johnsonauthor=C.+Doussonauthor=G.+B.+Hillauthor=A.+A.+Mortlockauthor=N.+Heronauthor=R.+W.+Wilkinsonauthor=S.+R.+Wedgeauthor=S.+P.+Heatonauthor=R.+Odedraauthor=N.+J.%3B+Green%2C+S.+Keenauthor=E.+Brownauthor=K.+Thompsonauthor=S.+Brightwell&title=Discovery+of+nove+l+and+potent+thiazoloquinazolines+as+selective+eaurora+A+and+B+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1021%2Fjm050786h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050786h%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DPasquet%26aufirst%3DG.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26aulast%3DLohmann%26aufirst%3DJ.-J.%2BM.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DRenaud%26aufirst%3DF.%26aulast%3DGermain%26aufirst%3DH.%26aulast%3DDe%2BSavi%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DDousson%26aufirst%3DC.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DMortlock%26aufirst%3DA.%2BA.%26aulast%3DHeron%26aufirst%3DN.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DHeaton%26aufirst%3DS.%2BP.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%253B%2BGreen%252C%2BS.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DBrightwell%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520nove%2520l%2520and%2520potent%2520thiazoloquinazolines%2520as%2520selective%2520eaurora%2520A%2520and%2520B%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D955%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bridges, A. J.</span><span> </span><span class="NLM_article-title">Chemical inhibitors of protein kinases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">101</span> <span class="NLM_fpage">2541</span> <span class="NLM_lpage">2572</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr000250y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvVWnt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=2541-2572&author=A.+J.+Bridges&title=Chemical+inhibitors+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical inhibitors of protein kinases</span></div><div class="casAuthors">Bridges, Alexander J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2541-2571</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 258 refs. on development protein kinase inhibitors as potential antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXWn7KO1AXzrVg90H21EOLACvtfcHk0ljv4bwd56DCuw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvVWnt7k%253D&md5=05ee78880cc9dcf485684e05327108db</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcr000250y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr000250y%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26atitle%3DChemical%2520inhibitors%2520of%2520protein%2520kinases%26jtitle%3DChem.%2520Rev.%26date%3D2001%26volume%3D101%26spage%3D2541%26epage%3D2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5â²-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">38</span> <span class="NLM_fpage">3482</span> <span class="NLM_lpage">3487</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00018a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3482-3487&author=G.+W.+Rewcastleauthor=W.+A.+Dennyauthor=A.+J.+Bridgesauthor=H.+Zhouauthor=D.+R.+Codyauthor=A.+McMichaelauthor=D.+W.+Fry&title=Tyrosine+kinase+inhibitors.+5.+Synthesis+and+structure-activity+relationships+for+4-%5B%28phenylmethyl%29amino%5D-+and+4-%28phenylamino%29quinazolines+as+potent+adenosine+5%E2%80%B2-triphosphate+binding+site+inhibitors+of+the+tyrosine+kinase+domain+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00018a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00018a008%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DCody%26aufirst%3DD.%2BR.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25205.%2520Synthesis%2520and%2520structure-activity%2520relationships%2520for%25204-%255B%2528phenylmethyl%2529amino%255D-%2520and%25204-%2528phenylamino%2529quinazolines%2520as%2520potent%2520adenosine%25205%25E2%2580%25B2-triphosphate%2520binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3482%26epage%3D3487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors. 8. An unusually steep structureâactivity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">39</span> <span class="NLM_fpage">267</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9503613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=267-276&author=A.+J.+Bridgesauthor=H.+Zhouauthor=D.+R.+Codyauthor=G.+W.+Rewcastleauthor=A.+McMichaelauthor=H.+D.+H.+Showalterauthor=D.+W.+Fryauthor=A.+J.+Krakerauthor=W.+A.+Denny&title=Tyrosine+kinase+inhibitors.+8.+An+unusually+steep+structure%E2%88%92activity+relationship+for+analogues+of+4-%283-bromoanilino%29-6%2C7-dimethoxyquinazoline+%28PD+153035%29%2C+a+potent+inhibitor+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm9503613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9503613%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DCody%26aufirst%3DD.%2BR.%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25208.%2520An%2520unusually%2520steep%2520structure%25E2%2588%2592activity%2520relationship%2520for%2520analogues%2520of%25204-%25283-bromoanilino%2529-6%252C7-dimethoxyquinazoline%2520%2528PD%2520153035%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D267%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Gazit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitzki, A.</span><span> </span><span class="NLM_article-title">Tyrphostins IV: highly potent inhibitors of EGF receptor kinase. Structureâactivity relationship study of 4-anilinoquinazolines</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">1203</span> <span class="NLM_lpage">1207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=1203-1207&author=A.+Gazitauthor=J.+Chenauthor=H.+Appauthor=G.+McMahonauthor=P.+Hirthauthor=I.+Chenauthor=A.+Levitzki&title=Tyrphostins+IV%3A+highly+potent+inhibitors+of+EGF+receptor+kinase.+Structure%E2%88%92activity+relationship+study+of+4-anilinoquinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGazit%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DLevitzki%26aufirst%3DA.%26atitle%3DTyrphostins%2520IV%253A%2520highly%2520potent%2520inhibitors%2520of%2520EGF%2520receptor%2520kinase.%2520Structure%25E2%2588%2592activity%2520relationship%2520study%2520of%25204-anilinoquinazolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1996%26volume%3D4%26spage%3D1203%26epage%3D1207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span> </span><span class="NLM_article-title">MPC-6827: A small molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">5865</span> <span class="NLM_lpage">5871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=5865-5871&author=S.+Kasibhatlaauthor=V.+Baichwalauthor=S.+X.+Caiauthor=B.+Rothauthor=I.+Skvortsovaauthor=S.+Skvortsovauthor=P.+Lukasauthor=N.+M.+Englishauthor=N.+Sirisomaauthor=J.+Dreweauthor=A.+Pervinauthor=B.+Tsengauthor=R.+O.+Carlsonauthor=C.+M.+Pleiman&title=MPC-6827%3A+A+small+molecule+inhibitor+of+microtubule+formation+that+is+not+a+substrate+for+multidrug+resistance+pumps"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSkvortsova%26aufirst%3DI.%26aulast%3DSkvortsov%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DP.%26aulast%3DEnglish%26aufirst%3DN.%2BM.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26atitle%3DMPC-6827%253A%2520A%2520small%2520molecule%2520inhibitor%2520of%2520microtubule%2520formation%2520that%2520is%2520not%2520a%2520substrate%2520for%2520multidrug%2520resistance%2520pumps%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D5865%26epage%3D5871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennisi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L.</span><span> </span><span class="NLM_article-title">A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">64</span> <span class="NLM_fpage">6652</span> <span class="NLM_lpage">6659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1158%2F0008-5472.CAN-04-1168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=15374980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6652-6659&author=E.+R.+Woodauthor=A.+T.+Truesdaleauthor=O.+B.+McDonaldauthor=D.+Yuanauthor=A.+Hassellauthor=S.+H.+Dickersonauthor=B.+Ellisauthor=C.+Pennisiauthor=E.+Horneauthor=K.+Lackeyauthor=K.+J.+Alligoodauthor=D.+W.+Rusnakauthor=T.+M.+Gilmerauthor=L.+Shewchuk&title=A+unique+structure+for+epidermal+growth+factor+receptor+bound+to+GW572016+%28Lapatinib%29%3A+relationships+among+protein+conformation%2C+inhibitor+off-rate%2C+and+receptor+activity+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells</span></div><div class="casAuthors">Wood, Edgar R.; Truesdale, Anne T.; McDonald, Octerloney B.; Yuan, Derek; Hassell, Anne; Dickerson, Scott H.; Ellis, Byron; Pennisi, Christopher; Horne, Earnest; Lackey, Karen; Alligood, Krystal J.; Rusnak, David W.; Gilmer, Tona M.; Shewchuk, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6652-6659</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">GW572016 (Lapatinib) is a tyrosine kinase inhibitor in clin. development for cancer that is a potent dual inhibitor of epidermal growth factor receptor (EGFR, ErbB-1) and ErbB-2.  The authors detd. the crystal structure of EGFR bound to GW572016.  The compd. is bound to an inactive-like conformation of EGFR that is very different from the active-like structure bound by the selective EGFR inhibitor OSI-774 (Tarceva) described previously.  Surprisingly, the authors found that GW572016 has a very slow off-rate from the purified intracellular domains of EGFR and ErbB-2 compared with OSI-774 and another EGFR selective inhibitor, ZD-1839 (Iressa).  Treatment of tumor cells with these inhibitors results in down-regulation of receptor tyrosine phosphorylation.  The authors evaluated the duration of the drug effect after washing away free compd. and found that the rate of recovery of receptor phosphorylation in the tumor cells reflected the inhibitor off-rate from the purified intracellular domain.  The slow off-rate of GW572016 correlates with a prolonged down-regulation of receptor tyrosine phosphorylation in tumor cells.  The differences in the off-rates of these drugs and the ability of GW572016 to inhibit ErbB-2 can be explained by the enzyme-inhibitor structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXjJPy6XYk4rVg90H21EOLACvtfcHk0lhguXdmfpGf7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D&md5=788d92fc5db9f1ecf9d3fbf3142e5c9f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1168%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DMcDonald%26aufirst%3DO.%2BB.%26aulast%3DYuan%26aufirst%3DD.%26aulast%3DHassell%26aufirst%3DA.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DEllis%26aufirst%3DB.%26aulast%3DPennisi%26aufirst%3DC.%26aulast%3DHorne%26aufirst%3DE.%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%26atitle%3DA%2520unique%2520structure%2520for%2520epidermal%2520growth%2520factor%2520receptor%2520bound%2520to%2520GW572016%2520%2528Lapatinib%2529%253A%2520relationships%2520among%2520protein%2520conformation%252C%2520inhibitor%2520off-rate%252C%2520and%2520receptor%2520activity%2520in%2520tumor%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6652%26epage%3D6659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Stamos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwkowski, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span> </span><span class="NLM_article-title">Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">277</span> <span class="NLM_fpage">46265</span> <span class="NLM_lpage">46272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1074%2Fjbc.M207135200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=12196540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKhsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46265-46272&author=J.+Stamosauthor=M.+X.+Sliwkowskiauthor=C.+Eigenbrot&title=Structure+of+the+epidermal+growth+factor+receptor+kinase+domain+alone+and+in+complex+with+a+4-anilinoquinazoline+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor</span></div><div class="casAuthors">Stamos, Jennifer; Sliwkowski, Mark X.; Eigenbrot, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">46265-46272</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been detd. to 2.6-Ã resoln., both with and without an EGFRK-specific inhibitor currently in Phase III clin. trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva).  The EGFR family members are distinguished from all other known receptor tyrosine kinases in possessing constitutive kinase activity without a phosphorylation event within their kinase domains.  Despite its lack of phosphorylation, we find that the EGFRK activation loop adopts a conformation similar to that of the phosphorylated active form of the kinase domain from the insulin receptor.  Surprisingly, key residues of a putative dimerization motif lying between the EGFRK domain and carboxyl-terminal substrate docking sites are found in close contact with the kinase domain.  Significant intermol. contacts involving the carboxyl-terminal tail are discussed with respect to receptor oligomerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsObp1WYFaC7Vg90H21EOLACvtfcHk0lgGdUU5EghW4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKhsL4%253D&md5=c63c60b93756bd45fb2375c56ba38941</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M207135200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M207135200%26sid%3Dliteratum%253Aachs%26aulast%3DStamos%26aufirst%3DJ.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26aulast%3DEigenbrot%26aufirst%3DC.%26atitle%3DStructure%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520domain%2520alone%2520and%2520in%2520complex%2520with%2520a%25204-anilinoquinazoline%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46265%26epage%3D46272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Shewchuk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisely, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocque, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuyper, L. F.</span><span> </span><span class="NLM_article-title">Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">133</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990401t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=133-138&author=L.+Shewchukauthor=A.+Hassellauthor=B.+Wiselyauthor=W.+Rocqueauthor=W.+Holmesauthor=J.+Vealauthor=L.+F.+Kuyper&title=Binding+mode+of+the+4-anilinoquinazoline+class+of+protein+kinase+inhibitor%3A+X-ray+crystallographic+studies+of+4-anilinoquinazolines+bound+to+cyclin-dependent+kinase+2+and+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm990401t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990401t%26sid%3Dliteratum%253Aachs%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DHassell%26aufirst%3DA.%26aulast%3DWisely%26aufirst%3DB.%26aulast%3DRocque%26aufirst%3DW.%26aulast%3DHolmes%26aufirst%3DW.%26aulast%3DVeal%26aufirst%3DJ.%26aulast%3DKuyper%26aufirst%3DL.%2BF.%26atitle%3DBinding%2520mode%2520of%2520the%25204-anilinoquinazoline%2520class%2520of%2520protein%2520kinase%2520inhibitor%253A%2520X-ray%2520crystallographic%2520studies%2520of%25204-anilinoquinazolines%2520bound%2520to%2520cyclin-dependent%2520kinase%25202%2520and%2520p38%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D133%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Myers, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setzer, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spada, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persons, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zulli, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zilberstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, K. J.</span><span> </span><span class="NLM_article-title">The synthesis and SAR of new 4-(<i>N</i>-alkyl-<i>N</i>-phenyl)amino-6,7-dimethoxyquinazolines and 4-(<i>N</i>-alkyl-<i>N</i>-phenyl)aminopyrazolo[3,4-<i>d</i>]pyrimidines, inhibitors of CSF-1R tyrosine kinase activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">421</span> <span class="NLM_lpage">424</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=421-424&author=M.+R.+Myersauthor=N.+N.+Setzerauthor=A.+P.+Spadaauthor=P.+E.+Personsauthor=C.+Q.+Lyauthor=M.+P.+Maguireauthor=A.+L.+Zulliauthor=D.+L.+Cheneyauthor=A.+Zilbersteinauthor=S.+E.+Johnsonauthor=C.+F.+Franksauthor=K.+J.+Mitchell&title=The+synthesis+and+SAR+of+new+4-%28N-alkyl-N-phenyl%29amino-6%2C7-dimethoxyquinazolines+and+4-%28N-alkyl-N-phenyl%29aminopyrazolo%5B3%2C4-d%5Dpyrimidines%2C+inhibitors+of+CSF-1R+tyrosine+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DM.%2BR.%26aulast%3DSetzer%26aufirst%3DN.%2BN.%26aulast%3DSpada%26aufirst%3DA.%2BP.%26aulast%3DPersons%26aufirst%3DP.%2BE.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DMaguire%26aufirst%3DM.%2BP.%26aulast%3DZulli%26aufirst%3DA.%2BL.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DZilberstein%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DS.%2BE.%26aulast%3DFranks%26aufirst%3DC.%2BF.%26aulast%3DMitchell%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520synthesis%2520and%2520SAR%2520of%2520new%25204-%2528N-alkyl-N-phenyl%2529amino-6%252C7-dimethoxyquinazolines%2520and%25204-%2528N-alkyl-N-phenyl%2529aminopyrazolo%255B3%252C4-d%255Dpyrimidines%252C%2520inhibitors%2520of%2520CSF-1R%2520tyrosine%2520kinase%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D421%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Antonello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morroni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrelia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multitarget-directed drug design strategy: A novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">6642</span> <span class="NLM_lpage">6645</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608762" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6642-6645&author=A.+Antonelloauthor=A.+Tarozziauthor=F.+Morroniauthor=A.+Cavalliauthor=M.+Rosiniauthor=P.+Hreliaauthor=M.+L.+Bolognesiauthor=C.+Melchiorre&title=Multitarget-directed+drug+design+strategy%3A+A+novel+molecule+designed+to+block+epidermal+growth+factor+receptor+%28EGFR%29+and+to+exert+proapoptotic+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0608762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608762%26sid%3Dliteratum%253Aachs%26aulast%3DAntonello%26aufirst%3DA.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DMorroni%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DHrelia%26aufirst%3DP.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMultitarget-directed%2520drug%2520design%2520strategy%253A%2520A%2520novel%2520molecule%2520designed%2520to%2520block%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520to%2520exert%2520proapoptotic%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6642%26epage%3D6645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Sapra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehlig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraft, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horak, I. D.</span><span> </span><span class="NLM_article-title">Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">1888</span> <span class="NLM_lpage">1896</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1158%2F1078-0432.CCR-07-4456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=18347192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtleis7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1888-1896&author=P.+Sapraauthor=H.+Zhaoauthor=M.+Mehligauthor=J.+Malabyauthor=P.+Kraftauthor=C.+Longleyauthor=L.+M.+Greenbergerauthor=I.+D.+Horak&title=Novel+delivery+of+SN38+markedly+inhibits+tumor+growth+in+xenografts%2C+including+a+camptothecin-11-refractory+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camptothecin-11-Refractory Model</span></div><div class="casAuthors">Sapra, Puja; Zhao, Hong; Mehlig, Mary; Malaby, Jennifer; Kraft, Patricia; Longley, Clifford; Greenberger, Lee M.; Horak, Ivan D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1888-1896</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Clin. development of SN38, the active metabolite of camptothecin-11 (CPT-11), has been hampered due to its poor soly.  We have developed a novel polymer-drug conjugate, EZN-2208, made by linking SN38 with a multiarm polyethylene glycol via a glycine linker.  Exptl. Design: The in vitro cytotoxicity of EZN-2208 was tested using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay.  The therapeutic efficacy of EZN-2208 was evaluated in various xenografts, including an in vivo-selected CPT-11-refractory model.  Tumor and blood concn. of EZN-2208, CPT-11, and SN38 was detd. by high-performance liq. chromatog.  Results: In vitro, EZN-2208 was 10- to 245-fold more potent than CPT-11 in a panel of human tumor cell lines.  In xenograft models of MX-1 breast, MiaPaCa-2 pancreatic, or HT-29 colon carcinoma, treatment with either a single dose or multiple injections of EZN-2208 was more efficacious (and in some cases produced tumor eradication for >16 wk) compared with CPT-11 at their resp. max. tolerated doses or corresponding dose levels (P < 0.01).  Most interestingly, EZN-2208 showed marked antitumor activity in animals that developed resistance to an 8-day course of CPT-11 treatment, as well as outperformed CPT-11 as second-round therapy in mice initially sensitive to CPT-11.  EZN-2208 had prolonged circulation in the blood compared with CPT-11, resulting in high tumor exposure.  This resulted in higher and longer-lasting tumor exposure of free SN38 in mice given EZN-2208 compared with those given CPT-11.  Conclusions: Preclin. data suggest that EZN-2208 may be a promising anticancer agent in a wide variety of clin. settings, including tumors refractory to CPT-11 treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph4l3Uv3BN4LVg90H21EOLACvtfcHk0lgGdUU5EghW4A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtleis7s%253D&md5=0d18ceb4c67434798d9f07d19d611352</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4456%26sid%3Dliteratum%253Aachs%26aulast%3DSapra%26aufirst%3DP.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMehlig%26aufirst%3DM.%26aulast%3DMalaby%26aufirst%3DJ.%26aulast%3DKraft%26aufirst%3DP.%26aulast%3DLongley%26aufirst%3DC.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DHorak%26aufirst%3DI.%2BD.%26atitle%3DNovel%2520delivery%2520of%2520SN38%2520markedly%2520inhibits%2520tumor%2520growth%2520in%2520xenografts%252C%2520including%2520a%2520camptothecin-11-refractory%2520model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D1888%26epage%3D1896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Wada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jinno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, K.</span><span> </span><span class="NLM_article-title">Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">1431</span> <span class="NLM_lpage">1435</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17595758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFynsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1431-1435&author=M.+Wadaauthor=H.+Jinnoauthor=M.+Uedaauthor=T.+Ikedaauthor=M.+Kitajimaauthor=T.+Konnoauthor=J.+Watanabeauthor=K.+Ishihara&title=Efficacy+of+an+MPC-BMA+co-polymer+as+a+nanotransporter+for+paclitaxel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel</span></div><div class="casAuthors">Wada, Masahiro; Jinno, Hiromitsu; Ueda, Masakazu; Ikeda, Tadashi; Kitajima, Masaki; Konno, Tomohiro; Watanabe, Junji; Ishihara, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3B</span>),
    <span class="NLM_cas:pages">1431-1435</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Paclitaxel (PTX) is administered as a soln. in polyoxyethylated castor oil (CO) due to its low water soly., but solvent-induced side-effects may be severe.  PMB30W is a co-polymer of 2-methacryloyloxyethyl phosphorylcholine (MPC) and Bu methacrylate (BMA).  Cytotoxicities of PTX in PMB30W (PTX-PMB30W) were examd. in cell culture and in vivo.  PTX-PMB30W and PTX in DMSO showed similar toxicity in breast cancer cell lines MCF-7, SK-BR-3 and MX-1.  Antitumor efficacies of PTX-PMB30W and PTX in CO (PTX-CO) were similar following weekly i.p. administration of 50 mg/kg PTX in nude mice transplanted with MX-1 cells.  At 200 mg/kg PTX, all animals died within 1 min of PTX-CO administration.  However, all animals receiving PTX-PBM30W survived.  Ulceration occurred following s.c. injection of PTX-CO, but injection of PTX-PMB30W did not cause skin changes.  Our data suggest that PMB30W can act as an effective PTX nanotransporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVuM-RYUsLZLVg90H21EOLACvtfcHk0lifXo1EVxO9vA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFynsrc%253D&md5=4f8e6f3b290ffd4b9f263a7d8d9c4523</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWada%26aufirst%3DM.%26aulast%3DJinno%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DT.%26aulast%3DKitajima%26aufirst%3DM.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DJ.%26aulast%3DIshihara%26aufirst%3DK.%26atitle%3DEfficacy%2520of%2520an%2520MPC-BMA%2520co-polymer%2520as%2520a%2520nanotransporter%2520for%2520paclitaxel%26jtitle%3DAnticancer%2520Res.%26date%3D2007%26volume%3D27%26spage%3D1431%26epage%3D1435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Deeken, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loscher, W.</span><span> </span><span class="NLM_article-title">The bloodâbrain barrier and cancer: transporters, treatment, and Trojan horses</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">1663</span> <span class="NLM_lpage">1674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1158%2F1078-0432.CCR-06-2854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17363519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1663-1674&author=J.+F.+Deekenauthor=W.+Loscher&title=The+blood%E2%88%92brain+barrier+and+cancer%3A+transporters%2C+treatment%2C+and+Trojan+horses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses</span></div><div class="casAuthors">Deeken, John F.; Loescher, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1663-1674</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Despite scientific advances in understanding the causes and treatment of human malignancy, a persistent challenge facing basic and clin. investigators is how to adequately treat primary and metastatic brain tumors.  The blood-brain barrier is a physiol. obstruction to the delivery of systemic chemotherapy to the brain parenchyma and central nervous system (CNS).  A no. of physiol. properties make the endothelium in the CNS distinct from the vasculature found in the periphery.  Recent evidence has shown that a crit. aspect of this barrier is composed of xenobiotic transporters which extrude substrates from the brain into the cerebrospinal fluid and systemic circulation.  These transporters also extrude drugs and toxins if they gain entry into the cytoplasm of brain endothelial cells before they enter the brain.  This review highlights the properties of the blood-brain barrier, including the location, function, and relative importance of the drug transporters that maintain this barrier.  Primary and metastatic brain malignancy can compromise this barrier, allowing some access of chemotherapy treatment to reach the tumor.  The responsiveness of brain tumors to systemic treatment found in past clin. research is discussed, as are possible explanations as to why CNS tumors are nonetheless able to evade therapy.  Finally, strategies to overcome this barrier and better deliver chemotherapy into CNS tumors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxa44seefNF7Vg90H21EOLACvtfcHk0lifXo1EVxO9vA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D&md5=dc7ea92d49779b99871f98a5e2b59858</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2854%26sid%3Dliteratum%253Aachs%26aulast%3DDeeken%26aufirst%3DJ.%2BF.%26aulast%3DLoscher%26aufirst%3DW.%26atitle%3DThe%2520blood%25E2%2588%2592brain%2520barrier%2520and%2520cancer%253A%2520transporters%252C%2520treatment%252C%2520and%2520Trojan%2520horses%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1663%26epage%3D1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structureâbrain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">7559</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%88%92brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2588%2592brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Broniscer, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panetta, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShaughnessy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajjar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. F.</span><span> </span><span class="NLM_article-title">Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">1511</span> <span class="NLM_lpage">1515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1158%2F1078-0432.CCR-06-2372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17332296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlSjt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1511-1515&author=A+Broniscerauthor=J.+C.+Panettaauthor=M.+O%E2%80%99Shaughnessyauthor=C.+Fragaauthor=F.+Baiauthor=M.+J.+Krasinauthor=A.+Gajjarauthor=C.+F.+Stewart&title=Plasma+and+cerebrospinal+fluid+pharmacokinetics+of+erlotinib+and+its+active+metabolite+OSI-420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420</span></div><div class="casAuthors">Broniscer, Alberto; Panetta, John C.; O'Shaughnessy, Melinda; Fraga, Charles; Bai, Feng; Krasin, Matthew J.; Gajjar, Amar; Stewart, Clinton F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1511-1515</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To report cerebrospinal fluid (CSF) penetration of erlotinib and its metabolite OSI-420.  Pharmacokinetic measurements were done in plasma (days 1, 2, 3, and 8 of therapy) and, concurrently, in plasma and CSF (before and at 1, 2, 4, 8, and 24 h after dose on day 34 of therapy) in an 8-yr-old patient diagnosed with glioblastoma who received local irradn. and oral erlotinib in a phase I protocol.  CSF samples were collected from a ventriculoperitoneal shunt, which was externalized because of infection.  Erlotinib concns. were detd. by liq. chromatog./mass spectrometry.  CSF penetration of erlotinib and OSI-420 were estd. by a compartmental model and by calcg. the ratio of CSF to plasma 24-h area under concn.-time curve (AUC0-24).  This patient was assigned to receive erlotinib at a dose level of 70 mg/m2, but the actual daily dose was 75 mg (78 mg/m2).  Erlotinib and OSI-420 plasma pharmacokinetic variables on days 8 and 34 overlapped to suggest that steady state had been reached.  Whereas erlotinib and OSI-420 AUC0-24 in plasma on day 34 were 30,365 and 2,527 ng h/mL, resp., the correspondent AUC0-24 in the CSF were 2,129 and 240 ng h/mL, resp.  Erlotinib and OSI-420 CSF penetration were 7% and â¼9%, resp., using both est. methods.  The max. steady-state CSF concn. of erlotinib was â¼130 ng/mL (325 nmol/L).  The plasma pharmacokinetics of erlotinib in this child overlapped with results described in adults.  Oral administration of erlotinib achieves CSF concns. comparable with those active against several cancer cell lines in preclin. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoldU23ij5mgLVg90H21EOLACvtfcHk0lifXo1EVxO9vA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlSjt7Y%253D&md5=9b1e3b0a3d448075085ee7fd38ca635e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2372%26sid%3Dliteratum%253Aachs%26aulast%3DBroniscer%26aufirst%3DA%26aulast%3DPanetta%26aufirst%3DJ.%2BC.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DM.%26aulast%3DFraga%26aufirst%3DC.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DKrasin%26aufirst%3DM.%2BJ.%26aulast%3DGajjar%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26atitle%3DPlasma%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520erlotinib%2520and%2520its%2520active%2520metabolite%2520OSI-420%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1511%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b','cit26c'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 45 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yumiko Suzuki, Ayana Otake, Satoshi Ueno, Kensuke Hayashi, Hirosuke Ishii, Nao Miyoshi, Kenta Kuroiwa, Masashi Tachikawa, Yuki Fujimaki, Kotaro Nishiyama, Kei Manabe, Ryuta Yamazaki, <span class="NLM_string-name hlFld-ContribAuthor">Akira Asai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Anticancer Agent PVHD303 with in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1287-1291. <a href="https://doi.org/10.1021/acsmedchemlett.0c00119" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00119%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BAnticancer%252BAgent%252BPVHD303%252Bwith%252Bin%252BVivo%252BActivity%26aulast%3DSuzuki%26aufirst%3DYumiko%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09032020%26date%3D08052020%26date%3D11052020%26date%3D08052020%26volume%3D11%26issue%3D6%26spage%3D1287%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Marzaro</span>, <span class="hlFld-ContribAuthor ">Antonio  Coluccia</span>, <span class="hlFld-ContribAuthor ">Alessandro  Ferrarese</span>, <span class="hlFld-ContribAuthor ">Paola  Brun</span>, <span class="hlFld-ContribAuthor ">Ignazio  Castagliuolo</span>, <span class="hlFld-ContribAuthor ">Maria Teresa  Conconi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  La Regina</span>, <span class="hlFld-ContribAuthor ">Ruoli  Bai</span>, <span class="hlFld-ContribAuthor ">Romano  Silvestri</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, and <span class="hlFld-ContribAuthor ">Adriana  Chilin</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Biarylaminoquinazolines as Novel Tubulin Polymerization Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4598-4605. <a href="https://doi.org/10.1021/jm500034j" title="DOI URL">https://doi.org/10.1021/jm500034j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500034j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500034j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBiarylaminoquinazolines%252Bas%252BNovel%252BTubulin%252BPolymerization%252BInhibitors%26aulast%3DMarzaro%26aufirst%3DGiovanni%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08012014%26date%3D14052014%26date%3D12062014%26date%3D06052014%26volume%3D57%26issue%3D11%26spage%3D4598%26epage%3D4605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helge  Prinz</span>, <span class="hlFld-ContribAuthor ">Behfar  Chamasmani</span>, <span class="hlFld-ContribAuthor ">Kirsten  Vogel</span>, <span class="hlFld-ContribAuthor ">Konrad J.  BÃ¶hm</span>, <span class="hlFld-ContribAuthor ">Babette  Aicher</span>, <span class="hlFld-ContribAuthor ">Matthias  Gerlach</span>, <span class="hlFld-ContribAuthor ">Eckhard G.  GÃ¼nther</span>, <span class="hlFld-ContribAuthor ">Peter  Amon</span>, <span class="hlFld-ContribAuthor ">Igor  Ivanov</span>, and <span class="hlFld-ContribAuthor ">Klaus  MÃ¼ller</span>  . </span><span class="cited-content_cbyCitation_article-title">N-Benzoylated Phenoxazines and Phenothiazines: Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (12)
                                     , 4247-4263. <a href="https://doi.org/10.1021/jm200436t" title="DOI URL">https://doi.org/10.1021/jm200436t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200436t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200436t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-Benzoylated%252BPhenoxazines%252Band%252BPhenothiazines%25253A%252BSynthesis%25252C%252BAntiproliferative%252BActivity%25252C%252Band%252BInhibition%252Bof%252BTubulin%252BPolymerization%26aulast%3DPrinz%26aufirst%3DHelge%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D12042011%26date%3D26052011%26date%3D23062011%26date%3D12052011%26volume%3D54%26issue%3D12%26spage%3D4247%26epage%3D4263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Ying  Zhao</span>, <span class="hlFld-ContribAuthor ">Lu  Lin</span>, <span class="hlFld-ContribAuthor ">Sudhir  Raghavan</span>, <span class="hlFld-ContribAuthor ">Elizabeth G.  Roberts</span>, <span class="hlFld-ContribAuthor ">April L.  Risinger</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, and <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (22)
                                     , 8116-8128. <a href="https://doi.org/10.1021/jm101010n" title="DOI URL">https://doi.org/10.1021/jm101010n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101010n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101010n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BDiscovery%252Bof%252BWater-Soluble%252BMicrotubule%252BTargeting%252BAgents%252Bthat%252BBind%252Bto%252Bthe%252BColchicine%252BSite%252Bon%252BTubulin%252Band%252BCircumvent%252BPgp%252BMediated%252BResistance%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D04082010%26date%3D25102010%26date%3D25112010%26volume%3D53%26issue%3D22%26spage%3D8116%26epage%3D8128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Azra  Pervin</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">J. Adam  Willardsen</span>, <span class="hlFld-ContribAuthor ">Mark B.  Anderson</span>, <span class="hlFld-ContribAuthor ">Gary  Mather</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Pleiman</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span> and <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (8)
                                     , 2341-2351. <a href="https://doi.org/10.1021/jm801315b" title="DOI URL">https://doi.org/10.1021/jm801315b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm801315b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm801315b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525284-Methoxyphenyl%252529-N%25252C2-dimethylquinazolin-4-amine%25252C%252Ba%252BPotent%252BApoptosis%252BInducer%252Band%252BEfficacious%252BAnticancer%252BAgent%252Bwith%252BHigh%252BBlood%252BBrain%252BBarrier%252BPenetration%26aulast%3DSirisoma%26aufirst%3DNilantha%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D17%252010%25202008%26date%3D18032009%26date%3D23042009%26volume%3D52%26issue%3D8%26spage%3D2341%26epage%3D2351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helge  Prinz</span>, <span class="hlFld-ContribAuthor ">Peter  Schmidt</span>, <span class="hlFld-ContribAuthor ">Konrad J.  BÃ¶hm</span>, <span class="hlFld-ContribAuthor ">Silke  Baasner</span>, <span class="hlFld-ContribAuthor ">Klaus  MÃ¼ller</span>, <span class="hlFld-ContribAuthor ">Eberhard  Unger</span>, <span class="hlFld-ContribAuthor ">Matthias  Gerlach</span> and <span class="hlFld-ContribAuthor ">Eckhard G.  GÃ¼nther</span>. </span><span class="cited-content_cbyCitation_article-title">10-(2-oxo-2-Phenylethylidene)-10H-anthracen-9-ones as Highly Active Antimicrotubule Agents: Synthesis, Antiproliferative Activity, and Inhibition of Tubulin Polymerization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (5)
                                     , 1284-1294. <a href="https://doi.org/10.1021/jm801338r" title="DOI URL">https://doi.org/10.1021/jm801338r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm801338r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm801338r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D10-%2525282-oxo-2-Phenylethylidene%252529-10H-anthracen-9-ones%252Bas%252BHighly%252BActive%252BAntimicrotubule%252BAgents%25253A%252BSynthesis%25252C%252BAntiproliferative%252BActivity%25252C%252Band%252BInhibition%252Bof%252BTubulin%252BPolymerization%26aulast%3DPrinz%26aufirst%3DHelge%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D12%252003%25202009%26date%3D16%252002%25202009%26date%3D23%252010%25202008%26volume%3D52%26issue%3D5%26spage%3D1284%26epage%3D1294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shruti  Choudhary</span>, <span class="hlFld-ContribAuthor ">Arpit  Doshi</span>, <span class="hlFld-ContribAuthor ">Lerin  Luckett-Chastain</span>, <span class="hlFld-ContribAuthor ">Michael  Ihnat</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>, <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>. </span><span class="cited-content_cbyCitation_article-title">Potential of substituted quinazolines to interact with multiple targets in the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>35 </em>, 116061. <a href="https://doi.org/10.1016/j.bmc.2021.116061" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116061%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPotential%252Bof%252Bsubstituted%252Bquinazolines%252Bto%252Binteract%252Bwith%252Bmultiple%252Btargets%252Bin%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DChoudhary%26aufirst%3DShruti%26date%3D2021%26volume%3D35%26spage%3D116061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranju  Bansal</span>, <span class="hlFld-ContribAuthor ">Anjleena  Malhotra</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic progression of quinazolines as targeted chemotherapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113016. <a href="https://doi.org/10.1016/j.ejmech.2020.113016" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113016%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bprogression%252Bof%252Bquinazolines%252Bas%252Btargeted%252Bchemotherapeutic%252Bagents%26aulast%3DBansal%26aufirst%3DRanju%26date%3D2021%26volume%3D211%26spage%3D113016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.K.  Vyas</span>, <span class="hlFld-ContribAuthor ">G.  Qureshi</span>, <span class="hlFld-ContribAuthor ">H.  Dayani</span>, <span class="hlFld-ContribAuthor ">A.  Jha</span>, <span class="hlFld-ContribAuthor ">M.  Ghate</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore-based identification and in vitro validation of apoptosis inducers as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2020,</strong> <em>31 </em>
                                    (11)
                                     , 869-881. <a href="https://doi.org/10.1080/1062936X.2020.1827030" title="DOI URL">https://doi.org/10.1080/1062936X.2020.1827030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2020.1827030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2020.1827030%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DPharmacophore-based%252Bidentification%252Band%252Bin%252Bvitro%252Bvalidation%252Bof%252Bapoptosis%252Binducers%252Bas%252Banticancer%252Bagents%26aulast%3DVyas%26aufirst%3DV.K.%26date%3D2020%26date%3D2020%26volume%3D31%26issue%3D11%26spage%3D869%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Lei</span>, <span class="hlFld-ContribAuthor ">Liang  Ma</span>, <span class="hlFld-ContribAuthor ">Zhuang  Yang</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel Substituted 4âAnilinoquinazolines as Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>96 </em>
                                    (4)
                                     , 1084-1094. <a href="https://doi.org/10.1111/cbdd.12706" title="DOI URL">https://doi.org/10.1111/cbdd.12706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12706%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BSubstituted%252B4%2525E2%252580%252590Anilinoquinazolines%252Bas%252BAntitumor%252BAgents%26aulast%3DCao%26aufirst%3DDong%26date%3D2020%26date%3D2020%26volume%3D96%26issue%3D4%26spage%3D1084%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yvonnick  Loidreau</span>, <span class="hlFld-ContribAuthor ">Marie-RenÃ©e  Nourrisson</span>, <span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">CÃ©cile  CorbiÃ¨re</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-Assisted Synthesis of Potential Bioactive Benzo-, Pyrido- or Pyrazino-thieno[3,2-d]pyrimidin-4-amine Analogs of MPC-6827. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (9)
                                     , 202. <a href="https://doi.org/10.3390/ph13090202" title="DOI URL">https://doi.org/10.3390/ph13090202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13090202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13090202%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DMicrowave-Assisted%252BSynthesis%252Bof%252BPotential%252BBioactive%252BBenzo-%25252C%252BPyrido-%252Bor%252BPyrazino-thieno%25255B3%25252C2-d%25255Dpyrimidin-4-amine%252BAnalogs%252Bof%252BMPC-6827%26aulast%3DLoidreau%26aufirst%3DYvonnick%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D9%26spage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fateme  Azimi</span>, <span class="hlFld-ContribAuthor ">Jahan B.  Ghasemi</span>, <span class="hlFld-ContribAuthor ">Lotfollah  Saghaei</span>, <span class="hlFld-ContribAuthor ">Farshid  Hassanzadeh</span>, <span class="hlFld-ContribAuthor ">Mohammad  Mahdavi</span>, <span class="hlFld-ContribAuthor ">Hojjat  Sadeghi-Aliabadi</span>, <span class="hlFld-ContribAuthor ">Marcus T.  Scotti</span>, <span class="hlFld-ContribAuthor ">Luciana  Scotti</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Essential 2D and 3D Chemical Features for Discovery of the Novel Tubulin Polymerization Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (13)
                                     , 1092-1120. <a href="https://doi.org/10.2174/1568026619666190520083655" title="DOI URL">https://doi.org/10.2174/1568026619666190520083655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190520083655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190520083655%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BEssential%252B2D%252Band%252B3D%252BChemical%252BFeatures%252Bfor%252BDiscovery%252Bof%252Bthe%252BNovel%252BTubulin%252BPolymerization%252BInhibitors%26aulast%3DAzimi%26aufirst%3DFateme%26date%3D2019%26volume%3D19%26issue%3D13%26spage%3D1092%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Honghao  Yang</span>, <span class="hlFld-ContribAuthor ">Baijiao  An</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Zeng</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of 4-phenylamino-substituted naphthalene-1,2-diones as tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (18)
                                     , 3057-3063. <a href="https://doi.org/10.1016/j.bmcl.2018.07.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.07.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.07.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.07.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEvaluation%252Bof%252B4-phenylamino-substituted%252Bnaphthalene-1%25252C2-diones%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DYang%26aufirst%3DHonghao%26date%3D2018%26volume%3D28%26issue%3D18%26spage%3D3057%26epage%3D3063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adelina  Orellana</span>, <span class="hlFld-ContribAuthor ">Vicente  GarcÃ­a-GonzÃ¡lez</span>, <span class="hlFld-ContribAuthor ">Rosa  LÃ³pez</span>, <span class="hlFld-ContribAuthor ">Sonia  Pascual-Guiral</span>, <span class="hlFld-ContribAuthor ">Estrella  Lozoya</span>, <span class="hlFld-ContribAuthor ">Julia  DÃ­az</span>, <span class="hlFld-ContribAuthor ">Daniel  Casals</span>, <span class="hlFld-ContribAuthor ">AntolÃ­n  Barrena</span>, <span class="hlFld-ContribAuthor ">Stephane  Paris</span>, <span class="hlFld-ContribAuthor ">Miriam  AndrÃ©s</span>, <span class="hlFld-ContribAuthor ">Victor  Segarra</span>, <span class="hlFld-ContribAuthor ">Dolors  Vilella</span>, <span class="hlFld-ContribAuthor ">Rajneesh  Malhotra</span>, <span class="hlFld-ContribAuthor ">Paul  Eastwood</span>, <span class="hlFld-ContribAuthor ">Anna  PlanagumÃ </span>, <span class="hlFld-ContribAuthor ">Montserrat  Miralpeix</span>, <span class="hlFld-ContribAuthor ">Arsenio  Nueda</span>, . </span><span class="cited-content_cbyCitation_article-title">Application of a phenotypic drug discovery strategy to identify biological and chemical starting points for inhibition of TSLP production in lung epithelial cells. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (1)
                                     , e0189247. <a href="https://doi.org/10.1371/journal.pone.0189247" title="DOI URL">https://doi.org/10.1371/journal.pone.0189247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0189247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0189247%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DApplication%252Bof%252Ba%252Bphenotypic%252Bdrug%252Bdiscovery%252Bstrategy%252Bto%252Bidentify%252Bbiological%252Band%252Bchemical%252Bstarting%252Bpoints%252Bfor%252Binhibition%252Bof%252BTSLP%252Bproduction%252Bin%252Blung%252Bepithelial%252Bcells%26aulast%3DOrellana%26aufirst%3DAdelina%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D1%26spage%3De0189247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baijiao  An</span>, <span class="hlFld-ContribAuthor ">Shun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinhui  Hu</span>, <span class="hlFld-ContribAuthor ">Tingting  Pan</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Johnny Cheuk-on  Tang</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Albert S. C.  Chan</span>. </span><span class="cited-content_cbyCitation_article-title">The design, synthesis and evaluation of selenium-containing 4-anilinoquinazoline hybrids as anticancer agents and a study of their mechanism. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (25)
                                     , 4701-4714. <a href="https://doi.org/10.1039/C8OB00875B" title="DOI URL">https://doi.org/10.1039/C8OB00875B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB00875B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB00875B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DThe%252Bdesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bselenium-containing%252B4-anilinoquinazoline%252Bhybrids%252Bas%252Banticancer%252Bagents%252Band%252Ba%252Bstudy%252Bof%252Btheir%252Bmechanism%26aulast%3DAn%26aufirst%3DBaijiao%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D25%26spage%3D4701%26epage%3D4714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Lei</span>, <span class="hlFld-ContribAuthor ">Liang  Ma</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Chunyu  Wang</span>, <span class="hlFld-ContribAuthor ">Minghai  Tang</span>, <span class="hlFld-ContribAuthor ">Wei  Xiang</span>, <span class="hlFld-ContribAuthor ">Taijin  Wang</span>, <span class="hlFld-ContribAuthor ">Hongyang  Li</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (8)
                                     , 1931-1935. <a href="https://doi.org/10.1016/j.bmcl.2016.03.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bevaluation%252Bof%252Bnovel%252Bsubstituted%252BN-%2525284-%2525282-%2525284-benzylpiperazin-1-yl%252529ethoxy%252529phenyl%252529-N-methyl-quinazolin-4-amines%252Bas%252Bpotent%252Bantitumor%252Bagents%26aulast%3DCao%26aufirst%3DDong%26date%3D2016%26volume%3D26%26issue%3D8%26spage%3D1931%26epage%3D1935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">SoÅa  JantovÃ¡</span>, <span class="hlFld-ContribAuthor ">Martina  MeluÅ¡ovÃ¡</span>, <span class="hlFld-ContribAuthor ">Miroslav  PÃ¡nik</span>, <span class="hlFld-ContribAuthor ">Vlasta  BrezovÃ¡</span>, <span class="hlFld-ContribAuthor ">Zuzana  BarbierikovÃ¡</span>. </span><span class="cited-content_cbyCitation_article-title">UVA-induced effects of 2,6-disubstituted 4-anilinoquinazolines on cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Photochemistry and Photobiology B: Biology</span><span> <strong>2016,</strong> <em>154 </em>, 77-88. <a href="https://doi.org/10.1016/j.jphotobiol.2015.11.014" title="DOI URL">https://doi.org/10.1016/j.jphotobiol.2015.11.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphotobiol.2015.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphotobiol.2015.11.014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Photochemistry%2520and%2520Photobiology%2520B%253A%2520Biology%26atitle%3DUVA-induced%252Beffects%252Bof%252B2%25252C6-disubstituted%252B4-anilinoquinazolines%252Bon%252Bcancer%252Bcell%252Blines%26aulast%3DJantov%25C3%25A1%26aufirst%3DSo%25C5%2588a%26date%3D2016%26volume%3D154%26spage%3D77%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Richa  Rani</span>, <span class="hlFld-ContribAuthor ">Alka  Sharma</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazolineâbenzimidazole hybrid as dual optical sensor for cyanide and Pb2+ ions and Aurora kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Photochemistry and Photobiology A: Chemistry</span><span> <strong>2015,</strong> <em>311 </em>, 68-75. <a href="https://doi.org/10.1016/j.jphotochem.2015.05.025" title="DOI URL">https://doi.org/10.1016/j.jphotochem.2015.05.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphotochem.2015.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphotochem.2015.05.025%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Photochemistry%2520and%2520Photobiology%2520A%253A%2520Chemistry%26atitle%3DQuinazoline%2525E2%252580%252593benzimidazole%252Bhybrid%252Bas%252Bdual%252Boptical%252Bsensor%252Bfor%252Bcyanide%252Band%252BPb2%25252B%252Bions%252Band%252BAurora%252Bkinase%252Binhibitor%26aulast%3DLuxami%26aufirst%3DVijay%26date%3D2015%26volume%3D311%26spage%3D68%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuehui  Hou</span>, <span class="hlFld-ContribAuthor ">Jingyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuan  Zhao</span>, <span class="hlFld-ContribAuthor ">Liming  Chang</span>, <span class="hlFld-ContribAuthor ">Ping  Hu</span>, <span class="hlFld-ContribAuthor ">Hongmin  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Bioactivities Evaluation of Novel Quinazoline Analogs Containing Oxazole Units. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2014,</strong> <em>32 </em>
                                    (6)
                                     , 538-544. <a href="https://doi.org/10.1002/cjoc.201400271" title="DOI URL">https://doi.org/10.1002/cjoc.201400271</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201400271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201400271%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBioactivities%252BEvaluation%252Bof%252BNovel%252BQuinazoline%252BAnalogs%252BContaining%252BOxazole%252BUnits%26aulast%3DHou%26aufirst%3DXuehui%26date%3D2014%26date%3D2014%26volume%3D32%26issue%3D6%26spage%3D538%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Imtiaz  Khan</span>, <span class="hlFld-ContribAuthor ">Aliya  Ibrar</span>, <span class="hlFld-ContribAuthor ">Naeem  Abbas</span>, <span class="hlFld-ContribAuthor ">Aamer  Saeed</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: Synthetic approaches and multifarious applications. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>76 </em>, 193-244. <a href="https://doi.org/10.1016/j.ejmech.2014.02.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bstructural%252Blibrary%252Bof%252Bfunctionalized%252Bquinazoline%252Band%252Bquinazolinone%252Bscaffolds%25253A%252BSynthetic%252Bapproaches%252Band%252Bmultifarious%252Bapplications%26aulast%3DKhan%26aufirst%3DImtiaz%26date%3D2014%26volume%3D76%26spage%3D193%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bini  Mathew</span>, <span class="hlFld-ContribAuthor ">Larry  Ross</span>, <span class="hlFld-ContribAuthor ">Robert C.  Reynolds</span>. </span><span class="cited-content_cbyCitation_article-title">A novel quinoline derivative that inhibits mycobacterial FtsZ. </span><span class="cited-content_cbyCitation_journal-name">Tuberculosis</span><span> <strong>2013,</strong> <em>93 </em>
                                    (4)
                                     , 398-400. <a href="https://doi.org/10.1016/j.tube.2013.04.002" title="DOI URL">https://doi.org/10.1016/j.tube.2013.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tube.2013.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tube.2013.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTuberculosis%26atitle%3DA%252Bnovel%252Bquinoline%252Bderivative%252Bthat%252Binhibits%252Bmycobacterial%252BFtsZ%26aulast%3DMathew%26aufirst%3DBini%26date%3D2013%26volume%3D93%26issue%3D4%26spage%3D398%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alka  Sharma</span>, <span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, single crystal and antitumor activities of benzimidazoleâquinazoline hybrids. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (11)
                                     , 3288-3294. <a href="https://doi.org/10.1016/j.bmcl.2013.03.107" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.107%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bsingle%252Bcrystal%252Band%252Bantitumor%252Bactivities%252Bof%252Bbenzimidazole%2525E2%252580%252593quinazoline%252Bhybrids%26aulast%3DSharma%26aufirst%3DAlka%26date%3D2013%26volume%3D23%26issue%3D11%26spage%3D3288%26epage%3D3294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Lu</span>, <span class="hlFld-ContribAuthor ">Jianjun  Chen</span>, <span class="hlFld-ContribAuthor ">Min  Xiao</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Duane D.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Research</span><span> <strong>2012,</strong> <em>29 </em>
                                    (11)
                                     , 2943-2971. <a href="https://doi.org/10.1007/s11095-012-0828-z" title="DOI URL">https://doi.org/10.1007/s11095-012-0828-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11095-012-0828-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11095-012-0828-z%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Research%26atitle%3DAn%252BOverview%252Bof%252BTubulin%252BInhibitors%252BThat%252BInteract%252Bwith%252Bthe%252BColchicine%252BBinding%252BSite%26aulast%3DLu%26aufirst%3DYan%26date%3D2012%26date%3D2012%26volume%3D29%26issue%3D11%26spage%3D2943%26epage%3D2971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kuen-Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Kuan-Chuan  Pao</span>, <span class="hlFld-ContribAuthor ">Jung-Chen  Su</span>, <span class="hlFld-ContribAuthor ">Yi-Chieh  Chou</span>, <span class="hlFld-ContribAuthor ">Chun-Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Hui-Ju  Chen</span>, <span class="hlFld-ContribAuthor ">Jui-Wen  Huang</span>, <span class="hlFld-ContribAuthor ">InKi  Kim</span>, <span class="hlFld-ContribAuthor ">Chung-Wai  Shiau</span>. </span><span class="cited-content_cbyCitation_article-title">Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (20)
                                     , 6144-6153. <a href="https://doi.org/10.1016/j.bmc.2012.08.039" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.08.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.08.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Berlotinib%252Bderivatives%252Bas%252BCIP2A-ablating%252Bagents%252Bindependent%252Bof%252BEGFR%252Bactivity%26aulast%3DChen%26aufirst%3DKuen-Feng%26date%3D2012%26volume%3D20%26issue%3D20%26spage%3D6144%26epage%3D6153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramesh  Garlapati</span>, <span class="hlFld-ContribAuthor ">Narender  Pottabathini</span>, <span class="hlFld-ContribAuthor ">Venkateshwarlu  Gurram</span>, <span class="hlFld-ContribAuthor ">Avinash B.  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Venkata Rao  Chunduri</span>, <span class="hlFld-ContribAuthor ">Balaram  Patro</span>. </span><span class="cited-content_cbyCitation_article-title">Pd-catalyzed amination of 6-halo-2-cyclopropyl-3-(pyridyl-3-ylmethyl) quinazolin-4(3H)-one. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2012,</strong> <em>53 </em>
                                    (38)
                                     , 5162-5166. <a href="https://doi.org/10.1016/j.tetlet.2012.07.061" title="DOI URL">https://doi.org/10.1016/j.tetlet.2012.07.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2012.07.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2012.07.061%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DPd-catalyzed%252Bamination%252Bof%252B6-halo-2-cyclopropyl-3-%252528pyridyl-3-ylmethyl%252529%252Bquinazolin-4%2525283H%252529-one%26aulast%3DGarlapati%26aufirst%3DRamesh%26date%3D2012%26volume%3D53%26issue%3D38%26spage%3D5162%26epage%3D5166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Majid  Koohshari</span>, <span class="hlFld-ContribAuthor ">Minoo  Dabiri</span>, <span class="hlFld-ContribAuthor ">Peyman  Salehi</span>, <span class="hlFld-ContribAuthor ">Mahboobeh  Bahramnejad</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent Synthesis of 1,2,3-Triazol-4-yl-methylthio-3-arylquinazolin-4(3
              H
              )-one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2012,</strong> <em>42 </em>
                                    (16)
                                     , 2415-2422. <a href="https://doi.org/10.1080/00397911.2011.558968" title="DOI URL">https://doi.org/10.1080/00397911.2011.558968</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2011.558968&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2011.558968%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DMulticomponent%252BSynthesis%252Bof%252B1%25252C2%25252C3-Triazol-4-yl-methylthio-3-arylquinazolin-4%2525283%252BH%252B%252529-one%252BDerivatives%26aulast%3DKoohshari%26aufirst%3DMajid%26date%3D2012%26date%3D2012%26volume%3D42%26issue%3D16%26spage%3D2415%26epage%3D2422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeffrey W.  Lockman</span>, <span class="hlFld-ContribAuthor ">Yevgeniya  Klimova</span>, <span class="hlFld-ContribAuthor ">Mark B.  Anderson</span>, <span class="hlFld-ContribAuthor ">J. Adam  Willardsen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Substituted Quinazolines: Application to the Synthesis of Verubulin. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2012,</strong> <em>42 </em>
                                    (12)
                                     , 1715-1723. <a href="https://doi.org/10.1080/00397911.2010.529730" title="DOI URL">https://doi.org/10.1080/00397911.2010.529730</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2010.529730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2010.529730%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DSynthesis%252Bof%252BSubstituted%252BQuinazolines%25253A%252BApplication%252Bto%252Bthe%252BSynthesis%252Bof%252BVerubulin%26aulast%3DLockman%26aufirst%3DJeffrey%2BW.%26date%3D2012%26date%3D2012%26volume%3D42%26issue%3D12%26spage%3D1715%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esther  Moreno</span>, <span class="hlFld-ContribAuthor ">Daniel  Plano</span>, <span class="hlFld-ContribAuthor ">Iranzu  Lamberto</span>, <span class="hlFld-ContribAuthor ">MarÃ­a  Font</span>, <span class="hlFld-ContribAuthor ">Ignacio  EncÃ­o</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Palop</span>, <span class="hlFld-ContribAuthor ">Carmen  SanmartÃ­n</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: Synthesis and study of their potential cytotoxic activity inÂ vitro. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>47 </em>, 283-298. <a href="https://doi.org/10.1016/j.ejmech.2011.10.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.10.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.10.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.10.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSulfur%252Band%252Bselenium%252Bderivatives%252Bof%252Bquinazoline%252Band%252Bpyrido%25255B2%25252C3-d%25255Dpyrimidine%25253A%252BSynthesis%252Band%252Bstudy%252Bof%252Btheir%252Bpotential%252Bcytotoxic%252Bactivity%252Bin%2525C2%2525A0vitro%26aulast%3DMoreno%26aufirst%3DEsther%26date%3D2012%26volume%3D47%26spage%3D283%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Desiniotis</span>, <span class="hlFld-ContribAuthor ">Natasha  Kyprianou</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the design and synthesis of prazosin derivatives over the last ten years. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2011,</strong> <em>15 </em>
                                    (12)
                                     , 1405-1418. <a href="https://doi.org/10.1517/14728222.2011.641534" title="DOI URL">https://doi.org/10.1517/14728222.2011.641534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2011.641534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2011.641534%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DAdvances%252Bin%252Bthe%252Bdesign%252Band%252Bsynthesis%252Bof%252Bprazosin%252Bderivatives%252Bover%252Bthe%252Blast%252Bten%252Byears%26aulast%3DDesiniotis%26aufirst%3DAndreas%26date%3D2011%26date%3D2011%26volume%3D15%26issue%3D12%26spage%3D1405%26epage%3D1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhanaji Achyutrao  Thorat</span>, <span class="hlFld-ContribAuthor ">Munikumar Reddy  Doddareddy</span>, <span class="hlFld-ContribAuthor ">Seon Hee  Seo</span>, <span class="hlFld-ContribAuthor ">Tae-Joon  Hong</span>, <span class="hlFld-ContribAuthor ">Yong Seo  Cho</span>, <span class="hlFld-ContribAuthor ">Ji-Sook  Hahn</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 2,4-diaminoquinazoline derivatives as novel heat shock protein 90 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (6)
                                     , 1593-1597. <a href="https://doi.org/10.1016/j.bmcl.2011.01.117" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.01.117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.01.117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.01.117%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2%25252C4-diaminoquinazoline%252Bderivatives%252Bas%252Bnovel%252Bheat%252Bshock%252Bprotein%252B90%252Binhibitors%26aulast%3DThorat%26aufirst%3DDhanaji%2BAchyutrao%26date%3D2011%26volume%3D21%26issue%3D6%26spage%3D1593%26epage%3D1597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oliver  Kepp</span>, <span class="hlFld-ContribAuthor ">Lorenzo  Galluzzi</span>, <span class="hlFld-ContribAuthor ">Marta  Lipinski</span>, <span class="hlFld-ContribAuthor ">Junying  Yuan</span>, <span class="hlFld-ContribAuthor ">Guido  Kroemer</span>. </span><span class="cited-content_cbyCitation_article-title">Cell death assays for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2011,</strong> <em>10 </em>
                                    (3)
                                     , 221-237. <a href="https://doi.org/10.1038/nrd3373" title="DOI URL">https://doi.org/10.1038/nrd3373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd3373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd3373%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DCell%252Bdeath%252Bassays%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DKepp%26aufirst%3DOliver%26date%3D2011%26date%3D2011%26volume%3D10%26issue%3D3%26spage%3D221%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaekwang  Lee</span>, <span class="hlFld-ContribAuthor ">Suyeal  Bae</span>, <span class="hlFld-ContribAuthor ">Seo-hee  Lee</span>, <span class="hlFld-ContribAuthor ">Hojin  Choi</span>, <span class="hlFld-ContribAuthor ">Young Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Soo Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Gyu Tae  Park</span>, <span class="hlFld-ContribAuthor ">Seung Kee  Moon</span>, <span class="hlFld-ContribAuthor ">Dal-Hyun  Kim</span>, <span class="hlFld-ContribAuthor ">Sungsook  Lee</span>, <span class="hlFld-ContribAuthor ">Soon Kil  Ahn</span>, <span class="hlFld-ContribAuthor ">Nam Song  Choi</span>, <span class="hlFld-ContribAuthor ">Kyung Joo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a potent tubulin polymerization inhibitor: Synthesis and evaluation of water-soluble prodrugs of benzophenone analog. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (21)
                                     , 6327-6330. <a href="https://doi.org/10.1016/j.bmcl.2010.05.060" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.05.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.05.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.05.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bpotent%252Btubulin%252Bpolymerization%252Binhibitor%25253A%252BSynthesis%252Band%252Bevaluation%252Bof%252Bwater-soluble%252Bprodrugs%252Bof%252Bbenzophenone%252Banalog%26aulast%3DLee%26aufirst%3DJaekwang%26date%3D2010%26volume%3D20%26issue%3D21%26spage%3D6327%26epage%3D6330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia  Foucourt</span>, <span class="hlFld-ContribAuthor ">Carole  Dubouilh-Benard</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Chosson</span>, <span class="hlFld-ContribAuthor ">CÃ©cile  CorbiÃ¨re</span>, <span class="hlFld-ContribAuthor ">Catherine  Buquet</span>, <span class="hlFld-ContribAuthor ">Mauro  Iannelli</span>, <span class="hlFld-ContribAuthor ">Bertrand  Leblond</span>, <span class="hlFld-ContribAuthor ">Francis  Marsais</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-accelerated Dimroth rearrangement for the synthesis of 4-anilino-6-nitroquinazolines. Application to an efficient synthesis of a microtubule destabilizing agent. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2010,</strong> <em>66 </em>
                                    (25)
                                     , 4495-4502. <a href="https://doi.org/10.1016/j.tet.2010.04.066" title="DOI URL">https://doi.org/10.1016/j.tet.2010.04.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2010.04.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2010.04.066%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DMicrowave-accelerated%252BDimroth%252Brearrangement%252Bfor%252Bthe%252Bsynthesis%252Bof%252B4-anilino-6-nitroquinazolines.%252BApplication%252Bto%252Ban%252Befficient%252Bsynthesis%252Bof%252Ba%252Bmicrotubule%252Bdestabilizing%252Bagent%26aulast%3DFoucourt%26aufirst%3DAlicia%26date%3D2010%26volume%3D66%26issue%3D25%26spage%3D4495%26epage%3D4502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youssef  Kabri</span>, <span class="hlFld-ContribAuthor ">Pierre  Verhaeghe</span>, <span class="hlFld-ContribAuthor ">Armand  Gellis</span>, <span class="hlFld-ContribAuthor ">Patrice  Vanelle</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Suzuki-Miyaura Reaction: Application to the Microwave-promoted Synthesis of 4,7-Diarylquinazolines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2010,</strong> <em>15 </em>
                                    (5)
                                     , 2949-2961. <a href="https://doi.org/10.3390/molecules15052949" title="DOI URL">https://doi.org/10.3390/molecules15052949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules15052949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules15052949%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRegioselective%252BSuzuki-Miyaura%252BReaction%25253A%252BApplication%252Bto%252Bthe%252BMicrowave-promoted%252BSynthesis%252Bof%252B4%25252C7-Diarylquinazolines%26aulast%3DKabri%26aufirst%3DYoussef%26date%3D2010%26date%3D2010%26volume%3D15%26issue%3D5%26spage%3D2949%26epage%3D2961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Azra  Pervin</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">J.  Adam Willardsen</span>, <span class="hlFld-ContribAuthor ">Mark B.  Anderson</span>, <span class="hlFld-ContribAuthor ">Gary  Mather</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Pleiman</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-methyl-4-(4-methoxyanilino)quinazolines as potent apoptosis inducers. Structureâactivity relationship of the quinazoline ring. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (7)
                                     , 2330-2334. <a href="https://doi.org/10.1016/j.bmcl.2010.01.155" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.155%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-methyl-4-%2525284-methoxyanilino%252529quinazolines%252Bas%252Bpotent%252Bapoptosis%252Binducers.%252BStructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Bthe%252Bquinazoline%252Bring%26aulast%3DSirisoma%26aufirst%3DNilantha%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D2330%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Kemnitzer</span>, <span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Candace  Crogan-Grundy</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-aryl-9-oxo-9H-fluorene-1-carboxamides as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structureâactivity relationships of the 9-oxo-9H-fluorene ring. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (3)
                                     , 1288-1292. <a href="https://doi.org/10.1016/j.bmcl.2009.11.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-aryl-9-oxo-9H-fluorene-1-carboxamides%252Bas%252Ba%252Bnew%252Bseries%252Bof%252Bapoptosis%252Binducers%252Busing%252Ba%252Bcell-%252Band%252Bcaspase-based%252Bhigh-throughput%252Bscreening%252Bassay.%252B2.%252BStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bthe%252B9-oxo-9H-fluorene%252Bring%26aulast%3DKemnitzer%26aufirst%3DWilliam%26date%3D2010%26volume%3D20%26issue%3D3%26spage%3D1288%26epage%3D1292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Kemnitzer</span>, <span class="hlFld-ContribAuthor ">Jared  Kuemmerle</span>, <span class="hlFld-ContribAuthor ">Han-Zhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (15)
                                     , 4410-4415. <a href="https://doi.org/10.1016/j.bmcl.2009.05.052" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.05.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.05.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3-aryl-5-aryl-1%25252C2%25252C4-oxadiazoles%252Bas%252Ba%252Bnew%252Bseries%252Bof%252Bapoptosis%252Binducers.%252B2.%252BIdentification%252Bof%252Bmore%252Baqueous%252Bsoluble%252Banalogs%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DKemnitzer%26aufirst%3DWilliam%26date%3D2009%26volume%3D19%26issue%3D15%26spage%3D4410%26epage%3D4415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Kemnitzer</span>, <span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Chris  May</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d]pyrimidines as potent apoptosis inducers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (13)
                                     , 3536-3540. <a href="https://doi.org/10.1016/j.bmcl.2009.04.145" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.04.145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.04.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.04.145%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B4-anilino-N-methylthieno%25255B3%25252C2-d%25255Dpyrimidines%252Band%252B4-anilino-N-methylthieno%25255B2%25252C3-d%25255Dpyrimidines%252Bas%252Bpotent%252Bapoptosis%252Binducers%26aulast%3DKemnitzer%26aufirst%3DWilliam%26date%3D2009%26volume%3D19%26issue%3D13%26spage%3D3536%26epage%3D3540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Kemnitzer</span>, <span class="hlFld-ContribAuthor ">Jared  Kuemmerle</span>, <span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Candace  Crogan-Grundy</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structureâactivity relationships of the 4-, 5-, 6-, 7- and 8-positions. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (13)
                                     , 3481-3484. <a href="https://doi.org/10.1016/j.bmcl.2009.05.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.05.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.05.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B1-benzoyl-3-cyanopyrrolo%25255B1%25252C2-a%25255Dquinolines%252Bas%252Ba%252Bnew%252Bseries%252Bof%252Bapoptosis%252Binducers%252Busing%252Ba%252Bcell-%252Band%252Bcaspase-based%252Bhigh-throughput%252Bscreening%252Bassay.%252B2%25253A%252BStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bthe%252B4-%25252C%252B5-%25252C%252B6-%25252C%252B7-%252Band%252B8-positions%26aulast%3DKemnitzer%26aufirst%3DWilliam%26date%3D2009%26volume%3D19%26issue%3D13%26spage%3D3481%26epage%3D3484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Kemnitzer</span>, <span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Bao  Nguyen</span>, <span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Candace  Crogan-Grundy</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-aryl-9-oxo-9H-fluorene-1-carboxamides as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structureâactivity relationships of the carboxamide group. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (11)
                                     , 3045-3049. <a href="https://doi.org/10.1016/j.bmcl.2009.04.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-aryl-9-oxo-9H-fluorene-1-carboxamides%252Bas%252Ba%252Bnew%252Bseries%252Bof%252Bapoptosis%252Binducers%252Busing%252Ba%252Bcell-%252Band%252Bcaspase-based%252Bhigh-throughput%252Bscreening%252Bassay.%252B1.%252BStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bthe%252Bcarboxamide%252Bgroup%26aulast%3DKemnitzer%26aufirst%3DWilliam%26date%3D2009%26volume%3D19%26issue%3D11%26spage%3D3045%26epage%3D3049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Azra  Pervin</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of substituted Nâ²-(2-oxoindolin-3-ylidene)benzohydrazides as new apoptosis inducers using a cell- and caspase-based HTS assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (10)
                                     , 2710-2713. <a href="https://doi.org/10.1016/j.bmcl.2009.03.121" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.03.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.03.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.03.121%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bsubstituted%252BN%2525E2%252580%2525B2-%2525282-oxoindolin-3-ylidene%252529benzohydrazides%252Bas%252Bnew%252Bapoptosis%252Binducers%252Busing%252Ba%252Bcell-%252Band%252Bcaspase-based%252BHTS%252Bassay%26aulast%3DSirisoma%26aufirst%3DNilantha%26date%3D2009%26volume%3D19%26issue%3D10%26spage%3D2710%26epage%3D2713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han-Zhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Candace  Crogan-Grundy</span>, <span class="hlFld-ContribAuthor ">Chris  May</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and structureâactivity relationships of (2-(arylthio)benzylideneamino)guanidines as a novel series of potent apoptosis inducers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2009,</strong> <em>17 </em>
                                    (7)
                                     , 2852-2858. <a href="https://doi.org/10.1016/j.bmc.2009.02.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2009.02.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2009.02.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2009.02.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252B%2525282-%252528arylthio%252529benzylideneamino%252529guanidines%252Bas%252Ba%252Bnovel%252Bseries%252Bof%252Bpotent%252Bapoptosis%252Binducers%26aulast%3DZhang%26aufirst%3DHan-Zhong%26date%3D2009%26volume%3D17%26issue%3D7%26spage%3D2852%26epage%3D2858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Azra  Pervin</span>, <span class="hlFld-ContribAuthor ">Bao  Nguyen</span>, <span class="hlFld-ContribAuthor ">Candace  Crogan-Grundy</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of substituted 4-anilino-2-arylpyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 2. Structureâactivity relationships of the 2-aryl group. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (8)
                                     , 2305-2309. <a href="https://doi.org/10.1016/j.bmcl.2009.02.074" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.02.074</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.02.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.02.074%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bsubstituted%252B4-anilino-2-arylpyrimidines%252Bas%252Ba%252Bnew%252Bseries%252Bof%252Bapoptosis%252Binducers%252Busing%252Ba%252Bcell-%252Band%252Bcaspase-based%252Bhigh%252Bthroughput%252Bscreening%252Bassay.%252B2.%252BStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bthe%252B2-aryl%252Bgroup%26aulast%3DSirisoma%26aufirst%3DNilantha%26date%3D2009%26volume%3D19%26issue%3D8%26spage%3D2305%26epage%3D2309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Madapa</span>, <span class="hlFld-ContribAuthor ">Z.  Tusi</span>, <span class="hlFld-ContribAuthor ">A.  Mishra</span>, <span class="hlFld-ContribAuthor ">K.  Srivastava</span>, <span class="hlFld-ContribAuthor ">S.K.  Pandey</span>, <span class="hlFld-ContribAuthor ">R.  Tripathi</span>, <span class="hlFld-ContribAuthor ">S.K.  Puri</span>, <span class="hlFld-ContribAuthor ">S.  Batra</span>. </span><span class="cited-content_cbyCitation_article-title">Search for new pharmacophores for antimalarial activity. Part II: Synthesis and antimalarial activity of new 6-ureido-4-anilinoquinazolines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2009,</strong> <em>17 </em>
                                    (1)
                                     , 222-234. <a href="https://doi.org/10.1016/j.bmc.2008.11.005" title="DOI URL">https://doi.org/10.1016/j.bmc.2008.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2008.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2008.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSearch%252Bfor%252Bnew%252Bpharmacophores%252Bfor%252Bantimalarial%252Bactivity.%252BPart%252BII%25253A%252BSynthesis%252Band%252Bantimalarial%252Bactivity%252Bof%252Bnew%252B6-ureido-4-anilinoquinazolines%26aulast%3DMadapa%26aufirst%3DS.%26date%3D2009%26volume%3D17%26issue%3D1%26spage%3D222%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">Candace  Crogan-Grundy</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of (naphthalen-4-yl)(phenyl)methanones and N-methyl-N-phenylnaphthalen-1-amines as new apoptosis inducers using a cell- and caspase-based HTS assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2008,</strong> <em>18 </em>
                                    (21)
                                     , 5725-5728. <a href="https://doi.org/10.1016/j.bmcl.2008.09.088" title="DOI URL">https://doi.org/10.1016/j.bmcl.2008.09.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2008.09.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2008.09.088%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B%252528naphthalen-4-yl%252529%252528phenyl%252529methanones%252Band%252BN-methyl-N-phenylnaphthalen-1-amines%252Bas%252Bnew%252Bapoptosis%252Binducers%252Busing%252Ba%252Bcell-%252Band%252Bcaspase-based%252BHTS%252Bassay%26aulast%3DJiang%26aufirst%3DSongchun%26date%3D2008%26volume%3D18%26issue%3D21%26spage%3D5725%26epage%3D5728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0002.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0006.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) 4-R-PhNMeH (<b>4a</b>â<b>f</b>), IPA, HCl.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0005.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) ArNH<sub>2</sub> (<b>5a</b>â<b>i</b>), NaAc, THF/H<sub>2</sub>O; (b)MeI or EtI, NaH, DMF.</p></p></figure><figure data-id="cht1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0001.jpeg" id="rightTab-gc1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0010.jpeg" id="rightTab-gc2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>2b</b> inhibited the growth of established (â¼100 mm<sup>3</sup>) MX-1 (A) and (B), and PC-3 (C) tumor xenografts in Crl:Nu/Nu-nuBR mice. Compound <b>2b</b> was dosed iv once weekly for two weeks at 5, 7.5, or 10 mg/kg (MX-1 model, A), once a day for 5 days for two weeks at 1.25 or 2.5 mg/kg (MX-1 model, B), and once weekly for two weeks at 10 mg/kg (PC-3 model, C), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/medium/jm-2008-003653_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Concentration of compound <b>2b</b> in brain and plasma after a single iv dose of 2.5 mg/kg in mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-15/jm8003653/production/images/large/jm-2008-003653_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8003653&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47867" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47867" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Reed, J. C.</span><span> </span><span class="NLM_article-title">Apoptosis-based therapies</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">1</span> <span class="NLM_fpage">111</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1038%2Fnrd726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=12120092" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhs1ajt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2002&pages=111-121&author=J.+C.+Reed&title=Apoptosis-based+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis-based therapies</span></div><div class="casAuthors">Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many of today's medical illnesses can be attributed directly or indirectly to problems with apoptosis, a programmed cell-suicide mechanism.  Disorders in which defective regulation of apoptosis contributes to disease pathogenesis or progression can involve either cell accumulation, in which cell eradication or cell turnover is impaired, or cell loss, in which the cell-suicide program is inappropriately triggered.  Identification of the genes and gene products that are responsible for apoptosis, together with emerging information about the mechanisms of action and structures of apoptotic regulatory and effector proteins, has laid a foundation for the discovery of drugs, some of which are now undergoing evaluation in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpISfg-GY-sBLVg90H21EOLACvtfcHk0lijMXfkIbHJdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhs1ajt7w%253D&md5=6aa262ef018388d755e46a718b130aa2</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd726%26sid%3Dliteratum%253Aachs%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DApoptosis-based%2520therapies%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2002%26volume%3D1%26spage%3D111%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kumar, S.</span><span> </span><span class="NLM_article-title">Caspase function in programmed cell death</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">32</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1038%2Fsj.cdd.4402060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17082813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSqur%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=32-43&author=S.+Kumar&title=Caspase+function+in+programmed+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase function in programmed cell death</span></div><div class="casAuthors">Kumar, S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-43</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The first proapoptotic caspase, CED-3, was cloned from Caenorhabditis elegans in 1993 and shown to be essential for the developmental death of all somatic cells.  Following the discovery of CED-3, caspases have been cloned from several vertebrate and invertebrate species.  As reviewed in other articles in this issue of Cell Death and Differentiation, many caspases function in nonapoptotic pathways.  However, as is clear from the worm studies, the evolutionarily conserved role of caspases is to execute programmed cell death.  In this article, I will specifically focus on caspases that function primarily in cell death execution.  In particular, the physiol. function of caspases in apoptosis is discussed using examples from the worm, fly and mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzox0vEkRLhLVg90H21EOLACvtfcHk0lha1j97vNAgbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSqur%252FF&md5=c8ae1b9aebbf7a28a9b5e08a001bacbb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402060%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DCaspase%2520function%2520in%2520programmed%2520cell%2520death%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D32%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Callus, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span> </span><span class="NLM_article-title">Caspase inhibitors: viral, cellular and chemical</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">73</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1038%2Fsj.cdd.4402034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=16946729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlSqur%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=73-78&author=B.+A.+Callusauthor=D.+L.+Vaux&title=Caspase+inhibitors%3A+viral%2C+cellular+and+chemical"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase inhibitors: viral, cellular and chemical</span></div><div class="casAuthors">Callus, B. A.; Vaux, D. L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-78</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Caspases, key mediators of apoptosis, are a structurally related family of cysteine proteases that cleave their substrates at aspartic acid residues either to cause cell death or to activate cytokines as part of an immune response.  They can be controlled upstream by the regulation of signals that lead to zymogen activation, or downstream by inhibitors that prevent them from reaching their substrates.  This review specifically looks at caspase inhibitors as distinct from caspase regulators: those produced by the cell itself; those whose genes are carried by viruses; and artificial caspase inhibitors used for research and potentially as therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1O85HHyBCYbVg90H21EOLACvtfcHk0lha1j97vNAgbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlSqur%252FI&md5=179fae906a55facdd614a25e60036d1d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402034%26sid%3Dliteratum%253Aachs%26aulast%3DCallus%26aufirst%3DB.%2BA.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26atitle%3DCaspase%2520inhibitors%253A%2520viral%252C%2520cellular%2520and%2520chemical%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D73%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Linton, S. D.</span><span> </span><span class="NLM_article-title">Caspase inhibitors: a pharmaceutical industry perspective</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">1697</span> <span class="NLM_lpage">1717</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.2174%2F156802605775009720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=16375749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28XislSlsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1697-1717&author=S.+D.+Linton&title=Caspase+inhibitors%3A+a+pharmaceutical+industry+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Caspase inhibitors: a pharmaceutical industry perspective</span></div><div class="casAuthors">Linton, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1697-1716</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Caspase inhibition has been demonstrated to be therapeutically effective in moderating excessive programmed cell death, or apoptosis.  Publications detailing programs in the pharmaceutical industry have been more frequent in recent years, ranging from SAR studies to clin. relevant animal models of disease.  A summary of the work published in this exciting new area is presented, outlining the broad applicability of this fundamental cellular mechanism across several disease indications.  This area of research has matured to the level of advancing compds. into clin. trials: VX-740 (Pralnacasan) and VX-765 as anti-inflammatory agents, and IDN-6556, a pan-caspase inhibitor as an anti-apoptotic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNuWiIlXtZQLVg90H21EOLACvtfcHk0lha1j97vNAgbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislSlsb4%253D&md5=90117df2461483c7833cb80f27c4e861</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F156802605775009720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802605775009720%26sid%3Dliteratum%253Aachs%26aulast%3DLinton%26aufirst%3DS.%2BD.%26atitle%3DCaspase%2520inhibitors%253A%2520a%2520pharmaceutical%2520industry%2520perspective%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1697%26epage%3D1717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">OâDriscoll, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linehan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clynes, M.</span><span> </span><span class="NLM_article-title">Survivin: role in normal cells and in pathological conditions</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">131</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.2174%2F1568009033482038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=12678716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1alt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=131-152&author=L.+O%E2%80%99Driscollauthor=R.+Linehanauthor=M.+Clynes&title=Survivin%3A+role+in+normal+cells+and+in+pathological+conditions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Survivin: Role in normal cells and in pathological conditions</span></div><div class="casAuthors">O'Driscoll, L.; Linehan, R.; Clynes, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-152</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Survivin, an inhibitor of apoptosis (IAP) contg. one baculovirus IAP repeat (BIR) domain, has been reported to be capable of regulating both cellular proliferation and apoptotic cell death.  Survivin splice variants, survivin-ÎEx3 and survivin-2B, have apparently retained and lost anti-apoptotic potential, resp.  As survivin was first discovered due to its high homol. with effector cell protease receptor (EPR-1), a protein involved in blood coagulation, it has been suggested (but not proven) that EPR-1 may act as a natural anti-sense to survivin in cells.  Survivin homologs have been found in non-human species.  Survivin expression has been described during embryonic development and in adult cancerous tissues, with greatly reduced expression in adult normal differentiated tissues, particularly if their proliferation index is low.  Survivin has been defined as a universal tumor antigen and as the fourth most significant transcriptosome expressed in human tumors.  Although survivin is usually located in the cell cytoplasmic region and assocd. with poor prognosis in cancer, nuclear localization, indicative of favorable prognosis, has also been reported.  Survivin expression has also been reported in a no. of proliferating normal adult tissues.  Extensive research has been conducted, aimed at increasing our understanding of survivin, by detg. its sub-cellular structure and location, mechanism(s) of action and control of expression.  While much important information on this mol. has been accumulated, there are still many areas of controversy or limited information.  Further research may enable exploitation of survivin overexpression in cancer compared to normal tissues, making survivin a potentially attractive target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTyDh2jQIlKLVg90H21EOLACvtfcHk0liYI3oXYSj4gA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1alt7s%253D&md5=444e29c17b6ad4954f8a1a8e182850af</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568009033482038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033482038%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Driscoll%26aufirst%3DL.%26aulast%3DLinehan%26aufirst%3DR.%26aulast%3DClynes%26aufirst%3DM.%26atitle%3DSurvivin%253A%2520role%2520in%2520normal%2520cells%2520and%2520in%2520pathological%2520conditions%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D131%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Fischer, U</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Osthoff, K</span><span> </span><span class="NLM_article-title">New approaches and therapeutics targeting apoptosis in disease</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">57</span> <span class="NLM_fpage">187</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=187-215&author=U+Fischerauthor=K+Schulze-Osthoff&title=New+approaches+and+therapeutics+targeting+apoptosis+in+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DU%26aulast%3DSchulze-Osthoff%26aufirst%3DK%26atitle%3DNew%2520approaches%2520and%2520therapeutics%2520targeting%2520apoptosis%2520in%2520disease%26jtitle%3DPharmacol.%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D187%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Promoting apoptosis as a strategy for cancer drug discovery</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">876</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1038%2Fnrc1736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=16239906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Witb7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=876-885&author=S.+W.+Fesik&title=Promoting+apoptosis+as+a+strategy+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Promoting apoptosis as a strategy for cancer drug discovery</span></div><div class="casAuthors">Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">876-885</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Apoptosis is deregulated in many cancers, making it difficult to kill tumors.  Drugs that restore the normal apoptotic pathways have the potential for effectively treating cancers that depend on aberrations of the apoptotic pathway to stay alive.  Apoptosis targets that are currently being explored for cancer drug discovery include the tumor-necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors, the BCL2 family of anti-apoptotic proteins, inhibitor of apoptosis (IAP) proteins and MDM2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOkjz2FXKfBbVg90H21EOLACvtfcHk0liYI3oXYSj4gA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Witb7J&md5=0976f3fb83374260702a71fd856a4834</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrc1736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1736%26sid%3Dliteratum%253Aachs%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DPromoting%2520apoptosis%2520as%2520a%2520strategy%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D876%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span> </span><span class="NLM_article-title">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span> <span class="citation_source-journal">Cancer Cell.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">10</span> <span class="NLM_fpage">389</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1016%2Fj.ccr.2006.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17097561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=389-399&author=M.+F.+van+Delftauthor=A.+H.+Weiauthor=K.+D.+Masonauthor=C.+J.+Vandenbergauthor=L.+Chenauthor=P.+E.+Czabotarauthor=S.+N.+Willisauthor=C.+L.+Scottauthor=C.+L.+Dayauthor=S.+Coryauthor=J.+M.+Adamsauthor=A.+W.+Robertsauthor=D.+C.+Huang&title=The+BH3+mimetic+ABT-737+targets+selective+Bcl-2+proteins+and+efficiently+induces+apoptosis+via+Bak%2FBax+if+Mcl-1+is+neutralized"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span></div><div class="casAuthors">van Delft, Mark F.; Wei, Andrew H.; Mason, Kylie D.; Vandenberg, Cassandra J.; Chen, Lin; Czabotar, Peter E.; Willis, Simon N.; Scott, Clare L.; Day, Catherine L.; Cory, Suzanne; Adams, Jerry M.; Roberts, Andrew W.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Since apoptosis is impaired in malignant cells overexpressing prosurvival Bcl-2 proteins, drugs mimicking their natural antagonists, BH3-only proteins, might overcome chemoresistance.  Of seven putative BH3 mimetics tested, only ABT-737 triggered Bax/Bak-mediated apoptosis.  Despite its high affinity for Bcl-2, Bcl-xL, and Bcl-w, many cell types proved refractory to ABT-737.  We show that this resistance reflects ABT-737's inability to target another prosurvival relative, Mcl-1.  Downregulation of Mcl-1 by several strategies conferred sensitivity to ABT-737.  Furthermore, enforced Mcl-1 expression in a mouse lymphoma model conferred resistance.  In contrast, cells overexpressing Bcl-2 remained highly sensitive to ABT-737.  Hence, ABT-737 should prove efficacious in tumors with low Mcl-1 levels, or when combined with agents that inactivate Mcl-1, even to treat those tumors that overexpress Bcl-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAmMTX4bzgbVg90H21EOLACvtfcHk0ljJRNLTA5LDLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK&md5=6c1de734427cb187fbb9002fd9269ca8</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.027%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DVandenberg%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DScott%26aufirst%3DC.%2BL.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DThe%2520BH3%2520mimetic%2520ABT-737%2520targets%2520selective%2520Bcl-2%2520proteins%2520and%2520efficiently%2520induces%2520apoptosis%2520via%2520Bak%252FBax%2520if%2520Mcl-1%2520is%2520neutralized%26jtitle%3DCancer%2520Cell.%26date%3D2006%26volume%3D10%26spage%3D389%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Pyrogallol-based molecules as potent inhibitors of the antiapoptotic Bcl-2 proteins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">1723</span> <span class="NLM_lpage">1726</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061400l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1723-1726&author=G.+Tangauthor=C.-Y.+Yangauthor=Z.+Nikolovska-Coleskaauthor=J.+Guoauthor=S.+Qiuauthor=R.+Wangauthor=W.+Gaoauthor=G.+Wangauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=S.+Jiangauthor=P.+P.+Rollerauthor=S.+Wang&title=Pyrogallol-based+molecules+as+potent+inhibitors+of+the+antiapoptotic+Bcl-2+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm061400l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061400l%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPyrogallol-based%2520molecules%2520as%2520potent%2520inhibitors%2520of%2520the%2520antiapoptotic%2520Bcl-2%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1723%26epage%3D1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnie, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guyenne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallblad, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitching, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norbedo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saravanan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, H. M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunec, J.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of the MDM2-p53 proteinâprotein interaction based on an isoindolinone scaffold</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">6209</span> <span class="NLM_lpage">6221</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0601194" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6209-6221&author=I.+R.+Hardcastleauthor=S.+U.+Ahmedauthor=H.+Atkinsauthor=G.+Farnieauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=S.+Guyenneauthor=C.+Huttonauthor=P.+Kallbladauthor=S.+J.+Kempauthor=M.+S.+Kitchingauthor=D.+R.+Newellauthor=S.+Norbedoauthor=J.+S.+Northenauthor=R.+J.+Reidauthor=K.+Saravananauthor=H.+M.+G.+Willemsauthor=J.+Lunec&title=Small-molecule+inhibitors+of+the+MDM2-p53+protein%E2%88%92protein+interaction+based+on+an+isoindolinone+scaffold"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm0601194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0601194%26sid%3Dliteratum%253Aachs%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DAhmed%26aufirst%3DS.%2BU.%26aulast%3DAtkins%26aufirst%3DH.%26aulast%3DFarnie%26aufirst%3DG.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DGuyenne%26aufirst%3DS.%26aulast%3DHutton%26aufirst%3DC.%26aulast%3DKallblad%26aufirst%3DP.%26aulast%3DKemp%26aufirst%3DS.%2BJ.%26aulast%3DKitching%26aufirst%3DM.%2BS.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNorbedo%26aufirst%3DS.%26aulast%3DNorthen%26aufirst%3DJ.%2BS.%26aulast%3DReid%26aufirst%3DR.%2BJ.%26aulast%3DSaravanan%26aufirst%3DK.%26aulast%3DWillems%26aufirst%3DH.%2BM.%2BG.%26aulast%3DLunec%26aufirst%3DJ.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520protein%25E2%2588%2592protein%2520interaction%2520based%2520on%2520an%2520isoindolinone%2520scaffold%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6209%26epage%3D6221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">3432</span> <span class="NLM_lpage">3435</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051122a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3432-3435&author=K.+Dingauthor=Y.+Luauthor=Z.+Nikolovska-Coleskaauthor=G.+Wangauthor=S.+Qiuauthor=S.+Shangaryauthor=W.+Gaoauthor=D.+Qinauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=S.+Wang&title=Structure-based+design+of+spiro-oxindoles+as+potent%2C+specific+small-molecule+inhibitors+of+the+MDM2-p53+interaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Ding, Ke; Lu, Yipin; Nikolovska-Coleska, Zaneta; Wang, Guoping; Qiu, Su; Shangary, Sanjeev; Gao, Wei; Qin, Dongguang; Stuckey, Jeanne; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3432-3435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, specific, non-peptide small-mol. inhibitors of the MDM2-p53 interaction were successfully designed.  The most potent inhibitor (MI-63) has a Ki value of 3 nM binding to MDM2 and greater than 10,000-fold selectivity over Bcl-2/Bcl-xL proteins.  MI-63 is highly effective in activation of p53 function and in inhibition of cell growth in cancer cells with wild-type p53 status.  MI-63 has excellent specificity over cancer cells with deleted p53 and shows a minimal toxicity to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptppiErNrFXrVg90H21EOLACvtfcHk0ljJRNLTA5LDLQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D&md5=186a2ba028ad9b8f71107aa1c2555421</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm051122a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051122a%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520spiro-oxindoles%2520as%2520potent%252C%2520specific%2520small-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3432%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">5805</span> <span class="NLM_lpage">5808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5805-5808&author=J.+Chenauthor=Z.+Nikolovska-Coleskaauthor=G.+Wangauthor=S.+Qiuauthor=S.+Wang&title=Design%2C+synthesis%2C+and+characterization+of+new+embelin+derivatives+as+potent+inhibitors+of+X-linked+inhibitor+of+apoptosis+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520new%2520embelin%2520derivatives%2520as%2520potent%2520inhibitors%2520of%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5805%26epage%3D5808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Brabander, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harran, P. G.</span><span> </span><span class="NLM_article-title">A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death</span> <span class="citation_source-journal">Science</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">305</span> <span class="NLM_fpage">1471</span> <span class="NLM_lpage">1474</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1126%2Fscience.1098231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=15353805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFartL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1471-1474&author=L.+Liauthor=R.+M.+Thomasauthor=H.+Suzukiauthor=J.+K.+De+Brabanderauthor=X.+Wangauthor=P.+G.+Harran&title=A+small+molecule+Smac+mimic+potentiates+TRAIL-+and+TNFalpha-mediated+cell+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A Small Molecule Smac Mimic Potentiates TRAIL- and TNFÎ±-Mediated Cell Death</span></div><div class="casAuthors">Li, Lin; Thomas, Ranny Mathew; Suzuki, Hidetaka; De Brabander, Jef K.; Wang, Xiaodong; Harran, Patrick G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5689</span>),
    <span class="NLM_cas:pages">1471-1474</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We describe the synthesis and properties of a small mol. mimic of Smac, a pro-apoptotic protein that functions by relieving inhibitor-of-apoptosis protein (IAP)-mediated suppression of caspase activity.  The compd. binds to X chromosome-encoded IAP (XIAP), cellular IAP 1 (cIAP-1), and cellular IAP 2 (cIAP-2) and synergizes with both tumor necrosis factor Î± (TNFÎ±) and TNF-related apoptosis-inducing ligand (TRAIL) to potently induce caspase activation and apoptosis in human cancer cells.  The mol. has allowed a temporal, unbiased evaluation of the roles that IAP proteins play during signaling from TRAIL and TNF receptors.  The compd. is also a lead structure for the development of IAP antagonists potentially useful as therapy for cancer and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri19S7A9uW8bVg90H21EOLACvtfcHk0ljV8l5ts7Q-5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFartL8%253D&md5=75945f9e8637c8ce303e15f95395f449</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.1098231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1098231%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DDe%2BBrabander%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHarran%26aufirst%3DP.%2BG.%26atitle%3DA%2520small%2520molecule%2520Smac%2520mimic%2520potentiates%2520TRAIL-%2520and%2520TNFalpha-mediated%2520cell%2520death%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1471%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Putt, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandhorst, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoagland, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchwell, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerge, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helferich, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hergenrother, P. J.</span><span> </span><span class="NLM_article-title">Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">543</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1038%2Fnchembio814" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=16936720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1aht7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=543-550&author=K.+S.+Puttauthor=G.+W.+Chenauthor=J.+M.+Pearsonauthor=J.+S.+Sandhorstauthor=M.+S.+Hoaglandauthor=J.+T.+Kwonauthor=S.+K.+Hwangauthor=H.+Jinauthor=M.+I.+Churchwellauthor=M.+H.+Choauthor=D.+R.+Doergeauthor=W.+G.+Helferichauthor=P.+J.+Hergenrother&title=Small-molecule+activation+of+procaspase-3+to+caspase-3+as+a+personalized+anticancer+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy</span></div><div class="casAuthors">Putt, Karson S.; Chen, Grace W.; Pearson, Jennifer M.; Sandhorst, Joseph S.; Hoagland, Martin S.; Kwon, Jung-Taek; Hwang, Soon-Kyung; Jin, Hua; Churchwell, Mona I.; Cho, Myung-Haing; Doerge, Daniel R.; Helferich, William G.; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">543-550, S543/1-S543/29</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutation and aberrant expression of apoptotic proteins are hallmarks of cancer.  These changes prevent proapoptotic signals from being transmitted to executioner caspases, thereby averting apoptotic death and allowing cellular proliferation.  Caspase-3 is the key executioner caspase, and it exists as an inactive zymogen that is activated by upstream signals.  Notably, concns. of procaspase-3 in certain cancerous cells are significantly higher than those in noncancerous controls.  Here we report the identification of a small mol., PAC-1 (I) that directly activates procaspase-3 to caspase-3 in vitro and induces apoptosis in cancerous cells isolated from primary colon tumors in a manner directly proportional to the concn. of procaspase-3 inside these cells.  We found that PAC-1 retarded the growth of tumors in three different mouse models of cancer, including two models in which PAC-1 was administered orally.  PAC-1 is the first small mol. known to directly activate procaspase-3 to caspase-3, a transformation that allows induction of apoptosis even in cells that have defective apoptotic machinery.  The direct activation of executioner caspases is an anticancer strategy that may prove beneficial in treating the many cancers in which procaspase-3 concns. are elevated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0HBfttN1PcbVg90H21EOLACvtfcHk0ljV8l5ts7Q-5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1aht7g%253D&md5=0847c9ec073c912680dd1f715a94a5de</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnchembio814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio814%26sid%3Dliteratum%253Aachs%26aulast%3DPutt%26aufirst%3DK.%2BS.%26aulast%3DChen%26aufirst%3DG.%2BW.%26aulast%3DPearson%26aufirst%3DJ.%2BM.%26aulast%3DSandhorst%26aufirst%3DJ.%2BS.%26aulast%3DHoagland%26aufirst%3DM.%2BS.%26aulast%3DKwon%26aufirst%3DJ.%2BT.%26aulast%3DHwang%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DChurchwell%26aufirst%3DM.%2BI.%26aulast%3DCho%26aufirst%3DM.%2BH.%26aulast%3DDoerge%26aufirst%3DD.%2BR.%26aulast%3DHelferich%26aufirst%3DW.%2BG.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DSmall-molecule%2520activation%2520of%2520procaspase-3%2520to%2520caspase-3%2520as%2520a%2520personalized%2520anticancer%2520strategy%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D543%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, E.</span><span> </span><span class="NLM_article-title">Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">11</span> <span class="NLM_fpage">39</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=39-42&author=S.+X.+Caiauthor=H.-Z.+Zhangauthor=J.+Guastellaauthor=J.+Dreweauthor=W.+Yangauthor=E.+Weber&title=Design+and+synthesis+of+rhodamine+110+derivative+and+caspase-3+substrate+for+enzyme+and+cell-based+fluorescent+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWeber%26aufirst%3DE.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520rhodamine%2520110%2520derivative%2520and%2520caspase-3%2520substrate%2520for%2520enzyme%2520and%2520cell-based%2520fluorescent%2520assay%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D39%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span> </span><span class="NLM_article-title">A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structureâactivity relationship studies, to identification of potential anticancer agents and molecular targets</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">2627</span> <span class="NLM_lpage">2644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.2174%2F092986706778201521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17017915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1SktbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2627-2644&author=S.+X.+Caiauthor=J.+Dreweauthor=S.+Kasibhatla&title=A+chemical+genetics+approach+for+the+discovery+of+apoptosis+inducers%3A+from+phenotypic+cell+based+HTS+assay+and+structure%E2%88%92activity+relationship+studies%2C+to+identification+of+potential+anticancer+agents+and+molecular+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets</span></div><div class="casAuthors">Cai, Sui Xiong; Drewe, John; Kasibhatla, Shailaja</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2627-2644</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The approach of chem. genetics has been widely used to study biol. systems and to discover new drugs, signaling pathways and targets.  The current review focuses on the development and utilization of a cell- and caspase-based apoptosis induction assay for the discovery of apoptosis inducers.  We began with the development of a cell based phenotypic assay, which was used for the identification of small mols. that exhibit apoptosis inducing activities, including N-Ph nicotinamides, gambogic acid, indole-2-carboxylic acid benzylidene-hydrazides, 4-aryl-4H-chromenes and 3-aryl-5-aryl-1,2,4-oxadiazoles.  Through medicinal chem. and biol. studies, in vivo active compds. were identified, such as MX116407 as a tumor vascular disrupting agent with potent in vivo anticancer activity.  The mol. targets of in vivo active compds. were identified using reagents designed and synthesized based on the SAR, including the identification of tail-interacting protein 47 (TIP47), an insulin-like growth factor II (IGF II) receptor binding protein, as the mol. target of 3-aryl-5-aryl-1,2,4-oxadiazoles; and Transferrin receptor I (TfR), a transmembrane protein that interacts with transferrin (Tf) for the transport of iron into cells, as the mol. target of gambogic acid.  We demonstrated that chem. genetics is a very useful approach for anticancer drug research, from the discovery of potential drugs, to the understanding of signaling pathways and identification of druggable targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bmsD_VBUGLVg90H21EOLACvtfcHk0li9TsxruuUicA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1SktbY%253D&md5=d4ca29e8367b8dd6a882df747760c9a2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F092986706778201521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706778201521%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DKasibhatla%26aufirst%3DS.%26atitle%3DA%2520chemical%2520genetics%2520approach%2520for%2520the%2520discovery%2520of%2520apoptosis%2520inducers%253A%2520from%2520phenotypic%2520cell%2520based%2520HTS%2520assay%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520studies%252C%2520to%2520identification%2520of%2520potential%2520anticancer%2520agents%2520and%2520molecular%2520targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2627%26epage%3D2644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery, Characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">309</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=309-317&author=H.-Z.+Zhangauthor=S.+Kasibhatlaauthor=Y.+Wangauthor=J.+Herichauthor=J.+Guastellaauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery%2C+Characterization+and+SAR+of+gambogic+acid+as+a+potent+apoptosis+inducer+by+a+HTS+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%252C%2520Characterization%2520and%2520SAR%2520of%2520gambogic%2520acid%2520as%2520a%2520potent%2520apoptosis%2520inducer%2520by%2520a%2520HTS%2520assay%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D309%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maliartchouk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehlsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span> </span><span class="NLM_article-title">A novel role for transferrin receptor in triggering apoptosis when targeted with gambogic acid</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">102</span> <span class="NLM_fpage">12095</span> <span class="NLM_lpage">12100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=12095-12100&author=S.+Kasibhatlaauthor=K.+Jessenauthor=S.+Maliartchoukauthor=J.+Wangauthor=N.+Englishauthor=J.+Dreweauthor=L.+Quiauthor=S.+Archerauthor=A.+Ponceauthor=N.+Sirisomaauthor=S.+Jiangauthor=H.-Z.+Zhangauthor=K.+Gehlsenauthor=S.+X.+Caiauthor=D.+R.+Greenauthor=B.+Tseng&title=A+novel+role+for+transferrin+receptor+in+triggering+apoptosis+when+targeted+with+gambogic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DJessen%26aufirst%3DK.%26aulast%3DMaliartchouk%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DEnglish%26aufirst%3DN.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DQui%26aufirst%3DL.%26aulast%3DArcher%26aufirst%3DS.%26aulast%3DPonce%26aufirst%3DA.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DGehlsen%26aufirst%3DK.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DGreen%26aufirst%3DD.%2BR.%26aulast%3DTseng%26aufirst%3DB.%26atitle%3DA%2520novel%2520role%2520for%2520transferrin%2520receptor%2520in%2520triggering%2520apoptosis%2520when%2520targeted%2520with%2520gambogic%2520acid%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D12095%26epage%3D12100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuemmerle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliis-Mason, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogran-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery and structure activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">48</span> <span class="NLM_fpage">5215</span> <span class="NLM_lpage">5223</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050292k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5215-5223&author=H.-Z.+Zhangauthor=S.+Kasibhatlaauthor=J.+Kuemmerleauthor=W.+Kemnitzerauthor=K.+Oliis-Masonauthor=L.+Quiauthor=C.+Crogran-Grundyauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+and+structure+activity+relationship+of+3-aryl-5-aryl-1%2C2%2C4-oxadiazoles+as+a+new+series+of+apoptosis+inducers+and+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm050292k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050292k%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DKuemmerle%26aufirst%3DJ.%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DOliis-Mason%26aufirst%3DK.%26aulast%3DQui%26aufirst%3DL.%26aulast%3DCrogran-Grundy%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationship%2520of%25203-aryl-5-aryl-1%252C2%252C4-oxadiazoles%2520as%2520a%2520new%2520series%2520of%2520apoptosis%2520inducers%2520and%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5215%26epage%3D5223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Jessen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maliartchouk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuemmerle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gehlsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span> </span><span class="NLM_article-title">Identification of tail interacting protein (TIP47), an IGFII receptor binding protein as the molecular target for tumor selective apoptosis-inducing agents, 3,5-diaryl-[1,2,4]-oxadiazoles</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">761</span> <span class="NLM_lpage">771</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1158%2F1535-7163.MCT-04-0333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=15897240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFyksbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=761-771&author=K.+Jessenauthor=N.+Englishauthor=J.+Wangauthor=L.+Quiauthor=R.+Brandauthor=S.+Maliartchoukauthor=J.+Dreweauthor=J.+Kuemmerleauthor=H.-Z.+Zhangauthor=K.+Gehlsenauthor=B.+Tsengauthor=S.+X.+Caiauthor=S.+Kasibhatla&title=Identification+of+tail+interacting+protein+%28TIP47%29%2C+an+IGFII+receptor+binding+protein+as+the+molecular+target+for+tumor+selective+apoptosis-inducing+agents%2C+3%2C5-diaryl-%5B1%2C2%2C4%5D-oxadiazoles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery and mechanism of action of novel tumor-selective and apoptosis-inducing 3,5-diaryl-1,2,4-oxadiazole series using a chemical genetics approach</span></div><div class="casAuthors">Jessen, Katayoun A.; English, Nicole M.; Wang, Jean Yu; Maliartchouk, Sergei; Archer, Shannon P.; Qiu, Ling; Brand, Regina; Kuemmerle, Jared; Zhang, Han-Zhong; Gehlsen, Kurt; Drewe, John; Tseng, Ben; Cai, Sui Xiong; Kasibhatla, Shailaja</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">761-771</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A novel series of 3,5-diaryl-oxadiazoles was identified as apoptosis-inducing agents through our cell and chem. genetics-based screening assay for compds. that induce apoptosis using a chem. genetics approach.  Several analogs from this series including MX-74420 and MX-126374 were further characterized.  MX-126374, a lead compd. from this series, was shown to induce apoptosis and inhibit cell growth selectively in tumor cells.  To elucidate the mechanism(s) by which this class of compds. alters the signal transduction pathway that ultimately leads to apoptosis, expression profiling using the Affymetrix Gene Chip array technol. was done along with other mol. and biochem. analyses.  Interestingly, we have identified several key genes (cyclin D1, transforming growth factor-Î²1, p21, and insulin-like growth factor-BP3) that are altered in the presence of this compd., leading to characterization of the pathway for activation of apoptosis.  MX-126374 also showed significant inhibition of tumor growth as a single agent and in combination with paclitaxel in murine tumor models.  Using photoaffinity labeling, tail-interacting protein 47, an insulin-like growth factor-II receptor binding protein, was identified as the mol. target.  Further studies indicated that down-regulation of tail-interacting protein 47 in cancer cells by small interfering RNA shows a similar pathway profile as compd. treatment.  These data suggest that 3,5-diaryl-oxadiazoles may be a new class of anticancer drugs that are tumor-selective and further support the discovery of novel drugs and drug targets using chem. genetic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEAny0NCb5B7Vg90H21EOLACvtfcHk0lgm4hIDoRKKlw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFyksbs%253D&md5=2c345caac3c38b49e28ae06ba68019de</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-04-0333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-04-0333%26sid%3Dliteratum%253Aachs%26aulast%3DJessen%26aufirst%3DK.%26aulast%3DEnglish%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DQui%26aufirst%3DL.%26aulast%3DBrand%26aufirst%3DR.%26aulast%3DMaliartchouk%26aufirst%3DS.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DKuemmerle%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DGehlsen%26aufirst%3DK.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DKasibhatla%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520tail%2520interacting%2520protein%2520%2528TIP47%2529%252C%2520an%2520IGFII%2520receptor%2520binding%2520protein%2520as%2520the%2520molecular%2520target%2520for%2520tumor%2520selective%2520apoptosis-inducing%2520agents%252C%25203%252C5-diaryl-%255B1%252C2%252C4%255D-oxadiazoles%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D761%26epage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labreque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meerovitch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouffard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rej, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structureâactivity relationships of the 4-aryl group</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">47</span> <span class="NLM_fpage">6299</span> <span class="NLM_lpage">6310</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049640t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6299-6310&author=W.+Kemnitzerauthor=S.+Kasibhatlaauthor=S.+Jiangauthor=H.+Zhangauthor=Y.+Wangauthor=J.+Zhaoauthor=S.+Jiaauthor=J.+Herichauthor=D.+Labrequeauthor=R.+Storerauthor=K.+Meerovitchauthor=D.+Bouffardauthor=R.+Rejauthor=R.+Denisauthor=C.+Blaisauthor=S.+Lamotheauthor=G.+Attardoauthor=H.+Gourdeauauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high-throughput+screening+assay.+1.+Structure%E2%88%92activity+relationships+of+the+4-aryl+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm049640t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049640t%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DLabreque%26aufirst%3DD.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DMeerovitch%26aufirst%3DK.%26aulast%3DBouffard%26aufirst%3DD.%26aulast%3DRej%26aufirst%3DR.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DBlais%26aufirst%3DC.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high-throughput%2520screening%2520assay.%25201.%2520Structure%25E2%2588%2592activity%2520relationships%2520of%2520the%25204-aryl%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6299%26epage%3D6310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogan-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 3. Structure-activity relationships of fused rings at the 7,8-positions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">50</span> <span class="NLM_fpage">2858</span> <span class="NLM_lpage">2864</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070216c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2858-2864&author=W.+Kemnitzerauthor=J.+Dreweauthor=S.+Jiangauthor=H.+Zhangauthor=J.+Zhaoauthor=C.+Crogan-Grundyauthor=L.+Xuauthor=S.+Lamotheauthor=H.+Gourdeauauthor=R.+Denisauthor=B.+Tsengauthor=S.+Kasibhatlaauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high-throughput+screening+assay.+3.+Structure-activity+relationships+of+fused+rings+at+the+7%2C8-positions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fjm070216c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070216c%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DCrogan-Grundy%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high-throughput%2520screening%2520assay.%25203.%2520Structure-activity%2520relationships%2520of%2520fused%2520rings%2520at%2520the%25207%252C8-positions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2858%26epage%3D2864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogan-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labreque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubenick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structureâactivity relationships of <i>N</i>-alkyl-substituted pyrrole fused at the 7-, 8-positions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">51</span> <span class="NLM_fpage">417</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7010657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=417-423&author=W.+Kemnitzerauthor=J.+Dreweauthor=S.+Jiangauthor=H.+Zhangauthor=C.+Crogan-Grundyauthor=D.+Labrequeauthor=M.+Bubenickauthor=G.+Attardoauthor=R.+Denisauthor=S.+Lamotheauthor=H.+Gourdeauauthor=B.+Tsengauthor=S.+Kasibhatlaauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+a+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high+throughput+screening+assay.+4.+Structure%E2%88%92activity+relationships+of+N-alkyl-substituted+pyrrole+fused+at+the+7-%2C+8-positions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Fjm7010657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7010657%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCrogan-Grundy%26aufirst%3DC.%26aulast%3DLabreque%26aufirst%3DD.%26aulast%3DBubenick%26aufirst%3DM.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520a%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high%2520throughput%2520screening%2520assay.%25204.%2520Structure%25E2%2588%2592activity%2520relationships%2520of%2520N-alkyl-substituted%2520pyrrole%2520fused%2520at%2520the%25207-%252C%25208-positions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D417%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meerovitch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouffard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span> </span><span class="NLM_article-title">Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">1365</span> <span class="NLM_lpage">1374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=15542775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslCktr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1365-1374&author=S.+Kasibhatlaauthor=H.+Gourdeauauthor=K.+Meerovitchauthor=J.+Dreweauthor=S.+Reddyauthor=L.+Qiuauthor=H.+Zhangauthor=F.+Bergeronauthor=D.+Bouffardauthor=Q.+Yangauthor=J.+Herichauthor=S.+Lamotheauthor=S.+X.+Caiauthor=B.+Tseng&title=Discovery+and+mechanism+of+action+of+a+novel+series+of+apoptosis+inducers+with+potential+vascular+targeting+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity</span></div><div class="casAuthors">Kasibhatla, Shailaja; Gourdeau, Henriette; Meerovitch, Karen; Drewe, John; Reddy, Sanjeeva; Qiu, Ling; Zhang, Hong; Bergeron, Frederick; Bouffard, David; Yang, Quan; Herich, John; Lamothe, Serge; Cai, Sui Xiong; Tseng, Ben</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1365-1374</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A novel series of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes was identified as apoptosis-inducing agents through our cell-based apoptosis screening assay.  Several analogs from this series, MX-58151, MX-58276, MX-76747, MX-116214, MX-126303, and MX-116407, were synthesized and further characterized.  MX-116407, a lead compd. from this series, induced apoptosis with an EC50 of 50 nmol/L and inhibited cell growth with a GI50 of 37 nmol/L in T47D breast cancer cells.  Treatment of cells with these analogs led to G2-M arrest, cleavage of essential proapoptotic caspase substrates, and induction of nuclear fragmentation.  We identified these compds. as tubulin destabilizers with binding site at or close to the colchicine binding site.  Compds. in this series were also active in drug-resistant cancer cell lines with a GI50 value for one of the analogs (MX-58151) of 2.5 nmol/L in paclitaxel-resistant, multidrug-resistant MES-SA/DX5 tumor cells.  This series of compds. displayed high selectivity against proliferating vs. resting cells.  Interestingly, these compds. were shown to disrupt preformed endothelial cell capillary tubules in vitro and affect functional vasculature to induce tumor necrosis in vivo and are thus likely to work as tumor vasculature targeting agents.  Among these compds., MX-116407 showed capillary tubule disruption activity in vitro at concns. well below the cytotoxic dose.  In a sep. study, we further characterized the antitumor efficacy and pharmacokinetic profile of this series of compds. and identified MX-116407 as a potent apoptosis-inducing agent with apparent activity as tumor vasculature targeting agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHfYJ2bcTW_LVg90H21EOLACvtfcHk0lhartmVepMxcQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslCktr4%253D&md5=912ac5b5c08149c875b7c60f132f50ff</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DMeerovitch%26aufirst%3DK.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBergeron%26aufirst%3DF.%26aulast%3DBouffard%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DTseng%26aufirst%3DB.%26atitle%3DDiscovery%2520and%2520mechanism%2520of%2520action%2520of%2520a%2520novel%2520series%2520of%2520apoptosis%2520inducers%2520with%2520potential%2520vascular%2520targeting%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1365%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblond, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desputeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kianicka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Custeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourdeau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span> </span><span class="NLM_article-title">Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4<i>H</i>-chromenes, a novel series of anticancer agents</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">1375</span> <span class="NLM_lpage">1383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=15542776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpslCktr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=1375-1383&author=H.+Gourdeauauthor=L.+Leblondauthor=B.+Hamelinauthor=C.+Desputeauauthor=K.+Dongauthor=I.+Kianickaauthor=D.+Custeauauthor=C.+Bourdeauauthor=L.+Geertsauthor=S.+X.+Caiauthor=J.+Dreweauthor=D.+Labrecqueauthor=S.+Kasibhatlaauthor=B.+Tseng&title=Antivascular+and+antitumor+evaluation+of+2-amino-4-%283-bromo-4%2C5-dimethoxy-phenyl%29-3-cyano-4H-chromenes%2C+a+novel+series+of+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents</span></div><div class="casAuthors">Gourdeau, Henriette; Leblond, Lorraine; Hamelin, Bettina; Desputeau, Clemence; Dong, Kelly; Kianicka, Irenej; Custeau, Dominique; Boudreau, Chantal; Geerts, Lilianne; Cai, Sui-Xiong; Drewe, John; Labrecque, Denis; Kasibhatla, Shailaja; Tseng, Ben</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1375-1384</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A novel series of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes was identified as potent apoptosis inducers through a cell-based high throughput screening assay.  Six compds. from this series, MX-58151, MX-58276, MX-76747, MX-116214, MX-116407, and MX-126303, were further profiled and shown to have potent in vitro cytotoxic activity toward proliferating cells only and to interact with tubulin at the colchicine-binding site, thereby inhibiting tubulin polymn. and leading to cell cycle arrest and apoptosis.  Furthermore, these compds. were shown to disrupt newly formed capillary tubes in vitro at low nanomolar concns.  These data suggested that the compds. might have vascular targeting activity.  In this study, we have evaluated the ability of these compds. to disrupt tumor vasculature and to induce tumor necrosis.  We investigated the pharmacokinetic and toxicity profiles of all six compds. and examd. their ability to induce tumor necrosis.  We next examd. the antitumor efficacy of a subset of compds. in three different human solid tumor xenografts.  In the human lung tumor xenograft (Calu-6), MX-116407 was highly active, producing tumor regressions in all 10 animals.  Moreover, MX-116407 significantly enhanced the antitumor activity of cisplatin, resulting in 40% tumor-free animals at time of sacrifice.  Our results identify MX-116407 as the lead candidate and strongly support its continued development as a novel anticancer agent for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYs5tq0pO-nbVg90H21EOLACvtfcHk0lhartmVepMxcQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpslCktr0%253D&md5=fa04cb51c2d3d9c3b51e4f286856f25b</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DLeblond%26aufirst%3DL.%26aulast%3DHamelin%26aufirst%3DB.%26aulast%3DDesputeau%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DK.%26aulast%3DKianicka%26aufirst%3DI.%26aulast%3DCusteau%26aufirst%3DD.%26aulast%3DBourdeau%26aufirst%3DC.%26aulast%3DGeerts%26aufirst%3DL.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DLabrecque%26aufirst%3DD.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26atitle%3DAntivascular%2520and%2520antitumor%2520evaluation%2520of%25202-amino-4-%25283-bromo-4%252C5-dimethoxy-phenyl%2529-3-cyano-4H-chromenes%252C%2520a%2520novel%2520series%2520of%2520anticancer%2520agents%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D1375%26epage%3D1383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Elslager, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortwine, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werbel, L. M.</span><span> </span><span class="NLM_article-title">Synthesis and antimalarial effects of <i>N</i><sup>2</sup>-aryl-<i>N</i><sup>4</sup>-[(dialkylamino)alkyl]- and <i>N</i><sup>4</sup>-aryl-<i>N</i><sup>2</sup>-[(dialkylamino)alkyl]-2,4-quinazolinediamines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1981</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">127</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00134a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=127-140&author=E.+F.+Elslagerauthor=C.+Hessauthor=J.+Johnsonauthor=D.+Ortwineauthor=V.+Chuauthor=L.+M.+Werbel&title=Synthesis+and+antimalarial+effects+of+N2-aryl-N4-%5B%28dialkylamino%29alkyl%5D-+and+N4-aryl-N2-%5B%28dialkylamino%29alkyl%5D-2%2C4-quinazolinediamines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00134a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00134a002%26sid%3Dliteratum%253Aachs%26aulast%3DElslager%26aufirst%3DE.%2BF.%26aulast%3DHess%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DOrtwine%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DV.%26aulast%3DWerbel%26aufirst%3DL.%2BM.%26atitle%3DSynthesis%2520and%2520antimalarial%2520effects%2520of%2520N2-aryl-N4-%255B%2528dialkylamino%2529alkyl%255D-%2520and%2520N4-aryl-N2-%255B%2528dialkylamino%2529alkyl%255D-2%252C4-quinazolinediamines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Badiger, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nargund, K. S.</span><span> </span><span class="NLM_article-title">Substituted phenyl quinazolyl ethers</span> <span class="citation_source-journal">J. Karnatak Univ.</span><span class="NLM_year" style="font-weight: bold;">1960</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">10</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADyaF3sXisleisQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1960&pages=10-17&author=V.+V.+Badigerauthor=K.+S.+Nargund&title=Substituted+phenyl+quinazolyl+ethers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted phenyl quinazolyl ethers</span></div><div class="casAuthors">Badiger, V. V.; Nargund, K. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Karnatak University</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10-17</span>CODEN:
                <span class="NLM_cas:coden">JKAUAR</span>;
        ISSN:<span class="NLM_cas:issn">0453-3348</span>.
    </div><div class="casAbstract">Several substituted phenyl 4-quinazolyl ethers which are expected to show enhanced antibacterial activity were prepd. by refluxing the substituted phenol (0.05 mole) and 4-chloroquinazoline (0.05 mole) 2 hrs. with a soln. of NaOEt prepd. from Na (0.05 mole) in abs. EtOH (15 ml.).  The mixt. was then dild. with H2O and made alk. to dissolve unreacted phenol.  In the case of dihydric phenols, the reaction mixt. was made neutral and steam distd.  If the ethers were solids, they were filtered off and crystd. from alc.  Liquid ethers were extd. with Et2O, dried over anhyd. CaCl2, the Et2O removed, and the residue distd. in vacuo.  The following (substituted phenyl)-4-quinazolyl ethers and their derivs. were prepd. [substituent, % yield, m.p. or b.p., picrate m.p. (crystd. from alc.) and, if any, the hydrochloride (HCl) m.p. (crystd. from Et2O) or acetyl (Ac) deriv. m.p. (crystn. solvent) given]: 2-Cl, 21, 123Â°, 178Â°, HCl 190Â° (decompn.); 3-Cl, 26, 101Â°, 176Â°;  4-Cl, 21, 113Â°, 184Â°, HCl 210Â°;  2,3-Cl2, 27, 146Â°, 174Â°, HCl 200Â° (decompn.); 2,4-Cl2, 36, 173Â°, 194Â°, HCl 180Â°;  2,6-Cl2, 20, 160Â°, 184-5Â°; 3,5-Cl2, 20, 133Â°, 163Â°, HCl 196Â° (decompn.); 3,4-Cl2, 21, 130Â°, 178Â°; 2-Me, 45, 135-40Â°/15 mm. (n27D 1.5671, d27 1.003), 178Â°; 3-Me, 66, 138-40Â°/15 mm. (n27D 1.5676, d27 1.003), 179Â°; 4-Me, 125-27Â°/10 mm. (n27D 1.5652, d27 1.003), 180Â°; 4-OH, 42, 209Â°, 185Â°, Ac 208Â° (Me2CO); 4-OH, 67, 196-7Â°, 174,Â° Ac 179Â° (dil. alc.); 2-MeO, 42, 155-60Â°/15 mm. (n27D 1.5700, d27 1.003), 180Â°; 3-MeO, 42, 145Â°/6 mm. (n27D 1.5683, d27 1.004), 185Â°; 4-MeO, 50, 144Â°/6 mm. (n27D 1.5680, d27 1.004), 183Â°; 4-NO2, 62, 209Â°, 185Â°; 2,4-Cl(O2N), 70, 206Â°, 198Â°; 2,6,4-Cl2(O2N), 90, 243Â°, 200Â°.  Î²-Naphthyl 4-quinazolyl ether (b10 165-6Â°, n27D 1.5990, d27 1.004) was prepd. in 43% yield (picrate m. 180-1Â°).  Î±-Naphthyl 4-quinazolyl ether (b10 163-5Â°, n27D 1.5998, d27 1.005) was prepd. in 50% yield (picrate m. 180-1Â°).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXglEwjVYOC7Vg90H21EOLACvtfcHk0liw3ybP0dPjJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3sXisleisQ%253D%253D&md5=d16ce0ffed06729fbb5ee2585a7c8e7f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBadiger%26aufirst%3DV.%2BV.%26aulast%3DNargund%26aufirst%3DK.%2BS.%26atitle%3DSubstituted%2520phenyl%2520quinazolyl%2520ethers%26jtitle%3DJ.%2520Karnatak%2520Univ.%26date%3D1960%26volume%3D5%26spage%3D10%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span> </span><span class="NLM_article-title">Discovery of substituted <i>N</i>-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">46</span> <span class="NLM_fpage">2474</span> <span class="NLM_lpage">2481</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0205200" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2474-2481&author=S.+X.+Caiauthor=B.+Nguyenauthor=S.+Jiaauthor=J.+Herichauthor=J.+Guastellaauthor=S.+Reddyauthor=B.+Tsengauthor=J.+Dreweauthor=S.+Kasibhatla&title=Discovery+of+substituted+N-phenyl+nicotinamides+as+potent+inducers+of+apoptosis+using+a+cell-+and+caspase-based+high+throughput+screening+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0205200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0205200%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DKasibhatla%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520substituted%2520N-phenyl%2520nicotinamides%2520as%2520potent%2520inducers%2520of%2520apoptosis%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high%2520throughput%2520screening%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2474%26epage%3D2481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mayer, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D.</span><span> </span><span class="NLM_article-title">Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P-glycoprotein</span> <span class="citation_source-journal">J. Exp. Ther. Oncol.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">107</span> <span class="NLM_lpage">120</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1046%2Fj.1359-4117.2002.1009x.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=12415627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD38XosVSgtbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=107-120&author=L.+D.+Mayerauthor=K.+T.+Limauthor=D.+Hartley&title=Identification+of+two+distinct+intracellular+sites+that+contribute+to+the+modulation+of+multidrug+resistance+in+P388%2FADR+cells+expressing+P-glycoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P-glycoprotein</span></div><div class="casAuthors">Mayer, Lawrence D.; Lim, Kye-Taek; Hartley, Daria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Therapeutics and Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-120</span>CODEN:
                <span class="NLM_cas:coden">JETOFX</span>;
        ISSN:<span class="NLM_cas:issn">1359-4117</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing, Inc.</span>)
        </div><div class="casAbstract">Although the ability of chemosensitizers to modulate P-glycoprotein (PGP)-based multidrug resistance (MDR) has been extensively studied, relatively little is known about the cellular pharmacol. of the PGP inhibitors themselves in MDR cells.  The studies described here have correlated the in vitro accumulation and retention properties of verapamil (VRP) in murine P388 (sensitive) and P388/ADR (MDR) cells with doxorubicin (DOX) uptake and cytotoxicity modulation characteristics in order to better understand VRP-tumor cell interactions that give rise to MDR modulation.  VRP is rapidly taken up by DOX-sensitive and -resistant P388 cells where greater than 50% maximal VRP uptake occurs within 10 min of initial exposure at 37Â°.  Whereas chemosensitization and DOX uptake in P388/ADR cells increase with increasing VRP concn. until a plateau is achieved at approx. 5 Î¼M VRP, cellular modulator levels increase proportionally with increasing VRP concns. beyond 20 Î¼M.  Subsequent to removal of noncell-assocd. modulator, VRP levels in both sensitive and resistant cells rapidly fall below 10% of those obtained at uptake equil.  However, a residual amt. of VRP remains assocd. with the cells for extended time periods after the cells are washed.  Pulse exposures of P388/ADR cells to high concns. of VRP (50-100 Î¼M) are capable of providing extended cell-assocd. VRP levels comparable to those obtained with continuous exposure at biol. active VRP concns. (1-3 Î¼M) and this leads to chemosensitization.  These results are consistent with the existence of high- and low-affinity intracellular VRP pools in P388 MDR cells, both of which can contribute to the reversal of drug resistance.  It is suggested that these properties should be taken into consideration during the design and evaluation of preclin. in vivo MDR models where pulsed exposure to high concns. of resistance modulators often occurs.  Special attention must be given to whether such high concn. pulses are desirable and/or achievable in relevant clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq3a5HR_0amLVg90H21EOLACvtfcHk0liw3ybP0dPjJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosVSgtbg%253D&md5=6ded8d99d931686ab685269eef68f937</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1046%2Fj.1359-4117.2002.1009x.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1359-4117.2002.1009x.x%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DL.%2BD.%26aulast%3DLim%26aufirst%3DK.%2BT.%26aulast%3DHartley%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520two%2520distinct%2520intracellular%2520sites%2520that%2520contribute%2520to%2520the%2520modulation%2520of%2520multidrug%2520resistance%2520in%2520P388%252FADR%2520cells%2520expressing%2520P-glycoprotein%26jtitle%3DJ.%2520Exp.%2520Ther.%2520Oncol.%26date%3D2002%26volume%3D2%26spage%3D107%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">56</span> <span class="NLM_fpage">51</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1016%2FS0014-827X%2801%2901026-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=11347967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltFKqsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=51-56&author=W.+A.+Denny&title=The+4-anilinoquinazoline+class+of+inhibitors+of+the+erbB+family+of+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases</span></div><div class="casAuthors">Denny, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">51-56</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">The erbB family of receptor tyrosine kinase enzymes, and particularly EGFR and HER2/neu, have become important targets for potential anticancer drugs.  The substrate protein binding site theor. is the more attractive intracellular target on these enzymes, possessing lower homol. than the ATP site between different receptor kinases.  However, a major breakthrough in this field was the discovery that 4-anilinoquinazolines are potent and selective inhibitors, despite binding at the ATP site.  The very tight structure-activity relationships shown by these compds. suggested a clearly-defined binding mode, where the quinazoline ring binds in the adenine pocket and the anilino ring binds in an adjacent, unique lipophilic pocket.  A unique cysteine (Cys-773) adjacent to the quinazoline binding site has prompted the development of irreversible inhibitors that target this residue.  Three 4-anilinoquinazoline analogs (two reversible and one irreversible inhibitor) have been evaluated clin. as anticancer drugs.  Data from the most advanced, the reversible inhibitor Iressa, suggest that this class of compds. may be of value in cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6rVaLzsNOfLVg90H21EOLACvtfcHk0liw3ybP0dPjJw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltFKqsbw%253D&md5=83511311545c258eb424046d446795c9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2801%2901026-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252801%252901026-6%26sid%3Dliteratum%253Aachs%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DThe%25204-anilinoquinazoline%2520class%2520of%2520inhibitors%2520of%2520the%2520erbB%2520family%2520of%2520receptor%2520tyrosine%2520kinases%26jtitle%3DFarmaco%26date%3D2001%26volume%3D56%26spage%3D51%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Klutchko, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Althaus, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meade, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherwood, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pace, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smaill, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-<i>d</i>]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">1475</span> <span class="NLM_lpage">1485</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050936o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1475-1485&author=S.+R.+Klutchkoauthor=H.+Zhouauthor=R.+T.+Wintersauthor=T.+P.+Tranauthor=A.+J.+Bridgesauthor=I.+W.+Althausauthor=D.+M.+Amatoauthor=W.+L.+Elliottauthor=P.+A.+Ellisauthor=M.+A.+Meadeauthor=B.+J.+Robertsauthor=D.+W.+Fryauthor=A.+J.+Gonzalesauthor=P.+J.+Harveyauthor=J.+M.+Nelsonauthor=V.+Sherwoodauthor=H.-K.+Hanauthor=G.+Paceauthor=J.+B.+Smaillauthor=W.+A.+Dennyauthor=H.+D.+H.+Showalter&title=Tyrosine+kinase+inhibitors.+19.+6-Alkynamides+of+4-anilinoquinazolines+and+4-anilinopyrido%5B3%2C4-d%5Dpyrimidines+as+irreversible+inhibitors+of+the+erbB+family+of+tyrosine+kinase+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm050936o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050936o%26sid%3Dliteratum%253Aachs%26aulast%3DKlutchko%26aufirst%3DS.%2BR.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWinters%26aufirst%3DR.%2BT.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DAlthaus%26aufirst%3DI.%2BW.%26aulast%3DAmato%26aufirst%3DD.%2BM.%26aulast%3DElliott%26aufirst%3DW.%2BL.%26aulast%3DEllis%26aufirst%3DP.%2BA.%26aulast%3DMeade%26aufirst%3DM.%2BA.%26aulast%3DRoberts%26aufirst%3DB.%2BJ.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DGonzales%26aufirst%3DA.%2BJ.%26aulast%3DHarvey%26aufirst%3DP.%2BJ.%26aulast%3DNelson%26aufirst%3DJ.%2BM.%26aulast%3DSherwood%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DH.-K.%26aulast%3DPace%26aufirst%3DG.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%252019.%25206-Alkynamides%2520of%25204-anilinoquinazolines%2520and%25204-anilinopyrido%255B3%252C4-d%255Dpyrimidines%2520as%2520irreversible%2520inhibitors%2520of%2520the%2520erbB%2520family%2520of%2520tyrosine%2520kinase%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1475%26epage%3D1485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert-van der Brempt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgentin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterbein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, G</span><span> </span><span class="NLM_article-title"><i>N</i>-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2<i>H</i>-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">6465</span> <span class="NLM_lpage">6488</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060434q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6465-6488&author=L.+F.+Hennequinauthor=J.+Allenauthor=J.+Breedauthor=J.+Curwenauthor=M.+Fennellauthor=T.+P.+Greenauthor=C.+Lambert-van+der+Bremptauthor=R.+Morgentinauthor=R.+A.+Normanauthor=A.+Olivierauthor=L.+Otterbeinauthor=P.+A.+Pleauthor=N.+Warinauthor=G+Costello&title=N-%285-Chloro-1%2C3-benzodioxol-4-yl%29-7-%5B2-%284-methylpiperazin-1-yl%29ethoxy%5D-5-%28tetrahydro-2H-pyran-4-yloxy%29quinazolin-4-amine%2C+a+novel%2C+highly+selective%2C+orally+available%2C+dual-specific+c-Src%2FAbl+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fjm060434q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060434q%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DCurwen%26aufirst%3DJ.%26aulast%3DFennell%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DT.%2BP.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26aulast%3DMorgentin%26aufirst%3DR.%26aulast%3DNorman%26aufirst%3DR.%2BA.%26aulast%3DOlivier%26aufirst%3DA.%26aulast%3DOtterbein%26aufirst%3DL.%26aulast%3DPle%26aufirst%3DP.%2BA.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DCostello%26aufirst%3DG%26atitle%3DN-%25285-Chloro-1%252C3-benzodioxol-4-yl%2529-7-%255B2-%25284-methylpiperazin-1-yl%2529ethoxy%255D-5-%2528tetrahydro-2H-pyran-4-yloxy%2529quinazolin-4-amine%252C%2520a%2520novel%252C%2520highly%2520selective%252C%2520orally%2520available%252C%2520dual-specific%2520c-Src%252FAbl%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6465%26epage%3D6488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert-van der Brempt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohmann, J.-J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renaud, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Savi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dousson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortlock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heron, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odedra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N. J.; Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brightwell, S.</span><span> </span><span class="NLM_article-title">Discovery of nove l and potent thiazoloquinazolines as selective eaurora A and B kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">955</span> <span class="NLM_lpage">970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050786h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=955-970&author=F.+H.+Jungauthor=G.+Pasquetauthor=C.+Lambert-van+der+Bremptauthor=J.-J.+M.+Lohmannauthor=N.+Warinauthor=F.+Renaudauthor=H.+Germainauthor=C.+De+Saviauthor=N.+Robertsauthor=T.+Johnsonauthor=C.+Doussonauthor=G.+B.+Hillauthor=A.+A.+Mortlockauthor=N.+Heronauthor=R.+W.+Wilkinsonauthor=S.+R.+Wedgeauthor=S.+P.+Heatonauthor=R.+Odedraauthor=N.+J.%3B+Green%2C+S.+Keenauthor=E.+Brownauthor=K.+Thompsonauthor=S.+Brightwell&title=Discovery+of+nove+l+and+potent+thiazoloquinazolines+as+selective+eaurora+A+and+B+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1021%2Fjm050786h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050786h%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DPasquet%26aufirst%3DG.%26aulast%3DLambert-van%2Bder%2BBrempt%26aufirst%3DC.%26aulast%3DLohmann%26aufirst%3DJ.-J.%2BM.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DRenaud%26aufirst%3DF.%26aulast%3DGermain%26aufirst%3DH.%26aulast%3DDe%2BSavi%26aufirst%3DC.%26aulast%3DRoberts%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DDousson%26aufirst%3DC.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DMortlock%26aufirst%3DA.%2BA.%26aulast%3DHeron%26aufirst%3DN.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DHeaton%26aufirst%3DS.%2BP.%26aulast%3DOdedra%26aufirst%3DR.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%253B%2BGreen%252C%2BS.%26aulast%3DBrown%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DBrightwell%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520nove%2520l%2520and%2520potent%2520thiazoloquinazolines%2520as%2520selective%2520eaurora%2520A%2520and%2520B%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D955%26epage%3D970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bridges, A. J.</span><span> </span><span class="NLM_article-title">Chemical inhibitors of protein kinases</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">101</span> <span class="NLM_fpage">2541</span> <span class="NLM_lpage">2572</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr000250y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvVWnt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=2541-2572&author=A.+J.+Bridges&title=Chemical+inhibitors+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical inhibitors of protein kinases</span></div><div class="casAuthors">Bridges, Alexander J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2541-2571</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 258 refs. on development protein kinase inhibitors as potential antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXWn7KO1AXzrVg90H21EOLACvtfcHk0ljZvYA3MbB-ew"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvVWnt7k%253D&md5=05ee78880cc9dcf485684e05327108db</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fcr000250y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr000250y%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26atitle%3DChemical%2520inhibitors%2520of%2520protein%2520kinases%26jtitle%3DChem.%2520Rev.%26date%3D2001%26volume%3D101%26spage%3D2541%26epage%3D2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5â²-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_volume">38</span> <span class="NLM_fpage">3482</span> <span class="NLM_lpage">3487</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00018a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3482-3487&author=G.+W.+Rewcastleauthor=W.+A.+Dennyauthor=A.+J.+Bridgesauthor=H.+Zhouauthor=D.+R.+Codyauthor=A.+McMichaelauthor=D.+W.+Fry&title=Tyrosine+kinase+inhibitors.+5.+Synthesis+and+structure-activity+relationships+for+4-%5B%28phenylmethyl%29amino%5D-+and+4-%28phenylamino%29quinazolines+as+potent+adenosine+5%E2%80%B2-triphosphate+binding+site+inhibitors+of+the+tyrosine+kinase+domain+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm00018a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00018a008%26sid%3Dliteratum%253Aachs%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DCody%26aufirst%3DD.%2BR.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DFry%26aufirst%3DD.%2BW.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25205.%2520Synthesis%2520and%2520structure-activity%2520relationships%2520for%25204-%255B%2528phenylmethyl%2529amino%255D-%2520and%25204-%2528phenylamino%2529quinazolines%2520as%2520potent%2520adenosine%25205%25E2%2580%25B2-triphosphate%2520binding%2520site%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520domain%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3482%26epage%3D3487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Bridges, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cody, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rewcastle, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMichael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Showalter, H. D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors. 8. An unusually steep structureâactivity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">39</span> <span class="NLM_fpage">267</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9503613" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=267-276&author=A.+J.+Bridgesauthor=H.+Zhouauthor=D.+R.+Codyauthor=G.+W.+Rewcastleauthor=A.+McMichaelauthor=H.+D.+H.+Showalterauthor=D.+W.+Fryauthor=A.+J.+Krakerauthor=W.+A.+Denny&title=Tyrosine+kinase+inhibitors.+8.+An+unusually+steep+structure%E2%88%92activity+relationship+for+analogues+of+4-%283-bromoanilino%29-6%2C7-dimethoxyquinazoline+%28PD+153035%29%2C+a+potent+inhibitor+of+the+epidermal+growth+factor+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm9503613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9503613%26sid%3Dliteratum%253Aachs%26aulast%3DBridges%26aufirst%3DA.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DCody%26aufirst%3DD.%2BR.%26aulast%3DRewcastle%26aufirst%3DG.%2BW.%26aulast%3DMcMichael%26aufirst%3DA.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26atitle%3DTyrosine%2520kinase%2520inhibitors.%25208.%2520An%2520unusually%2520steep%2520structure%25E2%2588%2592activity%2520relationship%2520for%2520analogues%2520of%25204-%25283-bromoanilino%2529-6%252C7-dimethoxyquinazoline%2520%2528PD%2520153035%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D267%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Gazit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levitzki, A.</span><span> </span><span class="NLM_article-title">Tyrphostins IV: highly potent inhibitors of EGF receptor kinase. Structureâactivity relationship study of 4-anilinoquinazolines</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">1203</span> <span class="NLM_lpage">1207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1996&pages=1203-1207&author=A.+Gazitauthor=J.+Chenauthor=H.+Appauthor=G.+McMahonauthor=P.+Hirthauthor=I.+Chenauthor=A.+Levitzki&title=Tyrphostins+IV%3A+highly+potent+inhibitors+of+EGF+receptor+kinase.+Structure%E2%88%92activity+relationship+study+of+4-anilinoquinazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGazit%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DI.%26aulast%3DLevitzki%26aufirst%3DA.%26atitle%3DTyrphostins%2520IV%253A%2520highly%2520potent%2520inhibitors%2520of%2520EGF%2520receptor%2520kinase.%2520Structure%25E2%2588%2592activity%2520relationship%2520study%2520of%25204-anilinoquinazolines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1996%26volume%3D4%26spage%3D1203%26epage%3D1207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span> </span><span class="NLM_article-title">MPC-6827: A small molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">67</span> <span class="NLM_fpage">5865</span> <span class="NLM_lpage">5871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=5865-5871&author=S.+Kasibhatlaauthor=V.+Baichwalauthor=S.+X.+Caiauthor=B.+Rothauthor=I.+Skvortsovaauthor=S.+Skvortsovauthor=P.+Lukasauthor=N.+M.+Englishauthor=N.+Sirisomaauthor=J.+Dreweauthor=A.+Pervinauthor=B.+Tsengauthor=R.+O.+Carlsonauthor=C.+M.+Pleiman&title=MPC-6827%3A+A+small+molecule+inhibitor+of+microtubule+formation+that+is+not+a+substrate+for+multidrug+resistance+pumps"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSkvortsova%26aufirst%3DI.%26aulast%3DSkvortsov%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DP.%26aulast%3DEnglish%26aufirst%3DN.%2BM.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26atitle%3DMPC-6827%253A%2520A%2520small%2520molecule%2520inhibitor%2520of%2520microtubule%2520formation%2520that%2520is%2520not%2520a%2520substrate%2520for%2520multidrug%2520resistance%2520pumps%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D5865%26epage%3D5871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wood, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennisi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alligood, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusnak, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L.</span><span> </span><span class="NLM_article-title">A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">64</span> <span class="NLM_fpage">6652</span> <span class="NLM_lpage">6659</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1158%2F0008-5472.CAN-04-1168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=15374980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6652-6659&author=E.+R.+Woodauthor=A.+T.+Truesdaleauthor=O.+B.+McDonaldauthor=D.+Yuanauthor=A.+Hassellauthor=S.+H.+Dickersonauthor=B.+Ellisauthor=C.+Pennisiauthor=E.+Horneauthor=K.+Lackeyauthor=K.+J.+Alligoodauthor=D.+W.+Rusnakauthor=T.+M.+Gilmerauthor=L.+Shewchuk&title=A+unique+structure+for+epidermal+growth+factor+receptor+bound+to+GW572016+%28Lapatinib%29%3A+relationships+among+protein+conformation%2C+inhibitor+off-rate%2C+and+receptor+activity+in+tumor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells</span></div><div class="casAuthors">Wood, Edgar R.; Truesdale, Anne T.; McDonald, Octerloney B.; Yuan, Derek; Hassell, Anne; Dickerson, Scott H.; Ellis, Byron; Pennisi, Christopher; Horne, Earnest; Lackey, Karen; Alligood, Krystal J.; Rusnak, David W.; Gilmer, Tona M.; Shewchuk, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6652-6659</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">GW572016 (Lapatinib) is a tyrosine kinase inhibitor in clin. development for cancer that is a potent dual inhibitor of epidermal growth factor receptor (EGFR, ErbB-1) and ErbB-2.  The authors detd. the crystal structure of EGFR bound to GW572016.  The compd. is bound to an inactive-like conformation of EGFR that is very different from the active-like structure bound by the selective EGFR inhibitor OSI-774 (Tarceva) described previously.  Surprisingly, the authors found that GW572016 has a very slow off-rate from the purified intracellular domains of EGFR and ErbB-2 compared with OSI-774 and another EGFR selective inhibitor, ZD-1839 (Iressa).  Treatment of tumor cells with these inhibitors results in down-regulation of receptor tyrosine phosphorylation.  The authors evaluated the duration of the drug effect after washing away free compd. and found that the rate of recovery of receptor phosphorylation in the tumor cells reflected the inhibitor off-rate from the purified intracellular domain.  The slow off-rate of GW572016 correlates with a prolonged down-regulation of receptor tyrosine phosphorylation in tumor cells.  The differences in the off-rates of these drugs and the ability of GW572016 to inhibit ErbB-2 can be explained by the enzyme-inhibitor structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXjJPy6XYk4rVg90H21EOLACvtfcHk0ljLmyGvXQ2iRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFOlu7g%253D&md5=788d92fc5db9f1ecf9d3fbf3142e5c9f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1168%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DE.%2BR.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26aulast%3DMcDonald%26aufirst%3DO.%2BB.%26aulast%3DYuan%26aufirst%3DD.%26aulast%3DHassell%26aufirst%3DA.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DEllis%26aufirst%3DB.%26aulast%3DPennisi%26aufirst%3DC.%26aulast%3DHorne%26aufirst%3DE.%26aulast%3DLackey%26aufirst%3DK.%26aulast%3DAlligood%26aufirst%3DK.%2BJ.%26aulast%3DRusnak%26aufirst%3DD.%2BW.%26aulast%3DGilmer%26aufirst%3DT.%2BM.%26aulast%3DShewchuk%26aufirst%3DL.%26atitle%3DA%2520unique%2520structure%2520for%2520epidermal%2520growth%2520factor%2520receptor%2520bound%2520to%2520GW572016%2520%2528Lapatinib%2529%253A%2520relationships%2520among%2520protein%2520conformation%252C%2520inhibitor%2520off-rate%252C%2520and%2520receptor%2520activity%2520in%2520tumor%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6652%26epage%3D6659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Stamos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliwkowski, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span> </span><span class="NLM_article-title">Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_year" style="font-weight: bold;">2002</span> <span class="NLM_volume">277</span> <span class="NLM_fpage">46265</span> <span class="NLM_lpage">46272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1074%2Fjbc.M207135200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=12196540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKhsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=46265-46272&author=J.+Stamosauthor=M.+X.+Sliwkowskiauthor=C.+Eigenbrot&title=Structure+of+the+epidermal+growth+factor+receptor+kinase+domain+alone+and+in+complex+with+a+4-anilinoquinazoline+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor</span></div><div class="casAuthors">Stamos, Jennifer; Sliwkowski, Mark X.; Eigenbrot, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">46265-46272</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been detd. to 2.6-Ã resoln., both with and without an EGFRK-specific inhibitor currently in Phase III clin. trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva).  The EGFR family members are distinguished from all other known receptor tyrosine kinases in possessing constitutive kinase activity without a phosphorylation event within their kinase domains.  Despite its lack of phosphorylation, we find that the EGFRK activation loop adopts a conformation similar to that of the phosphorylated active form of the kinase domain from the insulin receptor.  Surprisingly, key residues of a putative dimerization motif lying between the EGFRK domain and carboxyl-terminal substrate docking sites are found in close contact with the kinase domain.  Significant intermol. contacts involving the carboxyl-terminal tail are discussed with respect to receptor oligomerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsObp1WYFaC7Vg90H21EOLACvtfcHk0ljLmyGvXQ2iRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKhsL4%253D&md5=c63c60b93756bd45fb2375c56ba38941</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M207135200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M207135200%26sid%3Dliteratum%253Aachs%26aulast%3DStamos%26aufirst%3DJ.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26aulast%3DEigenbrot%26aufirst%3DC.%26atitle%3DStructure%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520kinase%2520domain%2520alone%2520and%2520in%2520complex%2520with%2520a%25204-anilinoquinazoline%2520inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D46265%26epage%3D46272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Shewchuk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisely, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocque, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuyper, L. F.</span><span> </span><span class="NLM_article-title">Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2000</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">133</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990401t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=133-138&author=L.+Shewchukauthor=A.+Hassellauthor=B.+Wiselyauthor=W.+Rocqueauthor=W.+Holmesauthor=J.+Vealauthor=L.+F.+Kuyper&title=Binding+mode+of+the+4-anilinoquinazoline+class+of+protein+kinase+inhibitor%3A+X-ray+crystallographic+studies+of+4-anilinoquinazolines+bound+to+cyclin-dependent+kinase+2+and+p38+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm990401t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990401t%26sid%3Dliteratum%253Aachs%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DHassell%26aufirst%3DA.%26aulast%3DWisely%26aufirst%3DB.%26aulast%3DRocque%26aufirst%3DW.%26aulast%3DHolmes%26aufirst%3DW.%26aulast%3DVeal%26aufirst%3DJ.%26aulast%3DKuyper%26aufirst%3DL.%2BF.%26atitle%3DBinding%2520mode%2520of%2520the%25204-anilinoquinazoline%2520class%2520of%2520protein%2520kinase%2520inhibitor%253A%2520X-ray%2520crystallographic%2520studies%2520of%25204-anilinoquinazolines%2520bound%2520to%2520cyclin-dependent%2520kinase%25202%2520and%2520p38%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D133%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Myers, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setzer, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spada, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persons, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, C. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zulli, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheney, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zilberstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franks, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, K. J.</span><span> </span><span class="NLM_article-title">The synthesis and SAR of new 4-(<i>N</i>-alkyl-<i>N</i>-phenyl)amino-6,7-dimethoxyquinazolines and 4-(<i>N</i>-alkyl-<i>N</i>-phenyl)aminopyrazolo[3,4-<i>d</i>]pyrimidines, inhibitors of CSF-1R tyrosine kinase activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">421</span> <span class="NLM_lpage">424</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=421-424&author=M.+R.+Myersauthor=N.+N.+Setzerauthor=A.+P.+Spadaauthor=P.+E.+Personsauthor=C.+Q.+Lyauthor=M.+P.+Maguireauthor=A.+L.+Zulliauthor=D.+L.+Cheneyauthor=A.+Zilbersteinauthor=S.+E.+Johnsonauthor=C.+F.+Franksauthor=K.+J.+Mitchell&title=The+synthesis+and+SAR+of+new+4-%28N-alkyl-N-phenyl%29amino-6%2C7-dimethoxyquinazolines+and+4-%28N-alkyl-N-phenyl%29aminopyrazolo%5B3%2C4-d%5Dpyrimidines%2C+inhibitors+of+CSF-1R+tyrosine+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DM.%2BR.%26aulast%3DSetzer%26aufirst%3DN.%2BN.%26aulast%3DSpada%26aufirst%3DA.%2BP.%26aulast%3DPersons%26aufirst%3DP.%2BE.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DMaguire%26aufirst%3DM.%2BP.%26aulast%3DZulli%26aufirst%3DA.%2BL.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DZilberstein%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DS.%2BE.%26aulast%3DFranks%26aufirst%3DC.%2BF.%26aulast%3DMitchell%26aufirst%3DK.%2BJ.%26atitle%3DThe%2520synthesis%2520and%2520SAR%2520of%2520new%25204-%2528N-alkyl-N-phenyl%2529amino-6%252C7-dimethoxyquinazolines%2520and%25204-%2528N-alkyl-N-phenyl%2529aminopyrazolo%255B3%252C4-d%255Dpyrimidines%252C%2520inhibitors%2520of%2520CSF-1R%2520tyrosine%2520kinase%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D421%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Antonello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morroni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrelia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multitarget-directed drug design strategy: A novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">6642</span> <span class="NLM_lpage">6645</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608762" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6642-6645&author=A.+Antonelloauthor=A.+Tarozziauthor=F.+Morroniauthor=A.+Cavalliauthor=M.+Rosiniauthor=P.+Hreliaauthor=M.+L.+Bolognesiauthor=C.+Melchiorre&title=Multitarget-directed+drug+design+strategy%3A+A+novel+molecule+designed+to+block+epidermal+growth+factor+receptor+%28EGFR%29+and+to+exert+proapoptotic+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0608762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608762%26sid%3Dliteratum%253Aachs%26aulast%3DAntonello%26aufirst%3DA.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DMorroni%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DHrelia%26aufirst%3DP.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMultitarget-directed%2520drug%2520design%2520strategy%253A%2520A%2520novel%2520molecule%2520designed%2520to%2520block%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520to%2520exert%2520proapoptotic%2520effects%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6642%26epage%3D6645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Sapra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehlig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malaby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraft, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberger, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horak, I. D.</span><span> </span><span class="NLM_article-title">Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">14</span> <span class="NLM_fpage">1888</span> <span class="NLM_lpage">1896</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1158%2F1078-0432.CCR-07-4456" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=18347192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtleis7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1888-1896&author=P.+Sapraauthor=H.+Zhaoauthor=M.+Mehligauthor=J.+Malabyauthor=P.+Kraftauthor=C.+Longleyauthor=L.+M.+Greenbergerauthor=I.+D.+Horak&title=Novel+delivery+of+SN38+markedly+inhibits+tumor+growth+in+xenografts%2C+including+a+camptothecin-11-refractory+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Delivery of SN38 Markedly Inhibits Tumor Growth in Xenografts, Including a Camptothecin-11-Refractory Model</span></div><div class="casAuthors">Sapra, Puja; Zhao, Hong; Mehlig, Mary; Malaby, Jennifer; Kraft, Patricia; Longley, Clifford; Greenberger, Lee M.; Horak, Ivan D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1888-1896</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Clin. development of SN38, the active metabolite of camptothecin-11 (CPT-11), has been hampered due to its poor soly.  We have developed a novel polymer-drug conjugate, EZN-2208, made by linking SN38 with a multiarm polyethylene glycol via a glycine linker.  Exptl. Design: The in vitro cytotoxicity of EZN-2208 was tested using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay.  The therapeutic efficacy of EZN-2208 was evaluated in various xenografts, including an in vivo-selected CPT-11-refractory model.  Tumor and blood concn. of EZN-2208, CPT-11, and SN38 was detd. by high-performance liq. chromatog.  Results: In vitro, EZN-2208 was 10- to 245-fold more potent than CPT-11 in a panel of human tumor cell lines.  In xenograft models of MX-1 breast, MiaPaCa-2 pancreatic, or HT-29 colon carcinoma, treatment with either a single dose or multiple injections of EZN-2208 was more efficacious (and in some cases produced tumor eradication for >16 wk) compared with CPT-11 at their resp. max. tolerated doses or corresponding dose levels (P < 0.01).  Most interestingly, EZN-2208 showed marked antitumor activity in animals that developed resistance to an 8-day course of CPT-11 treatment, as well as outperformed CPT-11 as second-round therapy in mice initially sensitive to CPT-11.  EZN-2208 had prolonged circulation in the blood compared with CPT-11, resulting in high tumor exposure.  This resulted in higher and longer-lasting tumor exposure of free SN38 in mice given EZN-2208 compared with those given CPT-11.  Conclusions: Preclin. data suggest that EZN-2208 may be a promising anticancer agent in a wide variety of clin. settings, including tumors refractory to CPT-11 treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph4l3Uv3BN4LVg90H21EOLACvtfcHk0ljT0DHIPGovvg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtleis7s%253D&md5=0d18ceb4c67434798d9f07d19d611352</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4456%26sid%3Dliteratum%253Aachs%26aulast%3DSapra%26aufirst%3DP.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMehlig%26aufirst%3DM.%26aulast%3DMalaby%26aufirst%3DJ.%26aulast%3DKraft%26aufirst%3DP.%26aulast%3DLongley%26aufirst%3DC.%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DHorak%26aufirst%3DI.%2BD.%26atitle%3DNovel%2520delivery%2520of%2520SN38%2520markedly%2520inhibits%2520tumor%2520growth%2520in%2520xenografts%252C%2520including%2520a%2520camptothecin-11-refractory%2520model%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D1888%26epage%3D1896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Wada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jinno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, K.</span><span> </span><span class="NLM_article-title">Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">27</span> <span class="NLM_fpage">1431</span> <span class="NLM_lpage">1435</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17595758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFynsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=1431-1435&author=M.+Wadaauthor=H.+Jinnoauthor=M.+Uedaauthor=T.+Ikedaauthor=M.+Kitajimaauthor=T.+Konnoauthor=J.+Watanabeauthor=K.+Ishihara&title=Efficacy+of+an+MPC-BMA+co-polymer+as+a+nanotransporter+for+paclitaxel"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel</span></div><div class="casAuthors">Wada, Masahiro; Jinno, Hiromitsu; Ueda, Masakazu; Ikeda, Tadashi; Kitajima, Masaki; Konno, Tomohiro; Watanabe, Junji; Ishihara, Kazuhiko</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3B</span>),
    <span class="NLM_cas:pages">1431-1435</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Paclitaxel (PTX) is administered as a soln. in polyoxyethylated castor oil (CO) due to its low water soly., but solvent-induced side-effects may be severe.  PMB30W is a co-polymer of 2-methacryloyloxyethyl phosphorylcholine (MPC) and Bu methacrylate (BMA).  Cytotoxicities of PTX in PMB30W (PTX-PMB30W) were examd. in cell culture and in vivo.  PTX-PMB30W and PTX in DMSO showed similar toxicity in breast cancer cell lines MCF-7, SK-BR-3 and MX-1.  Antitumor efficacies of PTX-PMB30W and PTX in CO (PTX-CO) were similar following weekly i.p. administration of 50 mg/kg PTX in nude mice transplanted with MX-1 cells.  At 200 mg/kg PTX, all animals died within 1 min of PTX-CO administration.  However, all animals receiving PTX-PBM30W survived.  Ulceration occurred following s.c. injection of PTX-CO, but injection of PTX-PMB30W did not cause skin changes.  Our data suggest that PMB30W can act as an effective PTX nanotransporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVuM-RYUsLZLVg90H21EOLACvtfcHk0ljT0DHIPGovvg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFynsrc%253D&md5=4f8e6f3b290ffd4b9f263a7d8d9c4523</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWada%26aufirst%3DM.%26aulast%3DJinno%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DT.%26aulast%3DKitajima%26aufirst%3DM.%26aulast%3DKonno%26aufirst%3DT.%26aulast%3DWatanabe%26aufirst%3DJ.%26aulast%3DIshihara%26aufirst%3DK.%26atitle%3DEfficacy%2520of%2520an%2520MPC-BMA%2520co-polymer%2520as%2520a%2520nanotransporter%2520for%2520paclitaxel%26jtitle%3DAnticancer%2520Res.%26date%3D2007%26volume%3D27%26spage%3D1431%26epage%3D1435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Deeken, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loscher, W.</span><span> </span><span class="NLM_article-title">The bloodâbrain barrier and cancer: transporters, treatment, and Trojan horses</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">1663</span> <span class="NLM_lpage">1674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1158%2F1078-0432.CCR-06-2854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17363519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1663-1674&author=J.+F.+Deekenauthor=W.+Loscher&title=The+blood%E2%88%92brain+barrier+and+cancer%3A+transporters%2C+treatment%2C+and+Trojan+horses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses</span></div><div class="casAuthors">Deeken, John F.; Loescher, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1663-1674</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Despite scientific advances in understanding the causes and treatment of human malignancy, a persistent challenge facing basic and clin. investigators is how to adequately treat primary and metastatic brain tumors.  The blood-brain barrier is a physiol. obstruction to the delivery of systemic chemotherapy to the brain parenchyma and central nervous system (CNS).  A no. of physiol. properties make the endothelium in the CNS distinct from the vasculature found in the periphery.  Recent evidence has shown that a crit. aspect of this barrier is composed of xenobiotic transporters which extrude substrates from the brain into the cerebrospinal fluid and systemic circulation.  These transporters also extrude drugs and toxins if they gain entry into the cytoplasm of brain endothelial cells before they enter the brain.  This review highlights the properties of the blood-brain barrier, including the location, function, and relative importance of the drug transporters that maintain this barrier.  Primary and metastatic brain malignancy can compromise this barrier, allowing some access of chemotherapy treatment to reach the tumor.  The responsiveness of brain tumors to systemic treatment found in past clin. research is discussed, as are possible explanations as to why CNS tumors are nonetheless able to evade therapy.  Finally, strategies to overcome this barrier and better deliver chemotherapy into CNS tumors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxa44seefNF7Vg90H21EOLACvtfcHk0ljT0DHIPGovvg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D&md5=dc7ea92d49779b99871f98a5e2b59858</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2854%26sid%3Dliteratum%253Aachs%26aulast%3DDeeken%26aufirst%3DJ.%2BF.%26aulast%3DLoscher%26aufirst%3DW.%26atitle%3DThe%2520blood%25E2%2588%2592brain%2520barrier%2520and%2520cancer%253A%2520transporters%252C%2520treatment%252C%2520and%2520Trojan%2520horses%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1663%26epage%3D1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structureâbrain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">49</span> <span class="NLM_fpage">7559</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure%E2%88%92brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure%25E2%2588%2592brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Broniscer, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panetta, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShaughnessy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajjar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. F.</span><span> </span><span class="NLM_article-title">Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">1511</span> <span class="NLM_lpage">1515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm8003653&amp;key=10.1158%2F1078-0432.CCR-06-2372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm8003653&amp;key=17332296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm8003653&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlSjt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1511-1515&author=A+Broniscerauthor=J.+C.+Panettaauthor=M.+O%E2%80%99Shaughnessyauthor=C.+Fragaauthor=F.+Baiauthor=M.+J.+Krasinauthor=A.+Gajjarauthor=C.+F.+Stewart&title=Plasma+and+cerebrospinal+fluid+pharmacokinetics+of+erlotinib+and+its+active+metabolite+OSI-420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420</span></div><div class="casAuthors">Broniscer, Alberto; Panetta, John C.; O'Shaughnessy, Melinda; Fraga, Charles; Bai, Feng; Krasin, Matthew J.; Gajjar, Amar; Stewart, Clinton F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1511-1515</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To report cerebrospinal fluid (CSF) penetration of erlotinib and its metabolite OSI-420.  Pharmacokinetic measurements were done in plasma (days 1, 2, 3, and 8 of therapy) and, concurrently, in plasma and CSF (before and at 1, 2, 4, 8, and 24 h after dose on day 34 of therapy) in an 8-yr-old patient diagnosed with glioblastoma who received local irradn. and oral erlotinib in a phase I protocol.  CSF samples were collected from a ventriculoperitoneal shunt, which was externalized because of infection.  Erlotinib concns. were detd. by liq. chromatog./mass spectrometry.  CSF penetration of erlotinib and OSI-420 were estd. by a compartmental model and by calcg. the ratio of CSF to plasma 24-h area under concn.-time curve (AUC0-24).  This patient was assigned to receive erlotinib at a dose level of 70 mg/m2, but the actual daily dose was 75 mg (78 mg/m2).  Erlotinib and OSI-420 plasma pharmacokinetic variables on days 8 and 34 overlapped to suggest that steady state had been reached.  Whereas erlotinib and OSI-420 AUC0-24 in plasma on day 34 were 30,365 and 2,527 ng h/mL, resp., the correspondent AUC0-24 in the CSF were 2,129 and 240 ng h/mL, resp.  Erlotinib and OSI-420 CSF penetration were 7% and â¼9%, resp., using both est. methods.  The max. steady-state CSF concn. of erlotinib was â¼130 ng/mL (325 nmol/L).  The plasma pharmacokinetics of erlotinib in this child overlapped with results described in adults.  Oral administration of erlotinib achieves CSF concns. comparable with those active against several cancer cell lines in preclin. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoldU23ij5mgLVg90H21EOLACvtfcHk0ljxeIw_zRxkoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlSjt7Y%253D&md5=9b1e3b0a3d448075085ee7fd38ca635e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2372%26sid%3Dliteratum%253Aachs%26aulast%3DBroniscer%26aufirst%3DA%26aulast%3DPanetta%26aufirst%3DJ.%2BC.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DM.%26aulast%3DFraga%26aufirst%3DC.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DKrasin%26aufirst%3DM.%2BJ.%26aulast%3DGajjar%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26atitle%3DPlasma%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520erlotinib%2520and%2520its%2520active%2520metabolite%2520OSI-420%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1511%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a href="/doi/suppl/10.1021/jm8003653">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_05788"></div></div></div></div></div><hr /></hr><p class="last">Table of elemental analysis and HPLC data for the targeted compounds <b>2b</b>â<b>2w</b> and <b>6a</b>â<b>6b</b>. Also included are experimentals for intermediates <b>6c</b>â<b>6h</b> and <b>6j</b>, procedures for caspase activation assay, growth inhibition assay, tubulin inhibition assay, colchicine binding competition assays as well as MX-1 and PC-3 tumor model studies of <b>2b</b>, and determination of brain/plasma AUC ratio of <b>2b</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm8003653/suppl_file/jm8003653-file003.pdf">jm8003653-file003.pdf (133.86 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm8003653&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm8003653%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-15%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm8003653" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                150KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799e66cee7c1929","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
